
<html lang="en"     class="pb-page"  data-request-id="618f668a-08e0-418e-9b55-910de79b76dc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b00609;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-19;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target" /></meta><meta name="dc.Creator" content="Gabrielle M.  Watson" /></meta><meta name="dc.Creator" content="Menachem J.  Gunzburg" /></meta><meta name="dc.Creator" content="Nigus D.  Ambaye" /></meta><meta name="dc.Creator" content="William A. H.  Lucas" /></meta><meta name="dc.Creator" content="Daouda A.  Traore" /></meta><meta name="dc.Creator" content="Ketav  Kulkarni" /></meta><meta name="dc.Creator" content="Katie M.  Cergol" /></meta><meta name="dc.Creator" content="Richard J.  Payne" /></meta><meta name="dc.Creator" content="Santosh  Panjikar" /></meta><meta name="dc.Creator" content="Stephanie C.  Pero" /></meta><meta name="dc.Creator" content="Patrick  Perlmutter" /></meta><meta name="dc.Creator" content="Matthew C. J.  Wilce" /></meta><meta name="dc.Creator" content="Jacqueline A.  Wilce" /></meta><meta name="dc.Description" content="The Grb7 adaptor protein is a therapeutic target for both TNBC and HER2+ breast cancer. A nonphosphorylated cyclic peptide 1 (known as G7–18NATE) inhibits Grb7 via targeting the Grb7-SH2 domain, bu..." /></meta><meta name="Description" content="The Grb7 adaptor protein is a therapeutic target for both TNBC and HER2+ breast cancer. A nonphosphorylated cyclic peptide 1 (known as G7–18NATE) inhibits Grb7 via targeting the Grb7-SH2 domain, bu..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 23, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00609" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00609" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00609" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00609" /></link>
        
    
    

<title>Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00609" /></meta><meta property="og:title" content="Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0006.jpeg" /></meta><meta property="og:description" content="The Grb7 adaptor protein is a therapeutic target for both TNBC and HER2+ breast cancer. A nonphosphorylated cyclic peptide 1 (known as G7–18NATE) inhibits Grb7 via targeting the Grb7-SH2 domain, but requires the presence of phosphate ions for both affinity and specificity. Here we report the discovery of malonate bound in the phosphotyrosine binding pocket of the apo-Grb7-SH2 structure. Based on this, we carried out the rational design and synthesis of two analogues of peptide 1 that incorporate carboxymethylphenylalanine (cmF) and carboxyphenylalanine (cF) as mimics of phosphotyrosine (pY). Binding studies using SPR confirmed that affinity for Grb7-SH2 domain is improved up to 9-fold over peptide 1 under physiological phosphate conditions (KD = 2.1–5.7 μM) and that binding is specific for Grb7-SH2 over closely related domains (low or no detectable binding to Grb2-SH2 and Grb10-SH2). X-ray crystallographic structural analysis of the analogue bearing a cmF moiety in complex with Grb7-SH2 has identified the precise contacts conferred by the pY mimic that underpin this improved molecular interaction. Together this study identifies and characterizes the tightest specific inhibitor of Grb7 to date, representing a significant development toward a new Grb7-targeted therapeutic." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00609"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00609">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00609&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00609&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00609&amp;href=/doi/10.1021/acs.jmedchem.5b00609" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 7707-7718</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00596" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00612" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabrielle+M.++Watson">Gabrielle M. Watson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Menachem+J.++Gunzburg">Menachem J. Gunzburg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nigus+D.++Ambaye">Nigus D. Ambaye</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+A.+H.++Lucas">William A. H. Lucas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daouda+A.++Traore">Daouda A. Traore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ketav++Kulkarni">Ketav Kulkarni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katie+M.++Cergol">Katie M. Cergol</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+J.++Payne">Richard J. Payne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Santosh++Panjikar">Santosh Panjikar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephanie+C.++Pero">Stephanie C. Pero</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Perlmutter">Patrick Perlmutter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+C.+J.++Wilce">Matthew C. J. Wilce</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacqueline+A.++Wilce">Jacqueline A. Wilce</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1a"><span class="aff-text"><sup>†</sup>Department of Biochemistry and Molecular Biology and <sup>‡</sup>School of Chemistry, Monash University, Melbourne, Victoria 3800, Australia</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Australian Synchrotron, 800 Blackburn Road, Clayton, Victoria 3168, Australia</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Surgery and Vermont Cancer Center, University of Vermont, Burlington, Vermont 05401, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#d9b3b8bab2b0bcf7aeb0b5babc99b4b6b7b8aab1f7bcbdac"><span class="__cf_email__" data-cfemail="412b20222a28246f36282d2224012c2e2f2032296f242534">[email protected]</span></a>. Phone: + 613 9902 9226. Fax: + 613 9902 9500.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00609&amp;href=/doi/10.1021%2Facs.jmedchem.5b00609" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 7707–7718</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 11, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 April 2015</li><li><span class="item_label"><b>Published</b> online</span>23 September 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 October 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00609" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00609</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7707%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGabrielle%2BM.%2BWatson%252C%2BMenachem%2BJ.%2BGunzburg%252C%2BNigus%2BD.%2BAmbaye%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D19%26contentID%3Dacs.jmedchem.5b00609%26title%3DCyclic%2BPeptides%2BIncorporating%2BPhosphotyrosine%2BMimetics%2Bas%2BPotent%2Band%2BSpecific%2BInhibitors%2Bof%2Bthe%2BGrb7%2BBreast%2BCancer%2BTarget%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7718%26publicationDate%3DOctober%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00609"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2025</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00609" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gabrielle&quot;,&quot;last_name&quot;:&quot;M. Watson&quot;},{&quot;first_name&quot;:&quot;Menachem&quot;,&quot;last_name&quot;:&quot;J. Gunzburg&quot;},{&quot;first_name&quot;:&quot;Nigus&quot;,&quot;last_name&quot;:&quot;D. Ambaye&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;A. H. Lucas&quot;},{&quot;first_name&quot;:&quot;Daouda&quot;,&quot;last_name&quot;:&quot;A. Traore&quot;},{&quot;first_name&quot;:&quot;Ketav&quot;,&quot;last_name&quot;:&quot;Kulkarni&quot;},{&quot;first_name&quot;:&quot;Katie&quot;,&quot;last_name&quot;:&quot;M. Cergol&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;J. Payne&quot;},{&quot;first_name&quot;:&quot;Santosh&quot;,&quot;last_name&quot;:&quot;Panjikar&quot;},{&quot;first_name&quot;:&quot;Stephanie&quot;,&quot;last_name&quot;:&quot;C. Pero&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Perlmutter&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;C. J. Wilce&quot;},{&quot;first_name&quot;:&quot;Jacqueline&quot;,&quot;last_name&quot;:&quot;A. Wilce&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;7707-7718&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00609&quot;},&quot;abstract&quot;:&quot;The Grb7 adaptor protein is a therapeutic target for both TNBC and HER2+ breast cancer. A nonphosphorylated cyclic peptide 1 (known as G7–18NATE) inhibits Grb7 via targeting the Grb7-SH2 domain, but requires the presence of phosphate ions for both affinity and specificity. Here we report the discovery of malonate bound in the phosphotyrosine binding pocket of the apo-Grb7-SH2 structure. Based on this, we carried out the rational design and synthesis of two analogues of peptide 1 that incorporate carboxymethylphenylalanine (cmF) and carboxyphenylalanine (cF) as mimics of phosphotyrosine (pY). Binding studies using SPR confirmed that affinity for Grb7-SH2 domain is improved up to 9-fold over peptide 1 under physiological phosphate conditions (KD = 2.1–5.7 μM) and that binding is specific for Grb7-SH2 over closely related domains (low or no detectable binding to Grb2-SH2 and Grb10-SH2). X-ray crystallographic structural analysis of the analogue bearing a cmF moiety in complex with Grb7-SH2 has identified the pre&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00609&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00609" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00609&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00609" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00609&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00609" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00609&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00609&amp;href=/doi/10.1021/acs.jmedchem.5b00609" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00609" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00609" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00609%26sid%3Dliteratum%253Aachs%26pmid%3D26359549%26genre%3Darticle%26aulast%3DWatson%26date%3D2015%26atitle%3DCyclic%2BPeptides%2BIncorporating%2BPhosphotyrosine%2BMimetics%2Bas%2BPotent%2Band%2BSpecific%2BInhibitors%2Bof%2Bthe%2BGrb7%2BBreast%2BCancer%2BTarget%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D19%26spage%3D7707%26epage%3D7718%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290672" title="Phosphates">Phosphates</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/jmcmar.2015.58.issue-19/20151008/jmcmar.2015.58.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/medium/jm-2015-006095_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00609&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The Grb7 adaptor protein is a therapeutic target for both TNBC and HER2+ breast cancer. A nonphosphorylated cyclic peptide <b>1</b> (known as G7–18NATE) inhibits Grb7 via targeting the Grb7-SH2 domain, but requires the presence of phosphate ions for both affinity and specificity. Here we report the discovery of malonate bound in the phosphotyrosine binding pocket of the apo-Grb7-SH2 structure. Based on this, we carried out the rational design and synthesis of two analogues of peptide <b>1</b> that incorporate carboxymethylphenylalanine (cmF) and carboxyphenylalanine (cF) as mimics of phosphotyrosine (pY). Binding studies using SPR confirmed that affinity for Grb7-SH2 domain is improved up to 9-fold over peptide <b>1</b> under physiological phosphate conditions (<i>K</i><sub>D</sub> = 2.1–5.7 μM) and that binding is specific for Grb7-SH2 over closely related domains (low or no detectable binding to Grb2-SH2 and Grb10-SH2). X-ray crystallographic structural analysis of the analogue bearing a cmF moiety in complex with Grb7-SH2 has identified the precise contacts conferred by the pY mimic that underpin this improved molecular interaction. Together this study identifies and characterizes the tightest specific inhibitor of Grb7 to date, representing a significant development toward a new Grb7-targeted therapeutic.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40142" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40142" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tumor development and progression into a metastatic and malignant state involves deregulation of signaling pathways governing cell proliferation, migration, and survival.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Key signaling proteins that are aberrantly overexpressed or act at critical junctions in cancer are therefore of interest for their potential as therapeutic targets. The multiadaptor protein Grb7 (growth factor receptor bound protein 7) operates via distinct signaling pathways to induce cell proliferation and migration in the progression of a variety of cancer types including the breast cancer subclasses HER2+ and triple negative breast cancer (TNBC).<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> In HER2+ cell lines, Grb7 is co-overexpressed with HER2, the well-known predictor for a poor prognosis in breast cancer patients, with Grb7 facilitating aberrant proliferative signaling.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> The removal or inhibition of Grb7 has been shown to reduce breast cancer cell viability and increase the activity of anti-HER2 cancer therapeutics.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Grb7 has also been shown to play an important role in the migratory potential of cancer cells.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In both HER2+ and TNBC cell lines, inhibition of Grb7 impairs cell migration and invasion as well as colony growth.<a onclick="showRef(event, 'ref3 ref9'); return false;" href="javascript:void(0);" class="ref ref3 ref9">(3, 9)</a> Furthermore, in a mouse model of pancreatic cancer, Grb7 inhibition reduced cancer cell metastasis.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Clinical investigations have shown that Grb7 overexpression is significantly associated with a higher clinical stage and larger tumor size for patients with breast cancer, and is a significant predictor for reduced cancer-free periods.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Thus, Grb7, which acts at the nexus of both growth and migratory signaling pathways, has been identified as a therapeutic target for the treatment of several cancer types including both HER2+ and TNBC.<a onclick="showRef(event, 'ref3 ref12'); return false;" href="javascript:void(0);" class="ref ref3 ref12">(3, 12)</a></div><div class="NLM_p">Grb7 is a 532 amino acid multidomain protein possessing an N-terminal proline-rich domain, a Ras-associating-like (RA) domain, a pleckstrin homology (PH) domain, and a C-terminal src-homology 2 (SH2) domain. It is through the C-terminal SH2 domain that Grb7 interacts with its upstream receptor tyrosine kinases and other signaling molecules including HER2, HER3, EGFR, and FAK, allowing Grb7 to propagate downstream signaling.<a onclick="showRef(event, 'ref8 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref8 ref13 ref14 ref15">(8, 13-15)</a> It is the SH2 domain, therefore, that has been the target for inhibitor development to date.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> SH2 domains are ∼100 amino acid domains that recognize phosphotyrosine (pY) residues of upstream binding partners with surrounding amino acid residues contributing to substrate specificity.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In the case of the Grb7-SH2 domain (residues 416–532), sequences with a pYXN motif that occur in a turn conformation are preferentially targeted.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> This feature guided the development of a nonphosphorylated cyclic peptide <b>1</b> (termed G7–18NATE), that targets the SH2 domain of Grb7 over closely related Grb2- and Grb14-SH2 domains.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The 11-residue peptide (WFEGYDNTFPC), cyclized via a thioether bond from the N-terminus to the C-terminal thiol side chain of cysteine, binds the Grb7-SH2 domain with micromolar affinity, with a reported equilibrium dissociation constant (<i>K</i><sub>D</sub>) of 347–4.1 μM depending upon the buffer conditions utilized.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> Promisingly, in cellular assays, peptide <b>1</b> conjugated to the cell permeability sequence Penetratin, reduced cell migration in both HER2+ and TNBC cell lines, and showed co-operative effects with the anticancer therapeutics doxorubicin and Herceptin in HER2+ cell lines.<a onclick="showRef(event, 'ref2 ref3 ref7'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref7">(2, 3, 7)</a> The cell permeable peptide <b>1</b> has also been tested in a mouse model of pancreatic cancer, resulting in reduction in the number and size of pancreatic tumors.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Hence, peptide <b>1</b> is a successful peptide for inhibiting Grb7 in breast cancer assays, and a promising starting point for therapeutics targeting TNBC and HER2+ breast cancer.</div><div class="NLM_p">Upon further investigation of the dependence of the peptide <b>1</b> interaction with Grb7-SH2 on the buffer conditions used, the low micromolar binding (<i>K</i><sub>D</sub> = 4 μM) and specificity of peptide <b>1</b> for Grb7 was discovered to only occur in the presence of high concentrations of phosphate (50 mM).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In the absence of phosphate, the affinity of peptide <b>1</b> for the Grb7-SH2 domain was reduced to <i>K</i><sub>D</sub> > 200 μM and selectivity for Grb7-SH2 over Grb2-, Grb10-, and Grb14-SH2 was lost. It was speculated that the phosphate from the buffer was acting at the pY binding pocket of the Grb7-SH2 domain, to stabilize the BC loop at the peptide binding site (note that the nomenclature used is as derived by Eck et al. for SH2 domain secondary structure).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Indeed, a previously reported structure of the apo-Grb7-SH2 domain revealed a sulfate ion bound at this site that appeared to constrain the BC loop in an optimal conformation for peptide binding.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Thus, in order to improve the potential of peptide <b>1</b> for therapeutic use, we predicted that the addition of a negatively charged or electronegative group appended to the inhibitor peptide tyrosine would improve peptide <b>1</b> binding selectivity and affinity under physiological phosphate conditions. Such phosphotyrosine (pY) mimetics have been used in the development of other SH2 domain inhibitors and are favored over pY itself, since the phosphate group would likely render the inhibitor peptide impermeable to cellular membranes and unstable due to constitutive phosphatase activity inside cells and therefore not efficacious in cellular or animal studies.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">Here we report the design, synthesis, and characterization of two peptide <b>1</b> analogues that incorporate carboxylic acid-based phosphotyrosine (pY) mimetics (carboxymethylphenylalanine (cmF) and carboxyphenylalanine (cF)) and show improved binding of these analogues to Grb7-SH2 under physiological conditions. Our choice of pY mimetic was guided by the high-resolution X-ray crystal structure of the Grb7-SH2 domain that was crystallized in the presence of the dicarboxylic acid, malonate. The malonate ion was discovered to reside precisely in the Grb7-SH2 pY binding pocket making similar contacts to surrounding residues as a sulfate or phosphate ion would. This inspired the design and synthesis of cmF peptide analogue <b>2</b> and cF peptide analogue <b>3</b>. The pY mimicking residues within the cyclic peptides would be expected to provide a negative charge for forming interactions in the pY binding pocket at physiological pH, but would neither interfere with the ability of the peptide to cross cell membranes nor compromise in vivo stability of the analogue.</div><div class="NLM_p last">We demonstrate that peptides <b>2</b> and <b>3</b> indeed bind with enhanced affinity to the Grb7-SH2 domain compared with peptide <b>1</b> under physiological phosphate concentrations, and that increased phosphate levels compete with the peptides for Grb7-SH2 domain binding. We also demonstrate that they retain their preferential binding to the Grb7-SH2 domain compared to the SH2 domains of the closely related Grb2 and Grb10. We furthermore report the X-ray crystal structure of cmF bearing analogue <b>2</b> in complex with the Grb7-SH2 domain. This demonstrates the binding mode of peptide <b>2</b> with the target and, in particular, the way in which the cmF group extends into the phosphotyrosine binding cleft forming additional contacts with core binding pocket residues. The cmF and cF containing peptides <b>2</b> and <b>3</b> thus represent the highest affinity inhibitors of Grb7 to date that possess specificity for Grb7 under physiological conditions. Cell permeable forms of these peptides will provide both a powerful tool for studies of Grb7 inhibition in cells and underpin future steps toward the development of a new therapeutic targeted to Grb7 for the treatment of HER2+ and TNBC.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15421" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15421" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Apo-Grb7-SH2 Domain Crystal Structures Reveals Both a Bound Malonate as well as a Truly “apo” SH2 Domain</h3><div class="NLM_p">In the course of our investigation of the Grb7-SH2 domain, we grew high quality crystals of the apoprotein for structure determination using crystallization conditions that included the dicarboxylic acid malonate. The protein crystallization and data collection statistics have been reported previously.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The apo-Grb7-SH2 domain crystal structure was solved to 1.8 Å using molecular replacement with PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QMS">2QMS</a> as the search model. The refinement statistics are provided in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and the coordinates are deposited in the Protein database (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ">4WWQ</a>). Interestingly, the asymmetric unit contains two chains of Grb7-SH2 (residues 421–532 in chain A and 415–532 in chain B visible in the electron density): chain A which contains malonate in the phosphotyrosine binding site, and chain B that contains no ligand and is thus a truly “apo” structure.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of Crystallographic Information</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">data collection</th><th class="colsep0 rowsep0" align="center">Apo Grb7-SH2</th><th class="colsep0 rowsep0" align="center">Grb7-SH2: <b>2</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">wavelength</td><td class="colsep0 rowsep0" align="left">0.954</td><td class="colsep0 rowsep0" align="left">0.954</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">space group</td><td class="colsep0 rowsep0" align="left"><i>P</i>6<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unit cell dimensions</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>a, b, c</i> (Å)</td><td class="colsep0 rowsep0" align="left">83.99 83.99, 75.95</td><td class="colsep0 rowsep0" align="left">55.48, 68.89, 77.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">  α, β, γ (deg)</td><td class="colsep0 rowsep0" align="left">90, 90, 120</td><td class="colsep0 rowsep0" align="left">90, 90, 90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Resolution (Å)</td><td class="colsep0 rowsep0" align="left">28.17–1.80 (1.9–1.8)</td><td class="colsep0 rowsep0" align="left">43.21–2.55 (2.641–2.55)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>merge<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></sub> (%)</td><td class="colsep0 rowsep0" align="left">10.6 (54.9)</td><td class="colsep0 rowsep0" align="left">11.07 (65.92)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I/σI</td><td class="colsep0 rowsep0" align="left">16.7 (4.9)</td><td class="colsep0 rowsep0" align="left">11.71 (3.23)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unique reflections measured</td><td class="colsep0 rowsep0" align="left">28306 (4125)</td><td class="colsep0 rowsep0" align="left">10038 (996)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">completeness (%)</td><td class="colsep0 rowsep0" align="left">100 (100)</td><td class="colsep0 rowsep0" align="left">99.53 (99.80)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">multiplicity</td><td class="colsep0 rowsep0" align="left">11.3 (11.3)</td><td class="colsep0 rowsep0" align="left">8.9 (9.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Refinement</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>work</sub> (%)</td><td class="colsep0 rowsep0" align="left">17.60 (20.49)</td><td class="colsep0 rowsep0" align="left">21.17 (28.31)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>free</sub> (%)</td><td class="colsep0 rowsep0" align="left">20.63 (22.52)</td><td class="colsep0 rowsep0" align="left">25.81 (34.72)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">No. of atoms</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">  protein</td><td class="colsep0 rowsep0" align="left">1809</td><td class="colsep0 rowsep0" align="left">1810</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">  ligand (MLA)</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">  solvent</td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Mean B-factors (Å<sup>2</sup>)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">  protein</td><td class="colsep0 rowsep0" align="left">20.70</td><td class="colsep0 rowsep0" align="left">45.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">  ligand (MLA)</td><td class="colsep0 rowsep0" align="left">15.90</td><td class="colsep0 rowsep0" align="left">52.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">  solvent</td><td class="colsep0 rowsep0" align="left">26.60</td><td class="colsep0 rowsep0" align="left">38.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RMSDs</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">  bond lengths (Å)</td><td class="colsep0 rowsep0" align="left">0.007</td><td class="colsep0 rowsep0" align="left">0.010</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">  bond angles (deg)</td><td class="colsep0 rowsep0" align="left">1.27</td><td class="colsep0 rowsep0" align="left">1.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ramachandran plot (%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">  favored regions</td><td class="colsep0 rowsep0" align="left">98.7</td><td class="colsep0 rowsep0" align="left">98.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">  allowed regions</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last"><i>R</i><sub>merge</sub> = Σ<sub><i>hkl</i></sub> Σ<sub><i>i</i></sub>|<i>I</i><sub><i>i</i></sub>(<i>hkl</i>) - ⟨<i>I</i>(<i>hkl</i>)⟩|/Σ<sub><i>hkl</i></sub> Σ<sub><i>i</i></sub><i>I</i><sub><i>i</i></sub>(<i>hkl</i>). where <i>I</i><sub><i>i</i></sub>(<i>hkl</i>) is the <i>i</i>th intensity measurement of reflection <i>hkl</i>, ⟨<i>I</i>(<i>hkl</i>)⟩ its average. Values given in brackets are for the high resolution shell.</p></div></div></div><div class="NLM_p">The chains both adopt the typical SH2 domain fold, with αββββα topology (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). Each chain is part of a noncovalent dimer with a chain from an adjacent asymmetric unit (chain A from one asymmetric unit to chain B of another). The noncovalent dimer forms through an interface centered on F511 (αB8) as has also been observed in all other crystal structures of Grb7 family member SH2 domains and has also been shown to form in solution.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28-30)</a> Interestingly, chains A and B within the asymmetric unit are also covalently linked through a disulfide bond that occurs between C526 in chain A and C527 in chain B. This occurrence is assumed to be a crystallization artifact and not physiologically relevant, since the cellular environment is reducing, but it may have played a role in stabilizing the crystal and contributed to the quality of the diffraction. It has not been seen previously in crystal forms of the Grb7-SH2 domain.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/medium/jm-2015-006095_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure based rationale for a functionalized peptide 2 derivative. (A) Structural overlay of the 2.4 Å Grb7-SH2:peptide <b>1</b> domain complex (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QMS">2QMS</a>: green sticks and purple cartoon, respectively) and the 1.8 Å apo-Grb7-SH2 structure (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ">4WWQ</a>: blue-white cartoon) with malonic acid (orange sticks) in the pY binding pocket. The inset shows the 2Fo-Fc map surrounding malonic acid contoured at 2σ; (B–E) Detail of the pY binding pocket: (B) Malonic acid bound Grb7-SH2, Chain A PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ">4WWQ</a>; (C) Sulfate bound Grb7-SH2, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QMS">2QMS</a>; (D) Ligand free Grb7-SH2, Chain B PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ">4WWQ</a>; (E) peptide <b>1</b> bound Grb7-SH2, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PQZ">3PQZ</a>. Key amino acids are shown as sticks and hydrogen bonds as dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00609&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The presence of malonate is an outcome of the crystallization condition that contained tacsimate, and it is unsurprising to observe this anion accommodated in the positively charged pY binding pocket. More surprising is the absence of this ligand in the second chain; however, the occurrence of ligand-bound alongside ligand-free protein chains in crystal structures is the result of the protein packing arrangement in which the ligand at one binding site partially occludes the binding site of the adjacent molecule, an occurrence that has been observed previously.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Thus, as well as providing a higher resolution structure for apo-Grb7-SH2 than previously achieved (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QMS">2QMS</a>; 2.1 Å resolution) this structure reveals the way in which a carboxylic acid group can be bound in the pY binding pocket of the Grb7-SH2 domain.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Malonate Mimics Phosphate in the pY Binding Pocket of the Grb7-SH2 Domain</h3><div class="NLM_p last">In chain A of the apo-Grb7-SH2 model, clear electron density allows malonate to be placed unambiguously in the pY binding pocket (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A - inset). The malonate forms ionic interactions and hydrogen bonds with Arg458 (βB5) and Arg438 (αA2) guanidino side chains and the backbone NH of Gln461 (BC1) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). This appears to hold the BC loop (residues 460–466) in a rigid position, similarly to the Grb7-SH2 domain solved with a sulfate ion bound in the pY binding pocket (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QMS">2QMS</a>; the BC loop of the apo-Grb7 SH2 chain A and the BC loop of the 2QMS chain A have a Cα atom RMSD of 0.358 Å.) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In the 2QMS structure the sulfate was engaged in salt bridge interactions with the guanadino side chains of Arg458 (βB5) and Arg462 (BC2), and H-bonding interactions with the Gln461 backbone NH (BC1) and also the Ser460 side chain hydroxyl (βB7). The fact that Arg462 (BC2) is observed to engage the sulfate, but not the malonate ion, is likely an artifact of the malonate-containing crystal form with Arg438 (αA2) of a symmetry-related chain B forming salt bridge interactions with the second carboxylic acid of the malonate instead of Arg462 (BC2). Overall, although there are some differences in the amino acids involved in the interactions, both of these anionic ligands are able to hold the BC loop in a position that is understood to represent the ligand binding conformation.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> pY Binding Site of the apo-Grb7-SH2 Domain Adopts an “Open” Conformation</h3><div class="NLM_p last">In chain B of the apo-Grb7-SH2 domain structure the BC loop adopts an alternative conformation (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>D). With an empty pY binding pocket, the side chains of Arg458 (βB5), Arg462 (BC2), and Ser460 (βB7) are all directed into the solvent, and Arg438 (αA2) forms salt bridge interactions with the symmetry related chain A (explaining why the ligand binding site of chain B is empty). As a consequence, the BC loop adopts a more open structure with a Cα RMSD of 2.503 Å between the chain B BC loop (residues 460–466) compared with the chain A BC loop. This is similar to the peptide <b>1</b> bound form of Grb7-SH2 that contains no anion in the pY site (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PQZ">3PQZ</a>; 2.4 Å resolution), in which these pY binding pocket amino acid residues are not engaged in hydrogen bonding except for Arg438 (αA2) that forms a bond with the backbone carbonyl of G4 of peptide <b>1</b>. (Note that in discussing protein–ligand interactions, the protein will be referred to in three-letter code and the peptide ligand in one-letter code to distinguish them). In this structure the BC loop is also in an “open” configuration and displays some disorder with Asn463 (BC3) not visible in the electron density (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>E).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> cmF and cF residues Are Predicted as pY Mimetics for Grb7-SH2 Inhibition</h3><div class="NLM_p">Thus, the current Grb7-SH2 domain structure reveals that an anionic ligand can form several interactions in the pY binding site. We therefore predicted that either a cmF or cF residue could serve to enhance the binding of peptide <b>1</b> to the Grb7-SH2 domain and this designed peptides <b>2</b> and <b>3</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). CmF has been previously observed to enhance SH2 domain-binding affinity in the case of a Grb2-targeted peptide and cF has also been used to enhance binding to an SH2 domain at the Y+3 position.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> From our structural analysis of the separately determined position of peptide <b>1</b> Y5 and malonate in the pY binding site of the Grb7-SH2 domain we can see that malonate is positioned 2.5 Å beyond the Y5 hydroxyl oxygen at an approximate angle of 130° (as depicted in the superposed structures shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). Thus, a cmF could mimic (or a cF closely mimic) this spatial relationship and potentially enhance the binding of peptide <b>1</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/medium/jm-2015-006095_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures and synthesis of peptide <b>2</b>. Shown is the synthetic pathway used for the preparation of the cmF containing peptide <b>2</b>. The suitably protected carboxymethylphenylalanine building block (<b>4</b>), for incorporation into the peptide target, is highlighted in blue. Also shown, in the inset, are the chemical structures of peptide <b>1</b> and the cF containing peptide <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00609&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Synthesis of Target Cyclic Peptides <b>2</b> and <b>3</b></h3><div class="NLM_p">Based upon this structural information a suitably protected cmF building block, Fmoc-cmF(OMe)-OH <b>4</b>, was synthesized that could be directly incorporated into Fmoc-solid-phase peptide synthesis to serve as a pY mimetic. Specifically, the building block was incorporated into peptide <b>1</b> at the Y5 position resulting in target cyclic peptide <b>2</b>. In this target the thioether linkage and remaining 10 amino acids were unchanged to allow for direct comparison with peptide <b>1</b>. Synthesis of the target amino acid Fmoc-cmF(OMe)-OH <b>4</b>, whereby the side chain carboxylic acid was protected as the corresponding methyl ester, was carried out from Boc-Tyr-O<i>t</i>Bu using slight modifications to a method previously reported by Tilley and co-workers.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Target cyclic peptide <b>2</b> was then prepared using Fmoc-SPPS on a Rink amide resin and subject to N-terminal chloroacetylation after the removal of the N-terminal Fmoc group (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Resin bound hexapeptide <b>5</b> was first assembled using an excess of the commercially available protected amino acids with HBTU and HOBt as the coupling reagents and 20% piperidine in DMF for Fmoc-deprotection. Fmoc-cmF(OMe)-OH <b>4</b> was next coupled using only a slight excess of the building block and coupling reagents to afford resin bound <b>6</b>. From here, elongation of the desired peptide sequence and N-terminal chloroacetylation provided the resin bound peptide <b>7</b>. After cleavage from the resin, thioether cyclization between the N-terminal chloroacetyl moiety and the C-terminal thiol was achieved in aqueous basic conditions to produce peptide <b>8</b> and the methyl ester side chain of the cmF residue was gently saponified using dilute aqueous sodium hydroxide. The target cyclic peptide <b>2</b> was purified by reverse-phase HPLC and produced in a 7% yield based on the original resin loading. The peptide was shown to possess suitable purity (>95%) by LC-MS analysis.</div><div class="NLM_p last">Cyclic peptide <b>3</b>, bearing a cF residue in place of the cmF present in <b>2</b>, was produced using solid-phase peptide synthesis by Wuxi Nordisk Biotech to >95% purity based on LC-MS analysis.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Target Cyclic Peptides <b>2</b> and <b>3</b> Show Enhanced Binding to the Grb7-SH2 Domain under Physiological Phosphate Conditions</h3><div class="NLM_p">Surface plasmon resonance (SPR) was utilized to measure differences in affinity for the Grb7-SH2 domain between peptide <b>1</b> and the target cyclic peptides <b>2</b> and <b>3</b>. GST-fused Grb7-SH2 domain was captured on the chip surface using anti-GST antibodies, as previously established for measuring Grb7-SH2:peptide interactions.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a><a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A shows that peptides <b>1</b>, <b>2</b>, and <b>3</b> each rapidly reach GST-Grb7-SH2 binding equilibrium upon peptide injection. This allows the response at equilibrium to be determined and binding curves constructed for <i>K</i><sub>D</sub> determination by fitting a single-site binding model (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A - bottom right).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/medium/jm-2015-006095_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SPR binding analysis of peptides <b>1</b>, <b>2</b>, and <b>3</b> binding to Grb7-, Grb2-, and Grb10-SH2 domains. (A) Sensorgrams of peptide <b>1</b> (bottom left), peptide <b>2</b> (top left), and peptide <b>3</b> (top right) at varying concentrations binding the Grb7-SH2 domain at 1 mM phosphate concentration, and the corresponding equilibrium binding curves (bottom right). (B) Equilibrium binding curves for peptide <b>2</b> (left) and peptide <b>3</b> (right) binding the Grb7-SH2 domain under buffers containing different concentrations of phosphate. All buffers contained 150 mM NaCl and 1 mM DTT. (C) Equilibrium binding curves for peptide <b>1</b> (right), peptide <b>2</b> (left), and peptide <b>3</b> (center) binding the SH2 domains of Grb7, Grb2, and Grb10 under 1 mM phosphate concentration. Sensorgrams for all experiments are supplied as <a href="/doi/suppl/10.1021/acs.jmedchem.5b00609/suppl_file/jm5b00609_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00609&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a buffer containing 1 mM phosphate at pH 7.4, peptide <b>2</b> bound to Grb7-SH2 with an affinity of <i>K</i><sub>D</sub> = 5.7 μM and peptide <b>3</b> bound to Grb7-SH2 with an affinity of <i>K</i><sub>D</sub> = 2.1 μM. Under the same conditions peptide <b>1</b> bound at a <i>K</i><sub>D</sub> = 18.1 μM (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The substitution of cmF and cF for Y thus confer a 3-fold and 9-fold enhancement of binding over peptide <b>1</b>, respectively, under physiologically relevant phosphate conditions.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SPR Binding Studies to Investigate the Cyclic Peptides <b>2</b> and <b>3</b>: Grb7-SH2 Interaction</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char=" ± " /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">affinity dissociation constant<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">buffer<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center" char=" ± "><b>2</b></th><th class="colsep0 rowsep0" align="center"><b>3</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">20 mM Tris</td><td class="colsep0 rowsep0" align="left">347<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=" ± ">3.9 ± 0.05</td><td class="colsep0 rowsep0" align="left">Not measured</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">50 mM NaPO<sub>4</sub></td><td class="colsep0 rowsep0" align="left">2.9 ± 0.004</td><td class="colsep0 rowsep0" align="char" char=" ± ">31.1 ± 0.07</td><td class="colsep0 rowsep0" align="left">6.57 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">350 mM NaPO<sub>4</sub></td><td class="colsep0 rowsep0" align="left">2.6 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=" ± ">77.3 ± 0.8</td><td class="colsep0 rowsep0" align="left">Not measured</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">20 mM Tris, 1 mM NaPO<sub>4</sub></td><td class="colsep0 rowsep0" align="left">18.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=" ± ">5.7 ± 0.03</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.006</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">All buffers contained 150 mM NaCl and 1 mM DTT.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last"><i>K</i><sub>D</sub> was derived from fits to single-site saturation model. Errors are standard errors arising from the fits.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Reported by Gunzburg et al. (2012) under the same experimental conditions.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Phosphate is Not Required for the Binding of Cyclic Peptides <b>2</b> and <b>3</b> to the Grb7-SH2 Domain</h3><div class="NLM_p last">We have previously determined that peptide <b>1</b> binding to the Grb7-SH2 domain is enhanced by the presence of phosphate in the buffer.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> This can be rationalized by the presence of a phosphate ion in the pY binding site that enhances peptide binding by stabilizing the BC loop. In the case of peptide <b>1</b>, binding to Grb7-SH2 was previously reported to range from <i>K</i><sub>D</sub> = 4.1 μM in 100 mM phosphate to 347 μM in the absence of any phosphate.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In the case of peptides <b>2</b> and <b>3</b> it was anticipated that there would no longer be a requirement for phosphate for high-affinity binding to the Grb7-SH2 domain. <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B shows a series of binding curves measured for peptides <b>2</b> and <b>3</b> in a range of phosphate concentrations. As expected, the highest affinity measurement for peptide <b>2</b> binding to Grb7-SH2 was observed in the absence of phosphate in the buffer (<i>K</i><sub>D</sub> = 3.9 μM) and, with increasing concentrations of phosphate in the buffer the binding was reduced. The affinity of peptide <b>2</b> was determined at <i>K</i><sub>D</sub> = 31.1 μM in 50 mM phosphate and <i>K</i><sub>D</sub> = 77.3 μM in 350 mM phosphate-containing buffer. Likewise, the affinity of peptide <b>3</b> was lowered to <i>K</i><sub>D</sub> = 6.6 μM in 50 mM phosphate-containing buffer (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>; SPR sensorgrams provided as <a href="/doi/suppl/10.1021/acs.jmedchem.5b00609/suppl_file/jm5b00609_si_001.pdf" class="ext-link">Supporting Information</a>). This was in stark contrast with peptide <b>1</b> binding of <i>K</i><sub>D</sub> = 2.9 and 2.6 μM at high phosphate concentrations (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>; SPR sensorgrams provided as <a href="/doi/suppl/10.1021/acs.jmedchem.5b00609/suppl_file/jm5b00609_si_001.pdf" class="ext-link">Supporting Information</a>). Thus, the cmF and cF substitutions successfully enhance peptide binding to the Grb7-SH2 domain, effectively acting as a substitute for phosphate in the pY binding site.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Cyclic Peptides <b>2</b> and <b>3</b> Are Specific for the Grb7-SH2 Domain over Other Closely Related SH2 Domains</h3><div class="NLM_p">SPR was further utilized to determine whether peptides <b>2</b> and <b>3</b> retain specificity for the Grb7-SH2 domain over closely related SH2 domains (Grb2-SH2 domain (34% identity) and Grb10-SH2 domain (70% identity)). Using the same SPR method, under physiological phosphate concentrations (1 mM phosphate), peptides <b>2</b> and <b>3</b> displayed low binding affinities for the Grb2-SH2 domain (<i>K</i><sub>D</sub> = 440 and 560 μM, respectively). Peptide <b>3</b> also had low affinity binding (<i>K</i><sub>D</sub> = 420 μM) for the Grb10-SH2 domain, whereas binding measurements could not be determined for peptide <b>2</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C; <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Peptide <b>1</b> also displayed low affinity for the Grb2-SH2 domain (<i>K</i><sub>D</sub> of 200 μM) and no detectable binding for the Grb10-SH2 domain (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C; <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Thus, peptides <b>2</b> and <b>3</b> successfully maintain specificity for Grb7-SH2 over closely related SH2 domains compared with peptide <b>1</b> under physiological phosphate conditions.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SPR Binding Studies to Determine Specificity of Cyclic Peptides <b>1</b>, <b>2</b>, and <b>3</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char=" ± " /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">affinity dissociation constant<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">protein</th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>2</b></th><th class="colsep0 rowsep0" align="center" char=" ± "><b>3</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Grb7-SH2</td><td class="colsep0 rowsep0" align="left">18.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">5.7 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=" ± ">2.1 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Grb2-SH2</td><td class="colsep0 rowsep0" align="left">200 ± 70</td><td class="colsep0 rowsep0" align="left">440 ± 70</td><td class="colsep0 rowsep0" align="char" char=" ± ">560 ± 40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Grb10-SH2</td><td class="colsep0 rowsep0" align="left">No detectable binding</td><td class="colsep0 rowsep0" align="left">No detectable binding</td><td class="colsep0 rowsep0" align="char" char=" ± ">420 ± 60</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last"><i>K</i><sub>D</sub> was derived from fits to single-site saturation model. Errors are standard errors arising from the fits. SPR specificity experiments were conducted in 20 mM Tris, 1 mM NaPO<sub>4</sub>, 150 mM NaCl, and 1 mM DTT</p></div></div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Crystal Structure of the Grb7-SH2:Peptide <b>2</b> Complex Reveals the Basis for Binding Affinity</h3><div class="NLM_p">To determine the structural basis of the enhanced binding affinity of <b>2</b> and <b>3</b> for the Grb7-SH2 domain, cocrystallization of the peptides with the Grb7-SH2 domain was pursued. Only the Grb7-SH2:peptide <b>2</b> complex gave rise to crystals suitable for diffraction experiments. The best crystal obtained from the PEG/Ion HT screen diffracted to 2.55 Å with the reservoir solution containing 12% w/v PEG3350, 0.05 M sodium HEPES and 1% w/v tryptone (parameters provided in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The complex crystallized in the <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> space group with unit cell dimensions of <i>a</i> = 55.55, <i>b</i> = 68.96, <i>c</i> = 77.12, α = β = γ = 90 °C. Molecular replacement was used to determine initial phases using a monomer of the apo-Grb7-SH2 domain as a search model (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ">4WWQ</a>). The data collection and refinement statistics are provided in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and the coordinates are deposited in the Protein database (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6S">4X6S</a>). The asymmetric unit contains two chains of the Grb7-SH2 domain, both in complex with cyclic peptide <b>2</b>. The electron density for the Grb7 chains encompasses residues 424–529 for chain A and 423–529 for chain B. In the peptide binding site, clear electron density is visible for the peptide ligand including density showing the position of the cmF group (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/medium/jm-2015-006095_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of the Grb7-SH2:peptide <b>2</b> complex. (A) Structure of Grb7 SH2 (blue-white cartoon) in complex with peptide <b>2</b> (yellow sticks) (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6S">4X6S</a>). 2Fo-Fc map surrounding peptide <b>2</b> shown contoured at 1.2σ. (B) Structural overlay of peptide <b>2</b> (yellow) and peptide <b>1</b> (green) from PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PQZ">3PQZ</a>. Grb7 SH2 shown as blue-white surface representation. (C–D) Close-up of the pY binding pocket of chain A and chain B. Key amino acids are shown as sticks and hydrogen bonds as black dashed lines (or gray if close to being defined as a hydrogen bond).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00609&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Grb7-SH2 domain adopts the canonical αββββα SH2 domain topology (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A) with Cα RMSDs of 0.35 and 0.39 for chains A and B, respectively, compared to chain A of the apo-Grb7 SH2 structure. The interchain covalent linkage observed in the apo-Grb7 structure was not present in this complex structure; but the typical Grb7 family dimerization interface was present, centering on F511 (αB8) from each protomer.</div><div class="NLM_p">Peptide <b>2</b> is positioned across the βD strand in both chains, making contacts with residues from the BC, EF, and BG loops, analogously to peptide <b>1</b> in the Grb7-SH2:peptide <b>1</b> complex structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PQZ">3PQZ</a>; <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). Peptide <b>2</b> has a Cα RMSD of 0.16 between the two chains in the asymmetric unit, and 0.27 and 0.21 for chains A and B, respectively, compared to peptide <b>1</b> chain L across the 11 amino acid residues.</div><div class="NLM_p">The peptide <b>2</b> residues G4, D6, and N7 display the highest level of similarity between the two peptides, with these residues forming the main binding interface with the Grb7-SH2 domain via electrostatic and van der Waals (vdW) interactions (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). The F2 and F9 aromatic rings form hydrophobic interactions with the Grb7-SH2 domain surface and the G4 backbone carbonyl forms H-bonding interactions with the Arg438 (αA2) side chain that are equivalent to those seen in the Grb7-SH2:peptide <b>1</b> complex structure. In contrast, the flexible solvent exposed residues (W1, E3, T8, and C11) adopt varied rotamer conformations compared with those in peptide <b>1</b>.</div><div class="NLM_p">As predicted, the cmF residue in peptide <b>2</b> probes the pY binding pocket of Grb7 mediating additional interactions to those made by peptide <b>1</b>. The cmF group is oriented slightly differently between the two chains with an approximate 11° twist at the Cβ position. The average temperature factor of the cmF residue in the two chains, 47 Å<sup>2</sup> for chain A and 52 Å<sup>2</sup> for chain B, is higher than the average temperature factor for the peptide chains, 43 Å<sup>2</sup> for chain A and 49 Å<sup>2</sup> for chain B, suggesting the phosphotyrosine mimetic is relatively mobile compared to the peptide as a whole. This shift between the two cmF groups slightly alters the H-bond network with BC loop residues in the pY binding pocket, but essentially the same contacts are made in chains A and B (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C and D). The cmF carboxylate O<sub>1</sub> forms H-bond or vdW (where the distance is slightly long for H-bond formation) contacts with the Ser460 (βB7) side chain and the backbone amides of Gln461 (BC1) and Arg462 (BC2), similarly to the mode of interaction seen in the sulfate containing Grb7-SH2 domain structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QMS">2QMS</a>). The cmF O<sub>2</sub> forms H-bond or vdW interactions with residues at the base of the pY binding pocket including the Arg438 (αA2) guanidinium side chain and bipartite interactions with the Arg458 (βB5) guanidinium group. These are the same amino acids that were observed to bind to malonate; however, the cmF O<sub>2</sub> interaction with Arg438 (αA2) is via the δNH group (since the ωNH<sub>2</sub> groups extends to the G4 backbone carbonyl in peptide <b>2</b>). In both chains the BC loop is consistently held in the closed conformation for peptide binding, similarly to the sulfate and malonate-bound Grb7-SH2 structures.</div><div class="NLM_p last">The crystal structure also reveals that the basis for peptide <b>2</b> specificity for the Grb7-SH2 domain is the same as previously reported for peptide <b>1</b>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Critical interactions are made with the nonconserved residue Leu481 (βD6) that is known to play a central role in Grb7 binding specificity.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The peptide <b>2</b> N7 side chain carbonyl and amine groups form bipartate hydrogen bonds with Grb7 Leu481 backbone amino and carbonyl groups, respectively. This positions the peptide such that the aromatic rings of both cmF5 and F2 form van der Waals interactions against the Leu481 side chain that could not occur in other Grb-SH2 domains. Another interaction between peptide <b>2</b> and Grb7 that may contribute to binding specificity is a hydrogen bond between the P10 carbonyl group and the nonconserved Grb7 Gln499 (EF4) side chain amine. In addition, due to the subtle effects of shape complementarity, van der Waals contributions to binding specificity are also likely to be at play in the same way as for peptide <b>1</b>. Overall, it can be seen that the incorporation of the cmF group in peptide <b>2</b> does not negatively impact on the molecular interactions that underlie specificity of binding to the Grb7-SH2 domain.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Peptides <b>2</b> and <b>3</b> Represent Improved Inhibitors of the Grb7-SH2 Domain</h3><div class="NLM_p last">The cmF group has thus successfully been utilized as a pY group replacement, effecting the interactions with the Grb7-SH2 domain similar to those previously observed for sulfate and malonate binding. Although structural data has not yet been obtained for the Grb7-SH2:peptide <b>3</b> complex, the cF group in peptide <b>3</b> likely makes similar contacts in the pY binding site. As well as providing enhanced binding affinity through direct electrostatic and hydrogen bond contributions, it is possible that the BC loop stabilization also contributes to peptide binding through subtle adjustments to the peptide binding site. The structure helps to explain the increased binding affinity of peptides <b>2</b> and <b>3</b> over peptide <b>1</b> under physiological phosphate concentrations as well as competition for peptide binding by phosphate at higher concentrations.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The role of Grb7 in cancer progression through migratory and proliferative signaling, and its overexpression in a myriad of cancers, has highlighted Grb7 as a viable target for developing novel anticancer agents.<a onclick="showRef(event, 'ref2 ref3 ref17'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref17">(2, 3, 17)</a> Initial success has been made with the discovery of the cyclic nonphosphorylated peptide <b>1</b>, with cell-permeable forms inhibiting cell migration, invasion, proliferation, and colony formation in HER2+ and TNBC cell lines.<a onclick="showRef(event, 'ref2 ref3 ref9'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref9">(2, 3, 9)</a> To further the potential of peptide <b>1</b> in therapeutic development, derivatives of this peptide need to be designed, synthesized, and characterized.</div><div class="NLM_p">The current study has identified two new cyclic derivatives, peptides <b>2</b> and <b>3</b>, with enhanced affinity for the Grb7-SH2 domain compared with peptide <b>1</b>. The introduction of the cmF and cF moieties at the Y5 position of peptide <b>1</b> was inspired by the observation of a malonate positioned in the pY binding site of the apo-Grb7-SH2 domain crystal structure. The target cyclic peptides were successfully prepared via solid-phase peptide synthesis and binding studies using SPR determined that peptide <b>2</b> improves binding 3-fold and peptide <b>3</b> 9-fold for the Grb7-SH2 domain compared with peptide <b>1</b>. Importantly, these measurements are in the presence of 1 mM phosphate, which reflects a physiological phosphate concentration.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Furthermore, peptides <b>2</b> and <b>3</b> show greater than 75-fold higher binding for the Grb7-SH2 domain over the closely related Grb2- and Grb10-SH2 domains under the same conditions. While these studies were not conducted on the full-length Grb proteins, it is anticipated that this specificity will be retained in the cellular environment. In studies conducted to test the binding of peptides <b>1</b>, <b>2</b>, and <b>3</b> to full-length Grb7 (using the same SPR strategy as for the SH2 domain alone) we were able to confirm binding affinities in the micromolar range (peptides <b>2</b> and <b>3</b> binding with approximately 4-fold and 8-fold higher affinity than peptide <b>1</b>, respectively), though the instability of full-length Grb7 over time prevented the determination of accurate values for peptide binding (the data and a description of these experiments are supplied as <a href="/doi/suppl/10.1021/acs.jmedchem.5b00609/suppl_file/jm5b00609_si_001.pdf" class="ext-link">Supporting Information</a>). This shows, however, that the inhibitor peptides do bind to the Grb7 in the context of the whole protein and not just to the isolated SH2 domain.</div><div class="NLM_p">Our structural studies confirm that the cmF group of peptide <b>2</b> reaches into the Grb7 pY-binding pocket mediating a combination of interactions previously observed in the malonate- and sulfate-bound Grb7-SH2 domain structures, effectively holding the BC loop in a closed and favorable conformation for peptide binding. The cmF is thus a successful pY mimetic for Grb7-SH2 inhibitors. Structural data have not been obtained for the Grb7-SH2:peptide <b>3</b> complex, so it is not yet known how the cF group interacts in the pY-binding pocket to effect the higher affinity interaction. In the case of the cF group, it is shorter than cmF by one methylene group and seemingly less ideal for placement in the binding site from inspection of Y in peptide <b>1</b> and malonate when bound to the Grb7-SH2 domain (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). Nevertheless, this study has shown it makes additional productive interactions with Grb7-SH2 domain target and is also a successful pY mimetic for Grb7-SH2 inhibitors.</div><div class="NLM_p">The cmF group has been utilized as a pY mimetic in previous studies of SH2 inhibition.<a onclick="showRef(event, 'ref33 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref33 ref38 ref39">(33, 38, 39)</a> Incorporation of the cmF group to Src SH2 and Grb2-targeted peptides improved binding >2-fold and from undetectable to low μM binding, respectively, compared to Y alone.<a onclick="showRef(event, 'ref33 ref38 ref40'); return false;" href="javascript:void(0);" class="ref ref33 ref38 ref40">(33, 38, 40)</a> It is the case, however, that cmF derivatives have reduced binding compared to their pY peptide counterparts: 940-fold for Src, 50-fold for Grb2, and 467-fold for a p56<sup>lck</sup> directed cmF peptide.<a onclick="showRef(event, 'ref33 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref33 ref38 ref39">(33, 38, 39)</a> It has been determined that the phosphate group can contribute up to half the total binding energy to SH2 domain binding.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Thus, the cmF group only partially mimics the pY group as may be expected for a single dicarboxylic acid with less capacity for H-bond formation than a phosphate. A further increase in binding affinity may be achieved with the use of a higher valency pY mimetic or with the use of a protected phosphate group as developed by McMurray et al.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> This study represents the first time, to our knowledge, that the cF group has been incorporated and tested as a pY mimetic for targeting an SH2 domain binding pocket. The cF group has previously been substituted for the Y+3 phenylalanine in Src targeting peptides. This single substitution showed a 180-fold improvement in inhibiting the substrate polyGlu<sub>4</sub>Tyr compared to the parent phenylalanine containing peptide.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">The current study has demonstrated that peptides <b>2</b> and <b>3</b> maintain specificity for Grb7-SH2 under physiological conditions. While the cF and cmF groups confer greater affinity for the Grb7-SH2 domain, binding to Grb2 and Grb10 is only marginally affected. Peptides <b>2</b> and <b>3</b>, in fact, showed decreased binding to Grb2-SH2 compared to peptide <b>1</b>, though peptide <b>3</b> showed a detectable interaction with the Grb10-SH2 domain where peptides <b>1</b> and <b>2</b> had shown no interaction. This is similar to the effect observed upon addition of phosphate to the buffer on peptide <b>1</b> binding. While peptide <b>1</b> binding to Grb7-SH2 domain was greatly enhanced in 100 mM phosphate, binding to Grb10-SH2 and Grb2-SH2 domain was either not enhanced or only marginally enhanced.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Grb10-SH2 possesses a significant sequence identity of ∼70% with Grb7-SH2, and although Grb2 possesses a low sequence identity of ∼34%, the SH2 domain shares the same substrate as Grb7, the ErbB2 receptor, and thus recognizes the same pYXN interaction motif. Furthermore, the amino acid side chains shown to be important for binding to the cmF group (of Ser460 (βB7), Arg438 (αA2), Arg458 (βB5)) are conserved between the Grb7 family members and Grb2. Specificity of cyclic peptides <b>2</b> and <b>3</b> for the Grb7-SH2 domain is thus likely to occur via other more subtle interactions across the surface of the protein where it makes contact across the βD strand, BG loop, and EF loop as previously observed for peptide <b>1</b>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p last">In the development of SH2 domain inhibitors it is an achievement to develop a specific inhibitor suitable for cellular studies due to the large number of SH2 domains that exist in the cell with similar substrate interactions. Peptide <b>1</b> was the first molecule to be discovered with specificity for Grb7, but its affinity depends upon the presence of phosphate ions. Other peptides and small molecules have been discovered that bind to Grb7 but have not been shown to possess binding specificity.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42-44)</a> This study thus reveals an important new class of inhibitor that is specific for the Grb7-SH2 domain under physiological conditions. Future work will focus on improving the inhibitor affinity. With a <i>K</i><sub>D</sub> = 2.1 μM binding affinity for the Grb7-SH2 domain, cyclic peptide <b>3</b> represents an improvement on peptide <b>1</b>, but still higher affinities are required for its therapeutic use. The structural information obtained for the Grb7-SH2:peptide <b>2</b> complex will facilitate the design of further modifications for improvement of this first generation inhibitor of Grb7. These may include additional hydrogen bonding functionalities and rigidification of the peptide backbone as have previously shown to be successful in peptide inhibitor design.<a onclick="showRef(event, 'ref26 ref45'); return false;" href="javascript:void(0);" class="ref ref26 ref45">(26, 45)</a> The effective synthesis and characterization of cyclic peptides <b>2</b> and <b>3</b> thus represents an important step toward a potent Grb7-SH2 domain inhibitor that will be used as a tool both for better understanding the downstream effects of Grb7 inside cells and for future potential therapeutic use in the treatment of HER2+ and TNBC.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51362" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51362" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Protein Expression and Purification</h3><div class="NLM_p last">The pGex2T plasmids containing the SH2 domain inserts of Grb2 (encoding residues 58–160), Grb7 (encoding residues 415–532) and Grb10 (encoding residues 471–594) were kindly provided by Roger Daly. The SH2 domains were expressed as GST fusion proteins in <i>Escherichia coli</i> strain BL21(DE3)pLysS and purified using glutathione affinity chromatography and size exclusion chromatography as described previously.<a onclick="showRef(event, 'ref24 ref30'); return false;" href="javascript:void(0);" class="ref ref24 ref30">(24, 30)</a> To obtain Grb7-SH2 domain alone for crystallization experiments, the GST tag was cleaved off with thrombin following glutathione affinity chromatography, and further purified with cation exchange and size exclusion chromatography as also described previously.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The GST alone, used as a control for SPR, was expressed from the pGex2T plasmid (GE Healthcare) and purified similarly to the GST-Grb proteins excluding size exclusion chromatography. The final concentrations of GST, GST-Grb7-SH2, GST-Grb2-SH2, GST-Grb10-SH2, and Grb7-SH2 were determined spectrophotometrically at <i>A</i><sub>280</sub> using extinction coefficients of 42860, 51340, 58330, 49850, and 8480 M<sup>–1</sup> cm<sup>–1</sup>, respectively.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Preparation of Fmoc-cmF(methyl ester)-OH</h3><div class="NLM_p last">Fmoc-cmF(OMe)-OH <b>4</b> was synthesized from Boc-cmF(OMe)-O<i>t</i>Bu that was in turn prepared using a procedure previously reported by Tilley et al.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Briefly, Boc-cmF(OMe)-O<i>t</i>Bu (108 mg, 0.27 mmol, 1 equiv) was treated with an acidic cocktail comprising a 90:5:5 v/v/v mixture of TFA:triisopropylsilane:H<sub>2</sub>O (2 mL) and allowed to stir at rt for 3 h before removal of the solution <i>in vacuo</i>. The crude product was used in the next step without further purification. A solution of the resulting amino acid in a 2:1 v/v mixture of 1,4-dioxane/sat. aq. NaHCO<sub>3</sub> solution (3 mL) was treated with Fmoc-OSu (102 mg, 0.3 mmol, 1.1 equiv) and allowed to stir at rt for 16 h. The resulting mixture was poured onto water, and acidified to pH 1–2 with 1 M HCl, extracted with EtOAc (3 times), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated <i>in vacuo</i>. The crude product was purified by column chromatography (1:1 v/v EtOAc/hexanes +1% to 3% MeOH), to afford Fmoc-cmF(OMe)-OH <b>4</b> as a colorless oil (107 mg, 86%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-acetone, 400 MHz) δ (ppm) 7.86 (d, <i>J</i> = 7.20 Hz, 2H), 7.70–7.63 (m, 2H), 7.45–7.20 (m, 8H), 6.72 (d, <i>J</i> = 8.34 Hz), 4.60–4.50 (m, 1H), 4.38–4.16 (m, 3H), 3.65–3.59 (m, 5H), 3.27 (dd, <i>J</i> = 4.78, 14.03 Hz, 1H), 3.06 (dd, <i>J</i> = 9.56, 14.03 Hz, 1H); <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-acetone, 100 MHz) δ (ppm) 173.3, 172.3, 156.8, 144.9, 142.0, 137.0, 133.8, 130.2, 130.1, 128.5, 127.9, 126.2, 120.8, 67.2, 56.1, 51.9, 47.9, 40.9, 37.7. HRMS: (<i>M</i><sub>expected</sub> = 459.1682 g/mol, <i>M</i><sub>measured</sub> = 459.1682 g/mol).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis of Peptides <b>1</b>, <b>2</b>, and <b>3</b></h3><div class="NLM_p">Peptide <b>2</b> (cyclo-(CH<sub>2</sub>CO-WFEG<b>cmF</b>DNTFPC)-CONH<sub>2</sub>) was synthesized on a 0.1 mmol scale using standard Fmoc-chemistry on Rink amide resin (0.7 mmol/g). Commercially available amino acids (3.1 equiv with respect to the resin loading), HBTU (3.0 equiv with respect to the resin loading), HOBt (3.0 equiv to resin loading), and DIPEA (4.5 equiv to resin loading) were dissolved in DMF (3 mL) and added to the resin with shaking for 45 min. These reactions were repeated twice to ensure complete coupling. Fmoc-cmF(OMe)-OH <b>4</b> was only coupled once in slight excess of 1.3 equiv to resin loading, along with HBTU (1.3 equiv with respect to the resin loading), HOBt (1.3 equiv to resin loading), and DIPEA (∼2 equiv to resin loading) in DMF (2 mL). After removal of the terminal Fmoc protecting group on the resin-bound peptide through the treatment with 20 vol % piperidine in DMF, the resin was treated with chloroacetic anhydride (1 mmol) and DIPEA (0.1 mmol) in DMF (2 mL) to afford a chloroacetyl-capped N-terminus. The resin was subsequently washed with DMF, CH<sub>2</sub>Cl<sub>2</sub>, and Et<sub>2</sub>O and dried. Cleavage was performed on 0.15 mmol of the resin by treating the resin with a cleavage solution comprising distilled water (2.5% v/v), triisopropylsilane (2.5% v/v), and ethanedithiol (0.5% v/v) in TFA (9.45 mL) for 1.5 h. The TFA was then evaporated under a stream of N<sub>2</sub> and the peptide precipitated by addition of cold Et<sub>2</sub>O. The precipitate was filtered and redissolved in H<sub>2</sub>O/CH<sub>3</sub>CN (1:1) for lyophilization.</div><div class="NLM_p">Thioether formation was effected by dissolving the peptide (2 mg/mL concentration) in 50 mM NH<sub>4</sub>HCO<sub>3</sub> solution (made up in 1:1 v/v CH<sub>3</sub>CN/H<sub>2</sub>O), at pH 8.0, for 1.5 h at room temperature. The cyclized peptide was then purified using reverse-phase HPLC. Hydrolysis of the methyl ester protecting group on the side chain of the cmF residue was carried out by dissolving the peptide (1 mg/mL concentration) in 10–11 mM NaOH solution (0.5 mL of CH<sub>3</sub>CN in 6.5 mL of H<sub>2</sub>O), at pH 8.0–9.0, for 30 h at room temperature. After final purification (to ≥95% purity based on LC) the peptide mass was verified by ion-trap mass spectrometry (<i>M</i><sub>expected</sub> (C<sub>69</sub>H<sub>81</sub>N<sub>14</sub>O<sub>20</sub>S)<sup>−</sup> = 1457.6; <i>M</i><sub>measured</sub> (C<sub>69</sub>H<sub>81</sub>N<sub>14</sub>O<sub>20</sub>S)<sup>−</sup> = 1457.6; <i>M</i><sub>expected</sub> (C<sub>69</sub>H<sub>81</sub>N<sub>14</sub>O<sub>20</sub>S)<sup>2–</sup> = 728.3; <i>M</i><sub>measured</sub> (C<sub>69</sub>H<sub>81</sub>N<sub>14</sub>O<sub>20</sub>S)<sup>2–</sup> = 728.5).</div><div class="NLM_p">The synthesis of cyclic peptide <b>3</b> (cyclo-(CH<sub>2</sub>CO-WFEG<b>cF</b>DNTFPC)-CONH<sub>2</sub>) was carried out using a similar protocol to that for peptide <b>2</b> by Wuxi Nordisk Biotech (China) to >95% purity based on LC-MS. In this case, the Fmoc-protected cF residue (Fmoc-<i>p</i>-carboxyphenylalanine(O<i>t</i>Bu)-OH) was commercially available (Chem-Impex). After purification using reverse-phase HPLC the peptide mass was verified by ion-trap mass spectrometry (<i>M</i><sub>expected</sub> (C<sub>68</sub>H<sub>79</sub>N<sub>14</sub>O<sub>20</sub>S)<sup>−</sup> = 1443.6; <i>M</i><sub>measured</sub> (C<sub>68</sub>H<sub>79</sub>N<sub>14</sub>O<sub>20</sub>S)<sup>−</sup> = 1443.9; <i>M</i><sub>expected</sub> (C<sub>68</sub>H<sub>79</sub>N<sub>14</sub>O<sub>20</sub>S)<sup>2–</sup> = 721.8; <i>M</i><sub>measured</sub> (C<sub>68</sub>H<sub>79</sub>N<sub>14</sub>O<sub>20</sub>S)<sup>2–</sup> = 721.6).</div><div class="NLM_p last">Peptide <b>1</b> (cyclo-(CH<sub>2</sub>CO-WFEGYDNTFPC)-amide) was prepared as described previously.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The final concentrations of peptides <b>1</b>, <b>2</b>, and <b>3</b> were determined spectrophotometrically at <i>A</i><sub>280</sub> using extinction coefficients of 6990 M<sup>–1</sup> cm<sup>–1</sup> and 5809 M<sup>–1</sup> cm<sup>–1</sup>, respectively, with the extinction coefficient for the latter two calculated using the DirectDetect (Millipore) system.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Protein Crystallization, X-ray Diffraction Data Collection, and Structure Determination</h3><div class="NLM_p">Apo-Grb7-SH2 crystals were prepared and data collected as previously described.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The diffraction images were indexed and integrated in the space group <i>P</i>6<sub>3</sub> using IMOSFLM scaled with SCALA from the CCP4 suite and cut to a high resolution limit of 1.80 Å.<a onclick="showRef(event, 'ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49">(47-49)</a> 5% of the total reflections were randomly assigned as an <i>R</i><sub>free</sub> set using UNIQUEIFY (CCP4 suite) and subsequently excluded from refinement. Molecular replacement was performed using MOLREP with a monomer from the previous Grb7-SH2 domain apo structure used as a search model (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QMS">2QMS</a>).<a onclick="showRef(event, 'ref21 ref50'); return false;" href="javascript:void(0);" class="ref ref21 ref50">(21, 50)</a> Rounds of structure refinement and model building were carried out using COOT, PHENIX, and REFMAC5.<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51-53)</a> Solvent molecules were automatically added during refinement, and then manually edited in COOT. The final apo-Grb7-SH2 model had an overall <i>R</i><sub>work</sub> of 17.60% and an <i>R</i><sub>free</sub> of 20.63%.</div><div class="NLM_p">The Grb7-SH2: peptide <b>2</b> complex was formed using 10 mg/mL protein in a 1:1.5 molar ratio of protein:peptide. Crystals were obtained using 2 μL hanging drops composed of 1:1 protein: reservoir with the reservoir solution containing 0.05 M HEPES, pH 7.0, 1% tryptone and 12% PEG3350 from the Hampton screen PEG/Ion HT Screen. Harvestable crystals were soaked in 15% v/v glycerol/mother liquor as a cryoprotectant and flash frozen in liquid nitrogen prior to data collection held in a stream of nitrogen gas at 100 K. Diffraction data were collected using the microfocus beamline (MX2) at the Australian Synchrotron at a wavelength of 0.954 Å using an ADSC Quantum 315r detector and BLU-ICE software for data acquisition.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Images were recorded with an oscillation angle of 1° and exposure time of 3 s. The diffraction images were integrated and scaled with the software pipeline XIA2, with the data restricted to a high-resolution limit of 2.55 Å.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> 5% of the total reflections were randomly assigned as an <i>R</i><sub>free</sub> set and excluded from refinement. Phaser was used for molecular replacement with one chain of the apo Grb7-SH2 domain structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ">4WWQ</a>) used as a search model.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Subsequent model building and refinement rounds occurred as for the apo Grb7 SH2 structure. The peptide <b>2</b> restraint files were generated using phenix.elbow from SMILES strings.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The final Grb7 SH2:peptide <b>1</b> model had an overall <i>R</i><sub>work</sub> of 21.17% and an <i>R</i><sub>free</sub> of 25.81%.</div><div class="NLM_p last">MOLPROBITY was used to assess the quality of the final structures, and figures were generated using PyMOL.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The data collection, processing, and refinement statistics for both structures are provided in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Binding Studies Using Surface Plasmon Resonance</h3><div class="NLM_p">Experiments were conducted on a BIAcore T100 using BIAcore CM5 series S sensor chips as previously reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The immobilization buffer consisted of 50 mM NaPO<sub>4</sub>, 150 mM NaCl, and 1 mM DTT (pH 7.4). Polyclonal anti-GST antibody was immobilized on the reference and active flow cells using amine coupling of the antibody to the surface of the chip (GE Healthcare GST capture kit). For this, the sensor chip was activated with 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride and <i>N</i>-hydroxysuccinimide, then polyclonal anti-GST antibody (at 30 μg/mL) in 10 mM sodium acetate pH 5.0 injected over the chip surface at 5 μL/min for 7 min. The flow cells were then blocked with 1 M ethanolamine, resulting in anti-GST antibody immobilization levels between 2755 RU and 6692 RU.</div><div class="NLM_p last">GST alone was immobilized on the reference flow cell and the GST-fusion proteins of Grb2-SH2, Grb7-SH2, and Grb10-SH2 immobilized on the active flow cells so that binding in the four flow cells could be simultaneously assessed. GST, Grb7-SH2, Grb2-SH2, and Grb10-SH2 (all at 0.7–0.9 μM in immobilization buffer) were injected over the corresponding flow cells for 7 min at 5 μL/min with 486–1272 RU, 767–1521 RU, 800–972 RU, and 811–1065 RU immobilized, respectively. Triplicate or duplicate samples of peptide were injected for 60 s at 30 μL/min, with 300–600 s dissociation in a range of buffers as described in the main text. The data were analyzed using Scrubber2.0 (BioLogic Software, Campbell, ACT, Australia) and SigmaPlot v 12.0 (Systat Software, Inc., Chicago, IL, USA) to determine <i>K</i><sub>D</sub> values.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00609">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00609" class="ext-link">10.1021/acs.jmedchem.5b00609</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Validation of compounds prepared for this study are provided, as are SPR sensorgrams used for <i>K</i><sub>D</sub> determination. <b>I</b>. Supporting Information and Methods. <b>II</b>. <sup>1</sup>H and <sup>13</sup>C NMR spectra of Fmoc-cmF(OMe)-OH <b>4</b>. <b>III</b>. MS for Fmoc-cmF(OMe)-OH <b>4</b>. <b>IV</b>. LC chromatogram for peptide <b>2</b>. <b>V</b>. MS for peptide <b>2</b>. <b>VI</b>. LC chromatogram for peptide <b>3</b>. <b>VII</b>. MS for peptide <b>3</b>. <b>VIII</b>. SPR sensorgrams for peptides <b>1</b>, <b>2</b>, and <b>3</b> binding to the SH2 domains of Grb2, Grb7, and Grb10. <b>IX</b>. SPR sensorgrams and equilibrium binding curves for peptides <b>1</b>, <b>2</b>, and <b>3</b> binding to full-length Grb7 and Grb7-SH2 (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00609/suppl_file/jm5b00609_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00609/suppl_file/jm5b00609_si_001.pdf">jm5b00609_si_001.pdf (2.4 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited in the PDB with accession numbers <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ">4WWQ</a> for apo-Grb7-SH2 and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6S">4X6S</a> for Grb7-SH2:<b>2</b> complex.</p><div class="testing" data-doi="10.1021/acs.jmedchem.5b00609" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacqueline A. Wilce</span> - <span class="hlFld-Affiliation affiliation">†Department
of Biochemistry and Molecular Biology and ‡School of Chemistry, Monash University, Melbourne, Victoria 3800, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Australian
Synchrotron, 800 Blackburn
Road, Clayton, Victoria 3168, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Surgery and Vermont Cancer Center, University
of Vermont, Burlington, Vermont 05401, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#94fef5f7fffdf1bae3fdf8f7f1d4f9fbfaf5e7fcbaf1f0e1"><span class="__cf_email__" data-cfemail="b7ddd6d4dcded299c0dedbd4d2f7dad8d9d6c4df99d2d3c2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabrielle M. Watson</span> - <span class="hlFld-Affiliation affiliation">†Department
of Biochemistry and Molecular Biology and ‡School of Chemistry, Monash University, Melbourne, Victoria 3800, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Australian
Synchrotron, 800 Blackburn
Road, Clayton, Victoria 3168, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Surgery and Vermont Cancer Center, University
of Vermont, Burlington, Vermont 05401, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Menachem J. Gunzburg</span> - <span class="hlFld-Affiliation affiliation">†Department
of Biochemistry and Molecular Biology and ‡School of Chemistry, Monash University, Melbourne, Victoria 3800, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Australian
Synchrotron, 800 Blackburn
Road, Clayton, Victoria 3168, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Surgery and Vermont Cancer Center, University
of Vermont, Burlington, Vermont 05401, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigus D. Ambaye</span> - <span class="hlFld-Affiliation affiliation">†Department
of Biochemistry and Molecular Biology and ‡School of Chemistry, Monash University, Melbourne, Victoria 3800, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Australian
Synchrotron, 800 Blackburn
Road, Clayton, Victoria 3168, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Surgery and Vermont Cancer Center, University
of Vermont, Burlington, Vermont 05401, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William A. H. Lucas</span> - <span class="hlFld-Affiliation affiliation">†Department
of Biochemistry and Molecular Biology and ‡School of Chemistry, Monash University, Melbourne, Victoria 3800, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Australian
Synchrotron, 800 Blackburn
Road, Clayton, Victoria 3168, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Surgery and Vermont Cancer Center, University
of Vermont, Burlington, Vermont 05401, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daouda A. Traore</span> - <span class="hlFld-Affiliation affiliation">†Department
of Biochemistry and Molecular Biology and ‡School of Chemistry, Monash University, Melbourne, Victoria 3800, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Australian
Synchrotron, 800 Blackburn
Road, Clayton, Victoria 3168, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Surgery and Vermont Cancer Center, University
of Vermont, Burlington, Vermont 05401, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ketav Kulkarni</span> - <span class="hlFld-Affiliation affiliation">†Department
of Biochemistry and Molecular Biology and ‡School of Chemistry, Monash University, Melbourne, Victoria 3800, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Australian
Synchrotron, 800 Blackburn
Road, Clayton, Victoria 3168, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Surgery and Vermont Cancer Center, University
of Vermont, Burlington, Vermont 05401, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katie M. Cergol</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard J. Payne</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Santosh Panjikar</span> - <span class="hlFld-Affiliation affiliation">Australian
Synchrotron, 800 Blackburn
Road, Clayton, Victoria 3168, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephanie C. Pero</span> - <span class="hlFld-Affiliation affiliation">Department
of Surgery and Vermont Cancer Center, University
of Vermont, Burlington, Vermont 05401, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Perlmutter</span> - <span class="hlFld-Affiliation affiliation">†Department
of Biochemistry and Molecular Biology and ‡School of Chemistry, Monash University, Melbourne, Victoria 3800, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Australian
Synchrotron, 800 Blackburn
Road, Clayton, Victoria 3168, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Surgery and Vermont Cancer Center, University
of Vermont, Burlington, Vermont 05401, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew C. J. Wilce</span> - <span class="hlFld-Affiliation affiliation">†Department
of Biochemistry and Molecular Biology and ‡School of Chemistry, Monash University, Melbourne, Victoria 3800, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Australian
Synchrotron, 800 Blackburn
Road, Clayton, Victoria 3168, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Surgery and Vermont Cancer Center, University
of Vermont, Burlington, Vermont 05401, United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2614e2759-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72134" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72134" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We wish to thank all the beamline staff at the MX2 at the Australian Synchrotron, Victoria, Australia where the diffraction data were collected. This work was supported by a grant from the National Health and Medical Research Council awarded to J.A.W., P.P., and S.C.P., a National Health and Medical Research Senior Research Fellowship awarded to M.C.J.W. as well as the Victorian Government’s Operational Infrastructure Support Program.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i26" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i26"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i27" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i27"> Abbreviations</h2><tr><td class="NLM_term">cmF</td><td class="NLM_def"><p class="first last">carboxymethylphenylalanine</p></td></tr><tr><td class="NLM_term">cF</td><td class="NLM_def"><p class="first last">carboxyphenylalanine</p></td></tr><tr><td class="NLM_term">Grb</td><td class="NLM_def"><p class="first last">growth factor receptor bound protein</p></td></tr><tr><td class="NLM_term">HER2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>D</sub></td><td class="NLM_def"><p class="first last">equilibrium dissociation constant</p></td></tr><tr><td class="NLM_term">LC</td><td class="NLM_def"><p class="first last">liquid chromatography</p></td></tr><tr><td class="NLM_term">MLA</td><td class="NLM_def"><p class="first last">malonic acid</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectrometry</p></td></tr><tr><td class="NLM_term">PH</td><td class="NLM_def"><p class="first last">pleckstrin homology</p></td></tr><tr><td class="NLM_term">pY</td><td class="NLM_def"><p class="first last">phosphotyrosine</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">ras-associating</p></td></tr><tr><td class="NLM_term">RU</td><td class="NLM_def"><p class="first last">response units</p></td></tr><tr><td class="NLM_term">SH2</td><td class="NLM_def"><p class="first last">src homology 2</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple negative breast cancer</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 58 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-74&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0ljmbBdSPLohwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D74%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Pradip, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzyk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyland-Jones, B.</span><span> </span><span class="NLM_article-title">Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules</span> <span class="citation_source-journal">Am. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=23593540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A280%3ADC%252BC3srlvFOqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=173-95&author=D.+Pradipauthor=M.+Bouzykauthor=N.+Deyauthor=B.+Leyland-Jones&title=Dissecting+GRB7-mediated+signals+for+proliferation+and+migration+in+HER2+overexpressing+breast+tumor+cells%3A+GTP-ase+rules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules</span></div><div class="casAuthors">Pradip De; Bouzyk Mark; Dey Nandini; Leyland-Jones Brian</div><div class="citationInfo"><span class="NLM_cas:title">American journal of cancer research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Amplification of human Her2 and its aberrant signaling in 20-30% of early breast cancer patients is responsible for highly aggressive tumors with poor outcome.  Grb7 is reported to be co-amplified with Her2.  We report a concurrent high expression of mRNA (from FFPE tumor samples; mRNA correlation, Pearson r(2)= 0.806), and high levels of GRB7 protein (immunoblot) in HER2+ breast cancer cell lines.  We demonstrated the signaling mechanism of HER2 and downstream effectors that contributes to proliferation and migration.  Using HER2+ and trastuzumab-resistant breast cancer cell lines, we identified the interaction between GRB7 and HER2 in the control of HER2+ cell proliferation.  Our co-IP data show that GRB7 recruits SHC into the HER2-GRB7 signaling complex.  This complex formation leads to activation of RAS-GTP.  We also observed that following integrin engagement, GRB7 is phosphorylated at tyrosine in a p-FAK (Y397) dependent manner.  This FAK-GRB7 complex leads to downstream activation of RAC1-GTP (responsible for migration) probably through the recruitment of VAV2.  Our CO-IP data demonstrate that GRB7 directly binds with VAV2 following fibronectin engagement in HER2+ cells.  To address whether GRB7 could serve as a pathway specific therapeutic target, we used siRNA to suppress GRB7 expression.  Knockdown of GRB7 expression in the HER2+ breast cancer cell lines decreases RAS activation, cell proliferation, 2D and 3D colony formation and also blocked integrin-mediated RAC1 activation along with integrin-directed cell migration.  These findings dissected the HER2-mediated signaling cascade into (1) HER2+ cell proliferation (HER2-GRB7-SHC-RAS) and (2) HER2+ cell migration (alpha5 beta1/alpha4 beta1-FAK-GRB7-VAV2-RAC1).  Our data clearly demonstrate that a coupling of GRB7 with HER2 is required for the proliferative and migratory signals in HER2+ breast tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQo49zaaj9yMMyail4HZd-ifW6udTcc2ea2otiNuyZxL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srlvFOqtw%253D%253D&md5=a09635d02e188705bcb24085c4b94c4b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPradip%26aufirst%3DD.%26aulast%3DBouzyk%26aufirst%3DM.%26aulast%3DDey%26aufirst%3DN.%26aulast%3DLeyland-Jones%26aufirst%3DB.%26atitle%3DDissecting%2520GRB7-mediated%2520signals%2520for%2520proliferation%2520and%2520migration%2520in%2520HER2%2520overexpressing%2520breast%2520tumor%2520cells%253A%2520GTP-ase%2520rules%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2013%26volume%3D3%26spage%3D173%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Giricz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparano, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. A.</span><span> </span><span class="NLM_article-title">GRB7 is required for triple-negative breast cancer cell invasion and survival</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1007/s10549-011-1822-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2Fs10549-011-1822-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=22005836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFOksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2012&pages=607-15&author=O.+Giriczauthor=V.+Calvoauthor=S.+C.+Peroauthor=D.+N.+Kragauthor=J.+A.+Sparanoauthor=P.+A.+Kenny&title=GRB7+is+required+for+triple-negative+breast+cancer+cell+invasion+and+survival&doi=10.1007%2Fs10549-011-1822-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">GRB7 is required for triple-negative breast cancer cell invasion and survival</span></div><div class="casAuthors">Giricz, Orsi; Calvo, Veronica; Pero, Stephanie C.; Krag, David N.; Sparano, Joseph A.; Kenny, Paraic A.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">607-615</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is a heterogeneous disease that is usually assocd. with poor prognosis, and frequently assocd. with the basal-like breast cancer gene expression profile.  There are no targeted therapeutic modalities for this disease, and no useful biomarkers.  High GRB7 RNA expression levels are assocd. with an elevated risk of recurrence in patients with operable TNBC treated with std. adjuvant anthracycline and taxane therapy.  To det. whether GRB7 is involved in the pathobiol. of TNBC, we evaluated the biol. effects of GRB7 inhibition in a panel of triple-neg. cell lines-MDA-MB-468, MDA-MB-231, HCC70, and T4-2.  We found GRB7 inhibition reduced cell motility and invasion of these cell lines and promoted cell death by apoptosis in 3D culture.  These data suggest that GRB7 itself, or GRB7-dependent pathways, may prove to be important therapeutic targets in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreB0Epb_bbMLVg90H21EOLACvtfcHk0lg04w0n8dj8vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFOksbc%253D&md5=8ad42003c4e5536023f81377e6f1bbc1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs10549-011-1822-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-011-1822-6%26sid%3Dliteratum%253Aachs%26aulast%3DGiricz%26aufirst%3DO.%26aulast%3DCalvo%26aufirst%3DV.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DSparano%26aufirst%3DJ.%2BA.%26aulast%3DKenny%26aufirst%3DP.%2BA.%26atitle%3DGRB7%2520is%2520required%2520for%2520triple-negative%2520breast%2520cancer%2520cell%2520invasion%2520and%2520survival%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2012%26volume%3D133%26spage%3D607%26epage%3D15%26doi%3D10.1007%2Fs10549-011-1822-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luoh, S. W.</span><span> </span><span class="NLM_article-title">GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1093/carcin/bgm221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1093%2Fcarcin%2Fbgm221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=473-479&author=T.+Baiauthor=S.+W.+Luoh&title=GRB-7+facilitates+HER-2%2FNeu-mediated+signal+transduction+and+tumor+formation&doi=10.1093%2Fcarcin%2Fbgm221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgm221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgm221%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DT.%26aulast%3DLuoh%26aufirst%3DS.%2BW.%26atitle%3DGRB-7%2520facilitates%2520HER-2%252FNeu-mediated%2520signal%2520transduction%2520and%2520tumor%2520formation%26jtitle%3DCarcinogenesis%26date%3D2007%26volume%3D29%26spage%3D473%26epage%3D479%26doi%3D10.1093%2Fcarcin%2Fbgm221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Chu, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T. L.</span><span> </span><span class="NLM_article-title">EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">29279</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1074/jbc.C110.114124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.C110.114124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=29279-85&author=P.+Y.+Chuauthor=T.+K.+Liauthor=S.+T.+Dingauthor=I.+R.+Laiauthor=T.+L.+Shen&title=EGF-induced+Grb7+recruits+and+promotes+Ras+activity+essential+for+the+tumorigenicity+of+Sk-Br3+breast+cancer+cells&doi=10.1074%2Fjbc.C110.114124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C110.114124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C110.114124%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DP.%2BY.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DDing%26aufirst%3DS.%2BT.%26aulast%3DLai%26aufirst%3DI.%2BR.%26aulast%3DShen%26aufirst%3DT.%2BL.%26atitle%3DEGF-induced%2520Grb7%2520recruits%2520and%2520promotes%2520Ras%2520activity%2520essential%2520for%2520the%2520tumorigenicity%2520of%2520Sk-Br3%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D29279%26epage%3D85%26doi%3D10.1074%2Fjbc.C110.114124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Nencioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garuti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passalacqua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffaghello, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoppoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistoia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballestrero, A.</span><span> </span><span class="NLM_article-title">Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e9024</span><span class="refDoi"> DOI: 10.1371/journal.pone.0009024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1371%2Fjournal.pone.0009024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9024&author=A.+Nencioniauthor=M.+Ceaauthor=A.+Garutiauthor=M.+Passalacquaauthor=L.+Raffaghelloauthor=D.+Sonciniauthor=E.+Moranauthor=G.+Zoppoliauthor=V.+Pistoiaauthor=F.+Patroneauthor=A.+Ballestrero&title=Grb7+upregulation+is+a+molecular+adaptation+to+HER2+signaling+inhibition+due+to+removal+of+Akt-mediated+gene+repression&doi=10.1371%2Fjournal.pone.0009024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009024%26sid%3Dliteratum%253Aachs%26aulast%3DNencioni%26aufirst%3DA.%26aulast%3DCea%26aufirst%3DM.%26aulast%3DGaruti%26aufirst%3DA.%26aulast%3DPassalacqua%26aufirst%3DM.%26aulast%3DRaffaghello%26aufirst%3DL.%26aulast%3DSoncini%26aufirst%3DD.%26aulast%3DMoran%26aufirst%3DE.%26aulast%3DZoppoli%26aufirst%3DG.%26aulast%3DPistoia%26aufirst%3DV.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DBallestrero%26aufirst%3DA.%26atitle%3DGrb7%2520upregulation%2520is%2520a%2520molecular%2520adaptation%2520to%2520HER2%2520signaling%2520inhibition%2520due%2520to%2520removal%2520of%2520Akt-mediated%2520gene%2520repression%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9024%26doi%3D10.1371%2Fjournal.pone.0009024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flemer, S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span> </span><span class="NLM_article-title">Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1520</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6603732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1038%2Fsj.bjc.6603732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=17426702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1KmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=1520-5&author=S.+C.+Peroauthor=G.+S.+Shuklaauthor=M.+M.+Cooksonauthor=S.+Flemerauthor=D.+N.+Krag&title=Combination+treatment+with+Grb7+peptide+and+Doxorubicin+or+Trastuzumab+%28Herceptin%29+results+in+cooperative+cell+growth+inhibition+in+breast+cancer+cells&doi=10.1038%2Fsj.bjc.6603732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells</span></div><div class="casAuthors">Pero, S. C.; Shukla, G. S.; Cookson, M. M.; Flemer, S., Jr.; Krag, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1520-1525</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Grb7 has potential importance in the progression of cancer.  We have previously identified a novel peptide that binds to the SH2 domain of Grb7 and inhibits its assocn. with several different receptor tyrosine kinases.  We have synthesized the Grb7 peptide, G7-18NATE, with two different cell penetrating peptides, Penetratin and Tat.  In this study, we have shown that both Penetratin- and Tat-conjugated G7-18NATE peptides are able to inhibit the proliferation of SK-BR-3, ZR-75-30, MDA-MB-361 and MDA-MB-231 breast cancer cells.  There was no significant effects on breast cancer MCF-7cells, non-malignant MCF 10A or 3T3 cells.  In addn., there was no significant inhibition of proliferation by Penetratin or Tat alone or by their conjugates with arbitrary peptide sequence in any of the cell lines tested.  We detd. the EC50 of G7-18NATE-P peptide for SK-BR-3 cell proliferation to be 7.663×10-6 M.  Co-treatment of G7-18NATE-P peptide plus Doxorubicin in SK-BR-3 breast cancer cells resulted in an addnl. inhibition of proliferation, resulting in 56 and 84% decreases in the Doxorubicin EC50 value in the presence of 5×10-6 and 1.0×10-5 M G7-18NATE-P peptide, resp.  Importantly, the co-treatment with Doxorubicin and the delivery peptide did not change the Doxorubicin EC50.  Since Grb7 assocs. with ErbB2, we assessed whether the peptide inhibitor would have a combined effect with a mol. that targets ErbB2, Herceptin.  Co-treatment of Herceptin plus 1.0×10-5 M G7-18NATE-P peptide in SK-BR-3 cells resulted in a 46% decrease in the Herceptin EC50 value and no decrease following the co-treatment with Herceptin and penetratin alone.  This Grb7 peptide has potential to be developed as a therapeutic agent alone, in combination with traditional chemotherapy, or in combination with other targeting mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYqBV3GdCebVg90H21EOLACvtfcHk0lhCSdOeLYUNQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1KmtLc%253D&md5=ef6c823762d834e077e70657ea28162d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603732%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DShukla%26aufirst%3DG.%2BS.%26aulast%3DCookson%26aufirst%3DM.%2BM.%26aulast%3DFlemer%26aufirst%3DS.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26atitle%3DCombination%2520treatment%2520with%2520Grb7%2520peptide%2520and%2520Doxorubicin%2520or%2520Trastuzumab%2520%2528Herceptin%2529%2520results%2520in%2520cooperative%2520cell%2520growth%2520inhibition%2520in%2520breast%2520cancer%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26spage%3D1520%26epage%3D5%26doi%3D10.1038%2Fsj.bjc.6603732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Han, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J. L.</span><span> </span><span class="NLM_article-title">Association of focal adhesion kinase with Grb7 and its role in cell migration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">24425</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1074/jbc.274.34.24425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.274.34.24425" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=24425-30&author=D.+C.+Hanauthor=J.+L.+Guan&title=Association+of+focal+adhesion+kinase+with+Grb7+and+its+role+in+cell+migration&doi=10.1074%2Fjbc.274.34.24425"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.34.24425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.34.24425%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DD.%2BC.%26aulast%3DGuan%26aufirst%3DJ.%2BL.%26atitle%3DAssociation%2520of%2520focal%2520adhesion%2520kinase%2520with%2520Grb7%2520and%2520its%2520role%2520in%2520cell%2520migration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D24425%26epage%3D30%26doi%3D10.1074%2Fjbc.274.34.24425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Lim, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span><span class="refDoi"> DOI: 10.1007/s10549-014-2838-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2Fs10549-014-2838-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=24464577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=593-603&author=R.+C.+Limauthor=J.+T.+Priceauthor=J.+A.+Wilce&title=Context-dependent+role+of+Grb7+in+HER2%2Bve+and+triple-negative+breast+cancer+cell+lines&doi=10.1007%2Fs10549-014-2838-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines</span></div><div class="casAuthors">Lim, Reece C. C.; Price, John T.; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">593-603</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Grb7 is an adapter protein, aberrantly co-overexpressed with HER2 and identified as an independent prognostic marker in breast cancer.  It has been established that Grb7 exacerbates the cellular growth and migratory behavior of HER2+ve breast cancer cells.  Less is known about Grb7's role in the context of HER2-ve cells.  Here we directly compare the effect of stable Grb7 knockdown in estrogen sensitive (T47D), HER2+ve (SKBR3) and triple-neg. (MDA-MB-468 and MDA-MB-231) breast cancer cell lines on anchorage dependent and independent cell growth, wound healing and chemotaxis.  All cell lines showed reduced ability to migrate upon Grb7 knockdown, despite their greatly varied endogenous levels of Grb7.  Decreased cell proliferation was not obsd. in any of the cell lines upon Grb7 knockdown; however, decreased ability to form colonies was obsd. for all but the estrogen sensitive cell line, depending upon the stringency of the growth conditions.  The data reveal that Grb7 plays an important role in breast cancer progression, beyond the context of HER2+ve cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4vHleefRXL7Vg90H21EOLACvtfcHk0lhCSdOeLYUNQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSqsr8%253D&md5=121ce4f7e3fe1fa16c790a63bdf6dce4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs10549-014-2838-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-014-2838-5%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DR.%2BC.%26aulast%3DPrice%26aufirst%3DJ.%2BT.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DContext-dependent%2520role%2520of%2520Grb7%2520in%2520HER2%252Bve%2520and%2520triple-negative%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2014%26volume%3D143%26spage%3D593%26epage%3D603%26doi%3D10.1007%2Fs10549-014-2838-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arii, S.</span><span> </span><span class="NLM_article-title">Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1093/jnci/djj105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1093%2Fjnci%2Fdjj105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=16595785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlamtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=491-8&author=S.+Tanakaauthor=S.+C.+Peroauthor=K.+Taguchiauthor=M.+Shimadaauthor=M.+Moriauthor=D.+N.+Kragauthor=S.+Arii&title=Specific+peptide+ligand+for+Grb7+signal+transduction+protein+and+pancreatic+cancer+metastasis&doi=10.1093%2Fjnci%2Fdjj105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Peptide Ligand for Grb7 Signal Transduction Protein and Pancreatic Cancer Metastasis</span></div><div class="casAuthors">Tanaka, Shinji; Pero, Stephanie C.; Taguchi, Kenichi; Shimada, Mitsuo; Mori, Masaki; Krag, David N.; Arii, Shigeki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">491-498</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Pancreatic cancer is one of the most aggressive malignancies, with high rates of invasion and metastasis and with generally poor prognosis.  We previously found that metastasis was strongly assocd. with the expression of growth factor receptor-bound protein 7 (Grb7), which contains a Src homol. 2 (SH2) domain.  In this study, we evaluated Grb7 protein as a mol. target of therapy for metastatic pancreatic cancer.  Methods: Grb7 protein expression was measured by immunohistochem. in 36 human pancreatic cancer specimens and adjacent normal pancreatic tissue.  We synthesized a nonphosphorylated peptide inhibitor that binds specifically to the SH2 domain of Grb7.  Intracellular signaling was assessed by immunopptn. and immunoblot assays in cultured human pancreatic cancer cells.  Cell migration was measured with a modified Boyden chamber method.  Peritoneal metastasis of the pancreatic cancer cells was measured with a mouse model.  All statistical tests were two-sided.  Results: We found that 22 (61%) of 36 pancreatic cancer specimens had higher levels of Grb7 protein than their corresponding normal pancreatic tissue specimens.  Grb7 expression was statistically significantly different between specimens from patients without lymph node metastasis (stage N0; two of the 10 patients) and patients with lymph node metastasis (stages N1 + N2; 20 of the 26 patients) (P = .006).  The Grb7 peptide inhibitor selectively blocked the interaction between Grb7 and focal adhesion kinase and blocked the phosphorylation of Grb7 protein.  In vivo Grb7 peptide inhibitor statistically significantly attenuated cell migration (for control peptide, 87.5 cells migrated, 95% confidence interval [CI] = 82.6 to 92.4 cells; for Grb7 peptide, 5.7 cells migrated, 95% CI = 2.3 to 9.0 cells; P<.001) and peritoneal metastasis of the pancreatic cancer cells in a mouse model, as assessed by the no. of nodules (control = 72.6 nodules, 95% CI = 55.8 to 89.4 nodules; and for Grb7 peptide = 3.2 nodules, 95% CI = 1.6 to 4.8 nodules; P<.001, t test) and their wt. (control = 4.13 g, 95% CI = 3.40 to 4.86 g; Grb7 peptide = 0.19 g, 95% CI = 0.06 to 0.32 g; P<.001, t test).  Conclusions: The Grb7 peptide inhibitor appears to be a promising molecularly targeted therapeutic agent against metastatic pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpletsYvkiEs7Vg90H21EOLACvtfcHk0lixMHFSh-q7rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlamtL8%253D&md5=8bf8b5624a76b39cde03cd269bb16f27</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjj105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjj105%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DArii%26aufirst%3DS.%26atitle%3DSpecific%2520peptide%2520ligand%2520for%2520Grb7%2520signal%2520transduction%2520protein%2520and%2520pancreatic%2520cancer%2520metastasis%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2006%26volume%3D98%26spage%3D491%26epage%3D8%26doi%3D10.1093%2Fjnci%2Fdjj105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ramsey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanlon Newell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troxell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luoh, S. W.</span><span> </span><span class="NLM_article-title">GRB7 protein over-expression and clinical outcome in breast cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span><span class="refDoi"> DOI: 10.1007/s10549-010-1010-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2Fs10549-010-1010-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=20635137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtlyku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2011&pages=659-69&author=B.+Ramseyauthor=T.+Baiauthor=A.+Hanlon+Newellauthor=M.+Troxellauthor=B.+Parkauthor=S.+Olsonauthor=E.+Keenanauthor=S.+W.+Luoh&title=GRB7+protein+over-expression+and+clinical+outcome+in+breast+cancer&doi=10.1007%2Fs10549-010-1010-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">GRB7 protein over-expression and clinical outcome in breast cancer</span></div><div class="casAuthors">Ramsey, Betsy; Bai, Tao; Newell, Amy Hanlon; Troxell, Megan; Park, Byung; Olson, Susan; Keenan, Edward; Luoh, Shiuh-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">659-669</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The growth factor receptor-bound protein-7 gene (GRB7) encodes a multi-domain signal transduction mol.  The purpose of this study was to examine the clin. significance of GRB7 protein expression in human breast cancer.  Western blotting anal. of protein exts. from 563 annotated frozen breast tumors was performed.  Expression status of GRB7 and HER-2 was correlated with clin. covariates and outcomes.  Cox proportional hazards were used to identify factors assocd. with breast cancer-free interval.  The median follow-up was 71 mo.  P values <0.05 were considered statistically significant (two-sided).  A discrepancy between HER-2 and GRB7 protein over-expression was obsd.  GRB7 protein over-expression was assocd. with neg. estrogen and progesterone receptor status, higher tumor grade, larger primary tumor size, (more) axillary lymph node involvement, higher clin. stage, and shortened breast cancer-free interval.  HER-2 protein over-expression was assocd. only with higher tumor grade.  Multi-variate anal. revealed that GRB7 protein over-expression was an independent adverse prognostic factor for breast cancer-free interval (hazard ratio 1.69, 95% confidence interval 1.07-2.67; P = 0.024).  The same was true of the subset of patients who did not receive any adjuvant systemic therapy (hazard ratio 1.68, 95% confidence interval 1.16-2.31; P = 0.0055).  Using FISH anal., 32/32 (100%; 95% CI 89-100%) tumors which over-expressed both HER-2 and GRB7 proteins and 1/35 (3%; 95% CI 0-15%) tumors with HER-2 but no GRB7 protein over-expression with Western blotting anal. demonstrated HER-2 gene amplification.  GRB7 protein over-expression is an independent adverse prognostic factor in human breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrChZB-XTObp7Vg90H21EOLACvtfcHk0lixMHFSh-q7rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtlyku7Y%253D&md5=600c4cb4b85ba9646ee9a9ee2e21864c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10549-010-1010-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-010-1010-0%26sid%3Dliteratum%253Aachs%26aulast%3DRamsey%26aufirst%3DB.%26aulast%3DBai%26aufirst%3DT.%26aulast%3DHanlon%2BNewell%26aufirst%3DA.%26aulast%3DTroxell%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DB.%26aulast%3DOlson%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DE.%26aulast%3DLuoh%26aufirst%3DS.%2BW.%26atitle%3DGRB7%2520protein%2520over-expression%2520and%2520clinical%2520outcome%2520in%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2011%26volume%3D127%26spage%3D659%26epage%3D69%26doi%3D10.1007%2Fs10549-010-1010-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Nadler, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimm, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluger, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluger, Y.</span><span> </span><span class="NLM_article-title">Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1093/annonc/mdp346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1093%2Fannonc%2Fmdp346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=19717535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A280%3ADC%252BC3c7isVCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=466-73&author=Y.+Nadlerauthor=A.+M.+Gonzalezauthor=R.+L.+Campauthor=D.+L.+Rimmauthor=H.+M.+Klugerauthor=Y.+Kluger&title=Growth+factor+receptor-bound+protein-7+%28Grb7%29+as+a+prognostic+marker+and+therapeutic+target+in+breast+cancer&doi=10.1093%2Fannonc%2Fmdp346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer</span></div><div class="casAuthors">Nadler Y; Gonzalez A M; Camp R L; Rimm D L; Kluger H M; Kluger Y</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">466-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Growth factor receptor-bound protein-7 (Grb7) is an adapter-type signaling protein recruited to various tyrosine kinases, including HER2/neu.  Grb7-specific inhibitors are in early development.  As with other targeted therapies, response to therapy might be associated with target expression.  MATERIALS AND METHODS:  Tissue microarrays containing 638 primary breast cancer specimens with 15-year patient follow-up were employed to assess Grb7 expression using our Automated QUantitative Analysis method; cytokeratin defines pixels as breast cancer (tumor mask) within the histospot, and Grb7 expression within the mask is measured with Cy5-conjugated antibodies.  RESULTS:  High Grb7 expression was strongly associated with decreased survival in the entire cohort and in the node-positive subset (P = 0.0034 and P = 0.0019, respectively).  On multivariable analysis, it remained an independent prognostic marker (P = 0.01).  High Grb7 was strongly associated with high HER2/neu, and coexpression of these molecules was associated with worse prognosis than HER2/neu overexpression alone.  CONCLUSIONS:  High Grb7 defines a subset of breast cancer patients with decreased survival, indicating that Grb7 might be a valuable prognostic marker and drug target.  Coexpression with HER2/neu indicates that cotargeting these molecules might be an effective approach for treating HER2/neu-positive breast cancers.  Future studies using Grb7-targeting agents should include assessment of Grb7 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHJAg2JMrEwkg6wdEZmT2rfW6udTcc2eb9f7LvCyhnBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7isVCltg%253D%253D&md5=d055d28672acb6dcd8fc5fa1a4eebb21</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdp346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdp346%26sid%3Dliteratum%253Aachs%26aulast%3DNadler%26aufirst%3DY.%26aulast%3DGonzalez%26aufirst%3DA.%2BM.%26aulast%3DCamp%26aufirst%3DR.%2BL.%26aulast%3DRimm%26aufirst%3DD.%2BL.%26aulast%3DKluger%26aufirst%3DH.%2BM.%26aulast%3DKluger%26aufirst%3DY.%26atitle%3DGrowth%2520factor%2520receptor-bound%2520protein-7%2520%2528Grb7%2529%2520as%2520a%2520prognostic%2520marker%2520and%2520therapeutic%2520target%2520in%2520breast%2520cancer%26jtitle%3DAnn.%2520Oncol.%26date%3D2010%26volume%3D21%26spage%3D466%26epage%3D73%26doi%3D10.1093%2Fannonc%2Fmdp346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Stein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuqua, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roonprapunt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yajnik, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Eustachio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchberg, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, B.</span><span> </span><span class="NLM_article-title">The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1994&pages=1331-40&author=D.+Steinauthor=J.+Wuauthor=S.+A.+Fuquaauthor=C.+Roonprapuntauthor=V.+Yajnikauthor=P.+D%E2%80%99Eustachioauthor=J.+J.+Moskowauthor=A.+M.+Buchbergauthor=C.+K.+Osborneauthor=B.+Margolis&title=The+SH2+domain+protein+GRB-7+is+co-amplified%2C+overexpressed+and+in+a+tight+complex+with+HER2+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DFuqua%26aufirst%3DS.%2BA.%26aulast%3DRoonprapunt%26aufirst%3DC.%26aulast%3DYajnik%26aufirst%3DV.%26aulast%3DD%25E2%2580%2599Eustachio%26aufirst%3DP.%26aulast%3DMoskow%26aufirst%3DJ.%2BJ.%26aulast%3DBuchberg%26aufirst%3DA.%2BM.%26aulast%3DOsborne%26aufirst%3DC.%2BK.%26aulast%3DMargolis%26aufirst%3DB.%26atitle%3DThe%2520SH2%2520domain%2520protein%2520GRB-7%2520is%2520co-amplified%252C%2520overexpressed%2520and%2520in%2520a%2520tight%2520complex%2520with%2520HER2%2520in%2520breast%2520cancer%26jtitle%3DEMBO%2520J.%26date%3D1994%26volume%3D13%26spage%3D1331%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Fiddes, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivertsen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallasch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span> </span><span class="NLM_article-title">Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">7717</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1074/jbc.273.13.7717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.273.13.7717" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=7717-24&author=R.+J.+Fiddesauthor=D.+H.+Campbellauthor=P.+W.+Janesauthor=S.+P.+Sivertsenauthor=H.+Sasakiauthor=C.+Wallaschauthor=R.+J.+Daly&title=Analysis+of+Grb7+recruitment+by+heregulin-activated+erbB+receptors+reveals+a+novel+target+selectivity+for+erbB3&doi=10.1074%2Fjbc.273.13.7717"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.13.7717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.13.7717%26sid%3Dliteratum%253Aachs%26aulast%3DFiddes%26aufirst%3DR.%2BJ.%26aulast%3DCampbell%26aufirst%3DD.%2BH.%26aulast%3DJanes%26aufirst%3DP.%2BW.%26aulast%3DSivertsen%26aufirst%3DS.%2BP.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DWallasch%26aufirst%3DC.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26atitle%3DAnalysis%2520of%2520Grb7%2520recruitment%2520by%2520heregulin-activated%2520erbB%2520receptors%2520reveals%2520a%2520novel%2520target%2520selectivity%2520for%2520erbB3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D7717%26epage%3D24%26doi%3D10.1074%2Fjbc.273.13.7717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Margolis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roonprapunt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">8894</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1073/pnas.89.19.8894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1073%2Fpnas.89.19.8894" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=8894-8&author=B.+Margolisauthor=O.+Silvennoinenauthor=F.+Comoglioauthor=C.+Roonprapuntauthor=E.+Skolnikauthor=A.+Ullrichauthor=J.+Schlessinger&title=High-efficiency+expression%2Fcloning+of+epidermal+growth+factor-receptor-binding+proteins+with+Src+homology+2+domains&doi=10.1073%2Fpnas.89.19.8894"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.19.8894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.19.8894%26sid%3Dliteratum%253Aachs%26aulast%3DMargolis%26aufirst%3DB.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DComoglio%26aufirst%3DF.%26aulast%3DRoonprapunt%26aufirst%3DC.%26aulast%3DSkolnik%26aufirst%3DE.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DHigh-efficiency%2520expression%252Fcloning%2520of%2520epidermal%2520growth%2520factor-receptor-binding%2520proteins%2520with%2520Src%2520homology%25202%2520domains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26spage%3D8894%26epage%3D8%26doi%3D10.1073%2Fpnas.89.19.8894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">McMurray, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klostergaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, F. M.</span><span> </span><span class="NLM_article-title">The consequences of selective inhibition of signal transducer and activator of transcription 3 (STAT3) tyrosine705 phosphorylation by phosphopeptide mimetic prodrugs targeting the Src homology 2 (SH2) domain</span> <span class="citation_source-journal">Jak-Stat</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span><span class="refDoi"> DOI: 10.4161/jkst.22682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.4161%2Fjkst.22682" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=263-347&author=J.+S.+McMurrayauthor=P.+K.+Mandalauthor=W.+S.+Liaoauthor=J.+Klostergaardauthor=F.+M.+Robertson&title=The+consequences+of+selective+inhibition+of+signal+transducer+and+activator+of+transcription+3+%28STAT3%29+tyrosine705+phosphorylation+by+phosphopeptide+mimetic+prodrugs+targeting+the+Src+homology+2+%28SH2%29+domain&doi=10.4161%2Fjkst.22682"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4161%2Fjkst.22682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fjkst.22682%26sid%3Dliteratum%253Aachs%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26aulast%3DMandal%26aufirst%3DP.%2BK.%26aulast%3DLiao%26aufirst%3DW.%2BS.%26aulast%3DKlostergaard%26aufirst%3DJ.%26aulast%3DRobertson%26aufirst%3DF.%2BM.%26atitle%3DThe%2520consequences%2520of%2520selective%2520inhibition%2520of%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520%2528STAT3%2529%2520tyrosine705%2520phosphorylation%2520by%2520phosphopeptide%2520mimetic%2520prodrugs%2520targeting%2520the%2520Src%2520homology%25202%2520%2528SH2%2529%2520domain%26jtitle%3DJak-Stat%26date%3D2012%26volume%3D1%26spage%3D263%26epage%3D347%26doi%3D10.4161%2Fjkst.22682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kraskouskaya, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duodu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arpin, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Progress towards the development of SH2 domain inhibitors</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3337</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1039/c3cs35449k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1039%2Fc3cs35449k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=3337-70&author=D.+Kraskouskayaauthor=E.+Duoduauthor=C.+C.+Arpinauthor=P.+T.+Gunning&title=Progress+towards+the+development+of+SH2+domain+inhibitors&doi=10.1039%2Fc3cs35449k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2Fc3cs35449k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cs35449k%26sid%3Dliteratum%253Aachs%26aulast%3DKraskouskaya%26aufirst%3DD.%26aulast%3DDuodu%26aufirst%3DE.%26aulast%3DArpin%26aufirst%3DC.%2BC.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DProgress%2520towards%2520the%2520development%2520of%2520SH2%2520domain%2520inhibitors%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2013%26volume%3D42%26spage%3D3337%26epage%3D70%26doi%3D10.1039%2Fc3cs35449k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haser, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechleider, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birge, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fajardo, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanafusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhausen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">SH2 domains recognize specific phosphopeptide sequences</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1016/0092-8674(93)90404-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2F0092-8674%2893%2990404-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=7680959" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1993&pages=767-778&author=S.+Zhouauthor=S.+E.+Shoelsonauthor=M.+Chaudhuriauthor=G.+Gishauthor=T.+Pawsonauthor=W.+G.+Haserauthor=F.+Kingauthor=T.+Robertsauthor=S.+Ratnofskyauthor=R.+J.+Lechleiderauthor=B.+G.+Neelauthor=R.+B.+Birgeauthor=J.+E.+Fajardoauthor=M.+M.+Chouauthor=H.+Hanafusaauthor=B.+Schaffhausenauthor=L.+C.+Cantley&title=SH2+domains+recognize+specific+phosphopeptide+sequences&doi=10.1016%2F0092-8674%2893%2990404-E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2893%2990404-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252893%252990404-E%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DChaudhuri%26aufirst%3DM.%26aulast%3DGish%26aufirst%3DG.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DHaser%26aufirst%3DW.%2BG.%26aulast%3DKing%26aufirst%3DF.%26aulast%3DRoberts%26aufirst%3DT.%26aulast%3DRatnofsky%26aufirst%3DS.%26aulast%3DLechleider%26aufirst%3DR.%2BJ.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DBirge%26aufirst%3DR.%2BB.%26aulast%3DFajardo%26aufirst%3DJ.%2BE.%26aulast%3DChou%26aufirst%3DM.%2BM.%26aulast%3DHanafusa%26aufirst%3DH.%26aulast%3DSchaffhausen%26aufirst%3DB.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DSH2%2520domains%2520recognize%2520specific%2520phosphopeptide%2520sequences%26jtitle%3DCell%26date%3D1993%26volume%3D72%26spage%3D767%26epage%3D778%26doi%3D10.1016%2F0092-8674%2893%2990404-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span> </span><span class="NLM_article-title">Grb7-based molecular therapeutics in cancer</span> <span class="citation_source-journal">Expert Rev. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1017/S1462399403006227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1017%2FS1462399403006227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=14585167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A280%3ADC%252BD3srgvFaltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=1-11&author=S.+C.+Peroauthor=R.+J.+Dalyauthor=D.+N.+Krag&title=Grb7-based+molecular+therapeutics+in+cancer&doi=10.1017%2FS1462399403006227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Grb7-based molecular therapeutics in cancer</span></div><div class="casAuthors">Pero Stephanie C; Daly Roger J; Krag David N</div><div class="citationInfo"><span class="NLM_cas:title">Expert reviews in molecular medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Traditional anti-cancer drugs preferentially kill rapidly growing tumour cells rather than normal cells.  However, most of these drugs have no preferential selection towards cancer cells and are taken up by the whole body, resulting in significant adverse side effects.  Therapeutic molecules that could specifically inhibit undesirable phenotypes are an attractive way of eliminating cancer cells.  There is a widespread effort to develop inhibitors against signal transduction molecules that play a key role in the proliferative, migratory and invasive properties of a cancer cell.  Grb7 is an adaptor-type signalling protein that is recruited via its Src-homology 2 (SH2) domain to a variety of tyrosine kinases.  Grb7 is overexpressed in breast, oesophageal and gastric cancers, and may contribute to the invasive potential of cancer cells.  Molecular interactions involving Grb7 therefore provide attractive targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7Lgiv6JFRiJ6KlWarZTAzfW6udTcc2eYp1-uvCL2vlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srgvFaltw%253D%253D&md5=584ec9b9538c8b523524d2ad26c52fc8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1017%2FS1462399403006227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1462399403006227%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26atitle%3DGrb7-based%2520molecular%2520therapeutics%2520in%2520cancer%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Med.%26date%3D2003%26volume%3D5%26spage%3D1%26epage%3D11%26doi%3D10.1017%2FS1462399403006227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oligino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span> </span><span class="NLM_article-title">Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">11918</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1074/jbc.M111816200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.M111816200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=11918-26&author=S.+C.+Peroauthor=L.+Oliginoauthor=R.+J.+Dalyauthor=A.+L.+Sodenauthor=C.+Liuauthor=P.+P.+Rollerauthor=P.+Liauthor=D.+N.+Krag&title=Identification+of+novel+non-phosphorylated+ligands%2C+which+bind+selectively+to+the+SH2+domain+of+Grb7&doi=10.1074%2Fjbc.M111816200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111816200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111816200%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DOligino%26aufirst%3DL.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DSoden%26aufirst%3DA.%2BL.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26atitle%3DIdentification%2520of%2520novel%2520non-phosphorylated%2520ligands%252C%2520which%2520bind%2520selectively%2520to%2520the%2520SH2%2520domain%2520of%2520Grb7%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D11918%26epage%3D26%26doi%3D10.1074%2Fjbc.M111816200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Porter, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pursglove, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidberger, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leedman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation</span> <span class="citation_source-journal">BMC Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="refDoi"> DOI: 10.1186/1472-6807-7-58</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1186%2F1472-6807-7-58" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=17894853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A280%3ADC%252BD2sjjsFertA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=58&author=C.+J.+Porterauthor=J.+M.+Matthewsauthor=J.+P.+Mackayauthor=S.+E.+Pursgloveauthor=J.+W.+Schmidbergerauthor=P.+J.+Leedmanauthor=S.+C.+Peroauthor=D.+N.+Kragauthor=M.+C.+J.+Wilceauthor=J.+A.+Wilce&title=Grb7+SH2+domain+structure+and+interactions+with+a+cyclic+peptide+inhibitor+of+cancer+cell+migration+and+proliferation&doi=10.1186%2F1472-6807-7-58"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation</span></div><div class="casAuthors">Porter Corrine J; Matthews Jacqueline M; Mackay Joel P; Pursglove Sharon E; Schmidberger Jason W; Leedman Peter J; Pero Stephanie C; Krag David N; Wilce Matthew C J; Wilce Jacqueline A</div><div class="citationInfo"><span class="NLM_cas:title">BMC structural biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Human growth factor receptor bound protein 7 (Grb7) is an adapter protein that mediates the coupling of tyrosine kinases with their downstream signaling pathways.  Grb7 is frequently overexpressed in invasive and metastatic human cancers and is implicated in cancer progression via its interaction with the ErbB2 receptor and focal adhesion kinase (FAK) that play critical roles in cell proliferation and migration.  It is thus a prime target for the development of novel anti-cancer therapies.  Recently, an inhibitory peptide (G7-18NATE) has been developed which binds specifically to the Grb7 SH2 domain and is able to attenuate cancer cell proliferation and migration in various cancer cell lines.  RESULTS:  As a first step towards understanding how Grb7 may be inhibited by G7-18NATE, we solved the crystal structure of the Grb7 SH2 domain to 2.1 A resolution.  We describe the details of the peptide binding site underlying target specificity, as well as the dimer interface of Grb 7 SH2.  Dimer formation of Grb7 was determined to be in the muM range using analytical ultracentrifugation for both full-length Grb7 and the SH2 domain alone, suggesting the SH2 domain forms the basis of a physiological dimer.  ITC measurements of the interaction of the G7-18NATE peptide with the Grb7 SH2 domain revealed that it binds with a binding affinity of Kd = approximately 35.7 microM and NMR spectroscopy titration experiments revealed that peptide binding causes perturbations to both the ligand binding surface of the Grb7 SH2 domain as well as to the dimer interface, suggesting that dimerisation of Grb7 is impacted on by peptide binding.  CONCLUSION:  Together the data allow us to propose a model of the Grb7 SH2 domain/G7-18NATE interaction and to rationalize the basis for the observed binding specificity and affinity.  We propose that the current study will assist with the development of second generation Grb7 SH2 domain inhibitors, potentially leading to novel inhibitors of cancer cell migration and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQIoJI-dpPcf69nzq6467DfW6udTcc2eYp1-uvCL2vlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjjsFertA%253D%253D&md5=93aa5bd889d183647f9030c25376ce1c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1472-6807-7-58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6807-7-58%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DC.%2BJ.%26aulast%3DMatthews%26aufirst%3DJ.%2BM.%26aulast%3DMackay%26aufirst%3DJ.%2BP.%26aulast%3DPursglove%26aufirst%3DS.%2BE.%26aulast%3DSchmidberger%26aufirst%3DJ.%2BW.%26aulast%3DLeedman%26aufirst%3DP.%2BJ.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DWilce%26aufirst%3DM.%2BC.%2BJ.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DGrb7%2520SH2%2520domain%2520structure%2520and%2520interactions%2520with%2520a%2520cyclic%2520peptide%2520inhibitor%2520of%2520cancer%2520cell%2520migration%2520and%2520proliferation%26jtitle%3DBMC%2520Struct.%2520Biol.%26date%3D2007%26volume%3D7%26spage%3D58%26doi%3D10.1186%2F1472-6807-7-58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertzog, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Borgo, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, M.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Use of SPR to Study the Interaction of G7–18NATE Peptide with the Grb7-SH2 Domain</span> <span class="citation_source-journal">Int. J. Pept. Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.1007/s10989-010-9222-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2Fs10989-010-9222-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlGgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=177-184&author=M.+J.+Gunzburgauthor=N.+D.+Ambayeauthor=J.+T.+Hertzogauthor=M.+P.+del+Borgoauthor=S.+C.+Peroauthor=D.+N.+Kragauthor=M.+C.+J.+Wilceauthor=M.-I.+Aguilarauthor=P.+Perlmutterauthor=J.+A.+Wilce&title=Use+of+SPR+to+Study+the+Interaction+of+G7%E2%80%9318NATE+Peptide+with+the+Grb7-SH2+Domain&doi=10.1007%2Fs10989-010-9222-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Use of SPR to Study the Interaction of G7-18NATE Peptide with the Grb7-SH2 Domain</span></div><div class="casAuthors">Gunzburg, Menachem J.; Ambaye, Nigus D.; Hertzog, Jack T.; Del, Borgo, Mark P.; Pero, Stephanie C.; Krag, David N.; Wilce, Matthew C. J.; Aguilar, Marie-Isabel; Perlmutter, Patrick; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide Research and Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">177-184</span>CODEN:
                <span class="NLM_cas:coden">IJPRFC</span>;
        ISSN:<span class="NLM_cas:issn">1573-3149</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Surface plasmon resonance (SPR) is a useful biosensor technique for the study of biomol. interactions, with the potential for high-throughput screening of ligand interactions with drug targets.  The key to its successful use, however, is in the appropriate design of the expt., including the mode of immobilization to the biosensor chip.  We report an investigation of the use of SPR for measuring the affinity of the G7-18NATE peptide ligand for its Grb7-SH2 domain target involved in the migratory and proliferative potential of cancer cells.  Previous studies have shown that the cyclic non-phosphorylated peptide, G7-18NATE, inhibits Grb7 interactions with upstream binding partners and is able to inhibit both cell migration and proliferation of cancer cells.  We report the synthesis of a biotinylated G7-18NATE covalently attached to a linker (G7-18NATE-ASASASK-Biotin) and compare its interaction with the Grb7-SH2 domain by SPR using three different immobilization strategies; immobilization of the peptide via streptavidin, immobilization of glutathione S-transferase (GST)-Grb7-SH2 domain via anti-GST antibody, and immobilization of biotinylated Grb7-SH2 domain via streptavidin.  This revealed that sensorgrams free from non-specific binding and displaying simple kinetics were most readily achieved by immobilizing the protein rather than the peptide, in spite of the lower response assocd. with this method.  KD values of ∼300 μM were detd. for both strategies at pH 7.4.  This compared with a KD value of 4.4 μM at pH 6 demonstrating the importance of pH on this interaction.  Overall, the immobilized protein systems are most suitable for future comparative screening efforts using SPR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoalIz8FFp587Vg90H21EOLACvtfcHk0lhHePcF6d8Bdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlGgu7w%253D&md5=c09eda161f8780e98aebf24bb6da042b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs10989-010-9222-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10989-010-9222-z%26sid%3Dliteratum%253Aachs%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DHertzog%26aufirst%3DJ.%2BT.%26aulast%3Ddel%2BBorgo%26aufirst%3DM.%2BP.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DWilce%26aufirst%3DM.%2BC.%2BJ.%26aulast%3DAguilar%26aufirst%3DM.-I.%26aulast%3DPerlmutter%26aufirst%3DP.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DUse%2520of%2520SPR%2520to%2520Study%2520the%2520Interaction%2520of%2520G7%25E2%2580%259318NATE%2520Peptide%2520with%2520the%2520Grb7-SH2%2520Domain%26jtitle%3DInt.%2520J.%2520Pept.%2520Res.%2520Ther.%26date%3D2010%26volume%3D16%26spage%3D177%26epage%3D184%26doi%3D10.1007%2Fs10989-010-9222-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Spuches, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argiros, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, B. A.</span><span> </span><span class="NLM_article-title">Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain</span> <span class="citation_source-journal">J. Mol. Recognit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1002/jmr.834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1002%2Fjmr.834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=17705331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVagsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=245-52&author=A.+M.+Spuchesauthor=H.+J.+Argirosauthor=K.+H.+Leeauthor=L.+L.+Haasauthor=S.+C.+Peroauthor=D.+N.+Kragauthor=P.+P.+Rollerauthor=D.+E.+Wilcoxauthor=B.+A.+Lyons&title=Calorimetric+investigation+of+phosphorylated+and+non-phosphorylated+peptide+ligand+binding+to+the+human+Grb7-SH2+domain&doi=10.1002%2Fjmr.834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain</span></div><div class="casAuthors">Spuches, A. M.; Argiros, H. J.; Lee, K. H.; Haas, L. Lowell; Pero, S. C.; Krag, D. N.; Roller, P. P.; Wilcox, D. E.; Lyons, B. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">245-252</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Grb7 is a member of the Grb7 family of proteins, which also includes Grb10 and Grb14.  All three proteins have been found to be overexpressed in certain cancers and cancer cell lines.  In particular, Grb7 (along with the receptor tyrosine kinase erbB2) is overexpressed in 20-30% of breast cancers.  In general, growth factor receptor bound (Grb) proteins bind to activated membrane-bound receptor tyrosine kinases (RTKs; e.g., the epidermal growth factor receptor, EGFR) through their Src homol. 2 (SH2) domains.  In particular, Grb7 binds to erbB2 (a.k.a. EGFR2) and may be involved in cell signaling pathways that promote the formation of metastases and inflammatory responses.  In previous studies, we reported the soln. structure and the backbone relaxation behavior of the Grb7-SH2/erbB2 peptide complex.  In this study, isothermal titrn. calorimetry studies have been completed by measuring the thermodn. binding parameters of several phosphorylated and non-phosphorylated peptides representative of natural Grb7 receptor ligands as well as ligands developed through combinatorial peptide screening methods.  The entirety of these calorimetric studies is interpreted in an effort to describe the specific ligand binding characteristics of the Grb7 protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqIL4vuG5eh7Vg90H21EOLACvtfcHk0lhUWn4sY8PX3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVagsbs%253D&md5=8c4c306b56b493d5fda199ecf59f7254</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjmr.834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.834%26sid%3Dliteratum%253Aachs%26aulast%3DSpuches%26aufirst%3DA.%2BM.%26aulast%3DArgiros%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DHaas%26aufirst%3DL.%2BL.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWilcox%26aufirst%3DD.%2BE.%26aulast%3DLyons%26aufirst%3DB.%2BA.%26atitle%3DCalorimetric%2520investigation%2520of%2520phosphorylated%2520and%2520non-phosphorylated%2520peptide%2520ligand%2520binding%2520to%2520the%2520human%2520Grb7-SH2%2520domain%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2007%26volume%3D20%26spage%3D245%26epage%3D52%26doi%3D10.1002%2Fjmr.834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Borgo, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Interaction of the non-phosphorylated peptide G7–18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity</span> <span class="citation_source-journal">J. Mol. Recognit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1002/jmr.2148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1002%2Fjmr.2148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=22213451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1yntrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=57-67&author=M.+J.+Gunzburgauthor=N.+D.+Ambayeauthor=M.+P.+Del+Borgoauthor=S.+C.+Peroauthor=D.+N.+Kragauthor=M.+C.+Wilceauthor=J.+A.+Wilce&title=Interaction+of+the+non-phosphorylated+peptide+G7%E2%80%9318NATE+with+Grb7-SH2+domain+requires+phosphate+for+enhanced+affinity+and+specificity&doi=10.1002%2Fjmr.2148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity</span></div><div class="casAuthors">Gunzburg, Menachem J.; Ambaye, Nigus D.; Del Borgo, Mark P.; Pero, Stephanie C.; Krag, David N.; Wilce, Matthew C. J.; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-67</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Src-homol. (SH2) domains are an attractive target for the inhibition of specific signaling pathways but pose the challenge of developing a truly specific inhibitor.  The G7-18NATE cyclic peptide is reported to specifically inhibit the growth factor receptor bound protein 7 (Grb7) adapter protein, implicated in the progression of several cancer types, via interactions with its SH2 domain.  G7-18NATE effectively inhibits the interaction of Grb7 with ErbB3 and focal adhesion kinase in cell lysates and, with the addn. of a cell permeability sequence, inhibits the growth and migration of a no. of breast cancer cell lines.  It is thus a promising lead in the development of therapeutics targeted to Grb7.  Here the authors investigate the degree to which G7-18NATE is specific for the Grb7-SH2 domain compared with closely related SH2 domains including those of Grb10, Grb14, and Grb2 using surface plasmon resonance.  The authors demonstrate that G7-18NATE binds with micromolar binding affinity to Grb7-SH2 domain (KD = 4-6 μm) compared with 50-200 times lower affinity for Grb10, Grb14, and Grb2 but that this specificity depends critically on the presence of phosphate in millimolar concns.  Other differences in buffer compn., including use of Tris or 2-(N-Morpholino)ethanesulfonic acid or varying the pH, do not impact on the interaction.  This suggests that under cellular conditions, G7-18NATE binds with highest affinity to Grb7.  In addn., the authors' findings demonstrate that the basis of specificity of G7-18NATE binding to the Grb7-SH2 domain is via other than intrinsic structural features of the protein, representing an unexpected mode of mol. recognition.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVOz6dLoaKNLVg90H21EOLACvtfcHk0lhUWn4sY8PX3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1yntrzK&md5=77073aec5afc99cfbf1f3b7d62039b8f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fjmr.2148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.2148%26sid%3Dliteratum%253Aachs%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DDel%2BBorgo%26aufirst%3DM.%2BP.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DWilce%26aufirst%3DM.%2BC.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DInteraction%2520of%2520the%2520non-phosphorylated%2520peptide%2520G7%25E2%2580%259318NATE%2520with%2520Grb7-SH2%2520domain%2520requires%2520phosphate%2520for%2520enhanced%2520affinity%2520and%2520specificity%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2012%26volume%3D25%26spage%3D57%26epage%3D67%26doi%3D10.1002%2Fjmr.2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. C.</span><span> </span><span class="NLM_article-title">Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span><span class="refDoi"> DOI: 10.1038/362087a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1038%2F362087a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1993&pages=87-91&author=M.+J.+Eckauthor=S.+E.+Shoelsonauthor=S.+C.+Harrison&title=Recognition+of+a+high-affinity+phosphotyrosyl+peptide+by+the+Src+homology-2+domain+of+p56lck&doi=10.1038%2F362087a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2F362087a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F362087a0%26sid%3Dliteratum%253Aachs%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26atitle%3DRecognition%2520of%2520a%2520high-affinity%2520phosphotyrosyl%2520peptide%2520by%2520the%2520Src%2520homology-2%2520domain%2520of%2520p56lck%26jtitle%3DNature%26date%3D1993%26volume%3D362%26spage%3D87%26epage%3D91%26doi%3D10.1038%2F362087a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Phosphotyrosyl mimetics in the development of signal transduction inhibitors</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1021/ar020127o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar020127o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslCmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=426-33&author=T.+R.+Burkeauthor=K.+Lee&title=Phosphotyrosyl+mimetics+in+the+development+of+signal+transduction+inhibitors&doi=10.1021%2Far020127o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphotyrosyl Mimetics in the Development of Signal Transduction Inhibitors</span></div><div class="casAuthors">Burke, Terrence R., Jr.; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">426-433</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Phosphotyrosyl (pTyr) residues play important roles in cellular signal transduction by facilitating recognition and binding necessary for crit. protein-protein interactions, and for this reason pTyr motifs represent attractive starting points in the development of signaling antagonists.  Although the pTyr phosphoryl moiety is central in these phenomena, its incorporation into signaling inhibitors is contraindicated due to enzymic lability and limited bioavailability assocd. with phosphate esters.  To address these limitations, an entire field of study has arisen devoted to the design and utilization of pTyr mimetics.  This Account provides a perspective on the roles of pTyr residues in signal transduction and approaches to pTyr mimetic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqecqbwygKL7bVg90H21EOLACvtfcHk0ljYzuCLtyB2og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslCmtLs%253D&md5=84c9610cea90bfcb3ce91a0ede387e77</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Far020127o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far020127o%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DPhosphotyrosyl%2520mimetics%2520in%2520the%2520development%2520of%2520signal%2520transduction%2520inhibitors%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2003%26volume%3D36%26spage%3D426%26epage%3D33%26doi%3D10.1021%2Far020127o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traore, D. A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Borgo, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonist</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F: Struct. Biol. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1107/S2053230X13033414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS2053230X13033414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=24637751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVejsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=182-186&author=N.+D.+Ambayeauthor=M.+J.+Gunzburgauthor=D.+A.+K.+Traoreauthor=M.+P.+Del+Borgoauthor=P.+Perlmutterauthor=M.+C.+J.+Wilceauthor=J.+A.+Wilce&title=Preparation+of+crystals+for+characterizing+the+Grb7+SH2+domain+before+and+after+complex+formation+with+a+bicyclic+peptide+antagonist&doi=10.1107%2FS2053230X13033414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonist</span></div><div class="casAuthors">Ambaye, Nigus D.; Gunzburg, Menachem J.; Traore, Daouda A. K.; Del Borgo, Mark P.; Perlmutter, Patrick; Wilce, Matthew C. J.; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-186</span>CODEN:
                <span class="NLM_cas:coden">ACSFEN</span>;
        ISSN:<span class="NLM_cas:issn">2053-230X</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Human growth factor receptor-bound protein 7 (Grb7) is an adapter protein involved in cell growth, migration and proliferation.  It is now recognized that Grb7 is an emerging therapeutic target in specific cancer subtypes.  Recently, the discovery of a bicyclic peptide inhibitor that targets the Grb7 SH2 domain, named G7-B1, was reported.  In an attempt to probe the foundation of its interaction with Grb7, the crystn. and preliminary data collection of both the apo and G7-B1-bound forms of the Grb7 SH2 domain are reported here.  Diffraction-quality crystals were obtained using the hanging-drop vapor-diffusion method.  After several rounds of microseeding, crystals of the apo Grb7 SH2 domain were obtained that diffracted to 1.8 Å resoln., while those of the G7-B1-Grb7 SH2 domain complex diffracted to 2.2 Å resoln.  The apo Grb7 SH2 domain crystd. in the trigonal space group P63, whereas the G7-B1-Grb7 SH2 domain complex crystd. in the monoclinic space group P21.  The exptl. aspects of crystn., crystal optimization and data collection and the preliminary data are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK7F-qcXcIQLVg90H21EOLACvtfcHk0ljYzuCLtyB2og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVejsb4%253D&md5=8fcad22b7bbcfa216fbbc5c9bdfe0674</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS2053230X13033414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053230X13033414%26sid%3Dliteratum%253Aachs%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DTraore%26aufirst%3DD.%2BA.%2BK.%26aulast%3DDel%2BBorgo%26aufirst%3DM.%2BP.%26aulast%3DPerlmutter%26aufirst%3DP.%26aulast%3DWilce%26aufirst%3DM.%2BC.%2BJ.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DPreparation%2520of%2520crystals%2520for%2520characterizing%2520the%2520Grb7%2520SH2%2520domain%2520before%2520and%2520after%2520complex%2520formation%2520with%2520a%2520bicyclic%2520peptide%2520antagonist%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Commun.%26date%3D2014%26volume%3D70%26spage%3D182%26epage%3D186%26doi%3D10.1107%2FS2053230X13033414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Stein, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghirlando, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span> </span><span class="NLM_article-title">Structural basis for dimerization of the Grb10 Src homology 2 domain. Implications for ligand specificity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">13257</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1074/jbc.M212026200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.M212026200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=13257-64&author=E.+G.+Steinauthor=R.+Ghirlandoauthor=S.+R.+Hubbard&title=Structural+basis+for+dimerization+of+the+Grb10+Src+homology+2+domain.+Implications+for+ligand+specificity&doi=10.1074%2Fjbc.M212026200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M212026200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M212026200%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%2BG.%26aulast%3DGhirlando%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26atitle%3DStructural%2520basis%2520for%2520dimerization%2520of%2520the%2520Grb10%2520Src%2520homology%25202%2520domain.%2520Implications%2520for%2520ligand%2520specificity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D13257%26epage%3D64%26doi%3D10.1074%2Fjbc.M212026200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Depetris, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimpelevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2Fj.molcel.2005.09.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=325-33&author=R.+S.+Depetrisauthor=J.+Huauthor=I.+Gimpelevichauthor=L.+J.+Holtauthor=R.+J.+Dalyauthor=S.+R.+Hubbard&title=Structural+basis+for+inhibition+of+the+insulin+receptor+by+the+adaptor+protein+Grb14&doi=10.1016%2Fj.molcel.2005.09.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DDepetris%26aufirst%3DR.%2BS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DGimpelevich%26aufirst%3DI.%26aulast%3DHolt%26aufirst%3DL.%2BJ.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520the%2520insulin%2520receptor%2520by%2520the%2520adaptor%2520protein%2520Grb14%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D20%26spage%3D325%26epage%3D33%26doi%3D10.1016%2Fj.molcel.2005.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Porter, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leedman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Grb7-SH2 domain dimerisation is affected by a single point mutation</span> <span class="citation_source-journal">Eur. Biophys. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1007/s00249-005-0480-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2Fs00249-005-0480-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=15841400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVOqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2005&pages=454-60&author=C.+J.+Porterauthor=M.+C.+Wilceauthor=J.+P.+Mackayauthor=P.+Leedmanauthor=J.+A.+Wilce&title=Grb7-SH2+domain+dimerisation+is+affected+by+a+single+point+mutation&doi=10.1007%2Fs00249-005-0480-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Grb7-SH2 domain dimerisation is affected by a single point mutation</span></div><div class="casAuthors">Porter, Corrine J.; Wilce, Matthew C. J.; Mackay, Joel P.; Leedman, Peter; Wilce, Jackie A.</div><div class="citationInfo"><span class="NLM_cas:title">European Biophysics Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">454-460</span>CODEN:
                <span class="NLM_cas:coden">EBJOE8</span>;
        ISSN:<span class="NLM_cas:issn">0175-7571</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Growth factor receptor-bound protein 7 (GRB7) is an adaptor protein that is co-overexpressed and forms a tight complex with the ErbB2 receptor in a no. of breast tumors and breast cancer cell lines.  The interaction of Grb7 with the ErbB2 receptor is mediated via its Src homol. 2 (SH2) domain.  While most SH2 domains exist as monomers, recently reported studies have suggested that the Grb7-SH2 domain exists as a homodimer.  The self-assocn. properties of the Grb7-SH2 domain were therefore studied using sedimentation equil. ultracentrifugation.  Anal. of the data demonstrated that the Grb7-SH2 domain is dimeric with a dissocn. const. of approx. 11 μM.  The authors also demonstrate, using size-exclusion chromatog., that mutation of phenylalanine 511 to an arginine produces a monomeric form of the Grb7-SH2 domain.  This mutation represents the first step in the engineering of a Grb7-SH2 domain with good soln. properties for further biophys. and structural investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_BoXzCvPyNbVg90H21EOLACvtfcHk0ljWchxPhsZhhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVOqsbg%253D&md5=d5cdec99e46b1b7ef98c80758181b1a2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00249-005-0480-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00249-005-0480-1%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DC.%2BJ.%26aulast%3DWilce%26aufirst%3DM.%2BC.%26aulast%3DMackay%26aufirst%3DJ.%2BP.%26aulast%3DLeedman%26aufirst%3DP.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DGrb7-SH2%2520domain%2520dimerisation%2520is%2520affected%2520by%2520a%2520single%2520point%2520mutation%26jtitle%3DEur.%2520Biophys.%2520J.%26date%3D2005%26volume%3D34%26spage%3D454%26epage%3D60%26doi%3D10.1007%2Fs00249-005-0480-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Borgo, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peletskaya, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer progression</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">412</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span><span class="refDoi"> DOI: 10.1016/j.jmb.2011.07.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2Fj.jmb.2011.07.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=21802427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFarurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=412&publication_year=2011&pages=397-411&author=N.+D.+Ambayeauthor=S.+C.+Peroauthor=M.+J.+Gunzburgauthor=M.+Yapauthor=D.+J.+Claytonauthor=M.+P.+Del+Borgoauthor=P.+Perlmutterauthor=M.+I.+Aguilarauthor=G.+S.+Shuklaauthor=E.+Peletskayaauthor=M.+M.+Cooksonauthor=D.+N.+Kragauthor=M.+C.+Wilceauthor=J.+A.+Wilce&title=Structural+basis+of+binding+by+cyclic+nonphosphorylated+peptide+antagonists+of+Grb7+implicated+in+breast+cancer+progression&doi=10.1016%2Fj.jmb.2011.07.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Binding by Cyclic Nonphosphorylated Peptide Antagonists of Grb7 Implicated in Breast Cancer Progression</span></div><div class="casAuthors">Ambaye, Nigus D.; Pero, Stephanie C.; Gunzburg, Menachem J.; Yap, Min Yin; Clayton, Daniel J.; Del Borgo, Mark P.; Perlmutter, Patrick; Aguilar, Marie-Isabel; Shukla, Girja S.; Peletskaya, Elena; Cookson, Michelle M.; Krag, David N.; Wilce, Matthew C. J.; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">412</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-411</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Growth-receptor-bound protein (Grb)7 is an adapter protein aberrantly overexpressed, along with the erbB-2 receptor in breast cancer and in other cancers.  Normally recruited to focal adhesions with a role in cell migration, it is assocd. with erbB-2 in cancer cells and is found to exacerbate cancer progression via stimulation of cell migration and proliferation.  The G7-18NATE peptide (sequence: WFEGYDNTFPC cyclized via a thioether bond) is a nonphosphorylated peptide that was developed for the specific inhibition of Grb7 by blocking its SH2 domain.  Cell-permeable versions of G7-18NATE are effective in the redn. of migration and proliferation in Grb7-overexpressing cells.  It thus represents a promising starting point for the development of a therapeutic against Grb7.  Here, the authors report the crystal structure of the G7-18NATE peptide in complex with the Grb7-SH2 domain, revealing the structural basis for its interaction.  The authors also report further rounds of phage display that have identified G7-18NATE analogs with micromolar affinity for Grb7-SH2.  These peptides retained amino acids F2, G4, and F9, as well as the YDN motif that the structural biol. study showed to be the main residues in contact with the Grb7-SH2 domain.  Isothermal titrn. calorimetry measurements reveal similar and better binding affinity of these peptides compared with G7-18NATE.  Together, this study facilitates the optimization of second-generation inhibitors of Grb7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEQ_mNcka417Vg90H21EOLACvtfcHk0ljWchxPhsZhhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFarurbF&md5=d00128a2cfbc35681abb5fd4f569840f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2011.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2011.07.030%26sid%3Dliteratum%253Aachs%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DYap%26aufirst%3DM.%26aulast%3DClayton%26aufirst%3DD.%2BJ.%26aulast%3DDel%2BBorgo%26aufirst%3DM.%2BP.%26aulast%3DPerlmutter%26aufirst%3DP.%26aulast%3DAguilar%26aufirst%3DM.%2BI.%26aulast%3DShukla%26aufirst%3DG.%2BS.%26aulast%3DPeletskaya%26aufirst%3DE.%26aulast%3DCookson%26aufirst%3DM.%2BM.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DWilce%26aufirst%3DM.%2BC.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DStructural%2520basis%2520of%2520binding%2520by%2520cyclic%2520nonphosphorylated%2520peptide%2520antagonists%2520of%2520Grb7%2520implicated%2520in%2520breast%2520cancer%2520progression%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D412%26spage%3D397%26epage%3D411%26doi%3D10.1016%2Fj.jmb.2011.07.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Waksman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pant, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowburn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/0092-8674(93)90405-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2F0092-8674%2893%2990405-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=7680960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1ejsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1993&pages=779-90&author=G.+Waksmanauthor=S.+E.+Shoelsonauthor=N.+Pantauthor=D.+Cowburnauthor=J.+Kuriyan&title=Binding+of+a+high+affinity+phosphotyrosyl+peptide+to+the+Src+SH2+domain%3A+crystal+structures+of+the+complexed+and+peptide-free+forms&doi=10.1016%2F0092-8674%2893%2990405-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of a high affinity phosphotyrosyl peptide the the Src SH2 domain: Crystal structures of the complexed and peptide-free forms</span></div><div class="casAuthors">Waksman, Gabriel; Shoelson, Steven E.; Pant, Nalin; Cowburn, David; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">779-90</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">The crystal structure of the Src SH2 domain complexed with a high affinity 11-residue phosphopeptide has been detd. at 2.7 Å resoln. by x-ray diffraction.  The peptide binds in an extended conformation and makes primary interactions with the SH2 domain at six central residues: PQ(pY)EEI.  The phosphotyrosine and the isoleucine are tightly bound by two well-defined pockets on the protein surface, resulting in a complex that resembles a two-pronged plug engaging a two-holed socket.  The glutamate residues are in solvent-exposed environments in the vicinity of basic side chains of the SH2 domain, and the two N-terminal residues cap the phosphotyrosine-binding site.  The crystal structure of Src SH2 in the absence of peptide has been detd. at 2.5 Å resoln., and comparison with the structure of the high affinity complex reveals only localized and relatively small changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1igz-31nXDbVg90H21EOLACvtfcHk0ljWchxPhsZhhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1ejsb0%253D&md5=1e9673f84cea2c549b2d47a57add2472</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2893%2990405-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252893%252990405-F%26sid%3Dliteratum%253Aachs%26aulast%3DWaksman%26aufirst%3DG.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DPant%26aufirst%3DN.%26aulast%3DCowburn%26aufirst%3DD.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DBinding%2520of%2520a%2520high%2520affinity%2520phosphotyrosyl%2520peptide%2520to%2520the%2520Src%2520SH2%2520domain%253A%2520crystal%2520structures%2520of%2520the%2520complexed%2520and%2520peptide-free%2520forms%26jtitle%3DCell%26date%3D1993%26volume%3D72%26spage%3D779%26epage%3D90%26doi%3D10.1016%2F0092-8674%2893%2990405-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span> </span><span class="NLM_article-title">Monocarboxylic-based phosphotyrosyl mimetics in the design of GRB2 SH2 domain inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/S0960-894X(98)00740-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2FS0960-894X%2898%2900740-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=347-52&author=T.+R.+Burkeauthor=J.+Luoauthor=Z.+J.+Yaoauthor=Y.+Gaoauthor=H.+Zhaoauthor=G.+W.+Milneauthor=R.+Guoauthor=J.+H.+Voigtauthor=C.+R.+Kingauthor=D.+Yang&title=Monocarboxylic-based+phosphotyrosyl+mimetics+in+the+design+of+GRB2+SH2+domain+inhibitors&doi=10.1016%2FS0960-894X%2898%2900740-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2898%2900740-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252898%252900740-9%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DZ.%2BJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMilne%26aufirst%3DG.%2BW.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKing%26aufirst%3DC.%2BR.%26aulast%3DYang%26aufirst%3DD.%26atitle%3DMonocarboxylic-based%2520phosphotyrosyl%2520mimetics%2520in%2520the%2520design%2520of%2520GRB2%2520SH2%2520domain%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D347%26epage%3D52%26doi%3D10.1016%2FS0960-894X%2898%2900740-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramdas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeyesekere, N. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budde, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, J. S.</span><span> </span><span class="NLM_article-title">Cyclic peptides incorporating 4-carboxyphenylalanine and phosphotyrosine are potent inhibitors of pp60(c-) (src)</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5221</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1021/bi992994f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi992994f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=5221-8&author=W.+Wangauthor=L.+Ramdasauthor=G.+Sunauthor=S.+Keauthor=N.+U.+Obeyesekereauthor=R.+J.+Buddeauthor=J.+S.+McMurray&title=Cyclic+peptides+incorporating+4-carboxyphenylalanine+and+phosphotyrosine+are+potent+inhibitors+of+pp60%28c-%29+%28src%29&doi=10.1021%2Fbi992994f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi992994f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi992994f%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DRamdas%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DKe%26aufirst%3DS.%26aulast%3DObeyesekere%26aufirst%3DN.%2BU.%26aulast%3DBudde%26aufirst%3DR.%2BJ.%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26atitle%3DCyclic%2520peptides%2520incorporating%25204-carboxyphenylalanine%2520and%2520phosphotyrosine%2520are%2520potent%2520inhibitors%2520of%2520pp60%2528c-%2529%2520%2528src%2529%26jtitle%3DBiochemistry%26date%3D2000%26volume%3D39%26spage%3D5221%26epage%3D8%26doi%3D10.1021%2Fbi992994f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Tilley, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulkerins, K.</span><span> </span><span class="NLM_article-title">Preparation of carboalkoxyalkylphenylalanine derivatives from tyrosine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span><span class="refDoi"> DOI: 10.1021/jo00290a021</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00290a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK3cXnslyqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=906-910&author=J.+W.+Tilleyauthor=R.+Sarabuauthor=R.+Wagnerauthor=K.+Mulkerins&title=Preparation+of+carboalkoxyalkylphenylalanine+derivatives+from+tyrosine&doi=10.1021%2Fjo00290a021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of carboalkoxyalkylphenylalanine derivatives from tyrosine</span></div><div class="casAuthors">Tilley, Jefferson W.; Sarabu, Ramakanth; Wagner, Rolf; Mulkerins, Kathleen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">906-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">In order to provide the means for the synthesis of peptides incorporating stable and relatively nonpolar mimics of tyrosine phosphates and sulfates, procedures have been developed for the conversion of tyrosine derivs. to carbalkoxyalkylphenylalanines.  Thus, tyrosine triflates I (Boc = Me3CO2C; R = CHPh2, CH2Ph) are coupled with an acrylate ester or preferably a 2-(trialkylstannyl)acrylate in the presence of Pd(PPh3)2Cl2 to give carbalkoxyethenylphenylalanine derivs. II (R = CHPh2, R1 = CMe3; R = CH2Ph, R1 = Me).  Hydrogenation of II affords the carbalkoxyethylphenylalanine derivs. III (R1 = same).  For the prepn. of carbalkoxymethylphenylalanines I (R = CH2Ph, Me) are coupled with CH2=CHCH2SnBu3 in the presence of Pd(PPh3)2Cl2 and LiCl to give an ester of 4-allylphenylalanine.  A two-stage oxidn. using RuO4-NaIO4 followed by NaO2Cl in phosphate buffer gives a carboxymethylphenylalanine.  Esterification of the newly formed carboxylic acid and selective deesterification of the α-carboxylate completes the synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_P9Dk0loiXbVg90H21EOLACvtfcHk0liEnjNG7V_4Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXnslyqug%253D%253D&md5=48f6c47b28f14bd8e42730a1ef43e380</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo00290a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00290a021%26sid%3Dliteratum%253Aachs%26aulast%3DTilley%26aufirst%3DJ.%2BW.%26aulast%3DSarabu%26aufirst%3DR.%26aulast%3DWagner%26aufirst%3DR.%26aulast%3DMulkerins%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520carboalkoxyalkylphenylalanine%2520derivatives%2520from%2520tyrosine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D906%26epage%3D910%26doi%3D10.1021%2Fjo00290a021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Janes, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span> </span><span class="NLM_article-title">Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">8490</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1074/jbc.272.13.8490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.272.13.8490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=8490-7&author=P.+W.+Janesauthor=M.+Lackmannauthor=W.+B.+Churchauthor=G.+M.+Sandersonauthor=R.+L.+Sutherlandauthor=R.+J.+Daly&title=Structural+determinants+of+the+interaction+between+the+erbB2+receptor+and+the+Src+homology+2+domain+of+Grb7&doi=10.1074%2Fjbc.272.13.8490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.13.8490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.13.8490%26sid%3Dliteratum%253Aachs%26aulast%3DJanes%26aufirst%3DP.%2BW.%26aulast%3DLackmann%26aufirst%3DM.%26aulast%3DChurch%26aufirst%3DW.%2BB.%26aulast%3DSanderson%26aufirst%3DG.%2BM.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520determinants%2520of%2520the%2520interaction%2520between%2520the%2520erbB2%2520receptor%2520and%2520the%2520Src%2520homology%25202%2520domain%2520of%2520Grb7%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D8490%26epage%3D7%26doi%3D10.1074%2Fjbc.272.13.8490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bevington, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundy, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanis, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radda, G. K.</span><span> </span><span class="NLM_article-title">A study of intracellular orthophosphate concentration in human muscle and erythrocytes by 31P nuclear magnetic resonance spectroscopy and selective chemical assay</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">729</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1042/cs0710729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1042%2Fcs0710729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=3024899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaL2sXkvVWnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1986&pages=729-35&author=A.+Bevingtonauthor=K.+I.+Mundyauthor=A.+J.+Yatesauthor=J.+A.+Kanisauthor=R.+G.+Russellauthor=D.+J.+Taylorauthor=B.+Rajagopalanauthor=G.+K.+Radda&title=A+study+of+intracellular+orthophosphate+concentration+in+human+muscle+and+erythrocytes+by+31P+nuclear+magnetic+resonance+spectroscopy+and+selective+chemical+assay&doi=10.1042%2Fcs0710729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A study of intracellular orthophosphate concentration in human muscle and erythrocytes by phosphorus-31 nuclear magnetic resonance spectroscopy and selective chemical assay</span></div><div class="casAuthors">Bevington, A.; Mundy, K. I.; Yates, A. J. P.; Kanis, J. A.; Russell, R. G. G.; Taylor, D. J.; Rajagopalan, B.; Radda, G. K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">729-35</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    </div><div class="casAbstract">To study the relation between extracellular and intracellular concns. of orthophosphate (Pi), phosphorus NMR spectra were recorded, at rest, from the flexor digitorum superficialis muscle of hypophosphatemic patients with vitamin D-resistant rickets, and patients with Paget's disease of bone before and after they had been made hyperphosphatemic by treatment with ethylidene-1-hydroxy-1,1-bisphosphonate.  Changes in i.m. Pi were estd. from the ratio of the areas of the Pi to ATP peaks.  Even though the plasma Pi concn. in these patients spanned a 4-fold range (0.5-2.0 mmol/L) the corresponding i.m. Pi concn. increased by only 70%.  A similar effect was obsd. in erythrocytes from patients with these disorders which were incubated in autologous plasma at 37°, under an atm. of O2 + CO2.  However, there was no general effect on passive anion distribution.  When erythrocytes from normal subjects were incubated in autologous plasma and in plasma supplemented with Pi the Pi concn. in the cells, at steady state, increased only from 0.57 to 0.78 mmol/L cells, suggesting that effect was not an artifact of disease or drug therapy.  Thus, in human skeletal myocytes and erythrocytes, the percentage change in the concn. of cytoplasmic Pi is lower than that in plasma.  This implies that these cells can buffer or regulate cytoplasmic Pi when the extracellular concn. is disturbed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVQuVo95gnZbVg90H21EOLACvtfcHk0lgd3gFkm4FXYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXkvVWnsA%253D%253D&md5=55a9afb0860b8079327f9bc6814ab888</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1042%2Fcs0710729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fcs0710729%26sid%3Dliteratum%253Aachs%26aulast%3DBevington%26aufirst%3DA.%26aulast%3DMundy%26aufirst%3DK.%2BI.%26aulast%3DYates%26aufirst%3DA.%2BJ.%26aulast%3DKanis%26aufirst%3DJ.%2BA.%26aulast%3DRussell%26aufirst%3DR.%2BG.%26aulast%3DTaylor%26aufirst%3DD.%2BJ.%26aulast%3DRajagopalan%26aufirst%3DB.%26aulast%3DRadda%26aufirst%3DG.%2BK.%26atitle%3DA%2520study%2520of%2520intracellular%2520orthophosphate%2520concentration%2520in%2520human%2520muscle%2520and%2520erythrocytes%2520by%252031P%2520nuclear%2520magnetic%2520resonance%2520spectroscopy%2520and%2520selective%2520chemical%2520assay%26jtitle%3DClin.%2520Sci.%26date%3D1986%26volume%3D71%26spage%3D729%26epage%3D35%26doi%3D10.1042%2Fcs0710729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Gilmer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimery, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternbach, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehrotra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradshaw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, J.</span><span> </span><span class="NLM_article-title">Peptide inhibitors of src SH3-SH2-phosphoprotein interactions</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">31711</span><span class="NLM_x">–</span> <span class="NLM_lpage">31719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=7527393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK2MXitVSksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=31711-31719&author=T.+Gilmerauthor=M.+Rodriguezauthor=S.+Jordanauthor=R.+Crosbyauthor=K.+Alligoodauthor=M.+Greenauthor=M.+Kimeryauthor=C.+Wagnerauthor=D.+Kinderauthor=P.+Charifsonauthor=A.+M.+Hassellauthor=D.+Willardauthor=M.+Lutherauthor=D.+Rusnakauthor=D.+D.+Sternbachauthor=M.+Mehrotraauthor=M.+Peelauthor=L.+Shampineauthor=R.+Davisauthor=J.+Robbinsauthor=I.+R.+Patelauthor=D.+Kasselauthor=W.+Burkhartauthor=M.+Moyerauthor=T.+Bradshawauthor=J.+Berman&title=Peptide+inhibitors+of+src+SH3-SH2-phosphoprotein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide inhibitors of src SH3-SH2-phosphoprotein interactions</span></div><div class="casAuthors">Gilmer, Tona; Rodriguez, Marc; Jordan, Steve; Crosby, Renae; Alligood, Krystal; Green, Michael; Kimery, Millard; Wagner, Craig; Kinder, Dan; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">31711-19</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Activated pp60c-src has been implicated in a no. of human malignancies including colon carcinoma and breast adenocarcinoma.  Assocn. of the src SH2 domain with tyrosine-phosphorylated proteins plays a role in src-mediated signal transduction.  Inhibitors of src SH2 domain-phosphoprotein interactions are, thus, of great interest in defining the role(s) of src in signal transduction pathways.  To facilitate such studies, an ELISA was developed to detect inhibitors of src SH2-phosphoprotein interactions.  This assay measures inhibition of binding of a fusion construct (glutathione S-transferase src SH3-SH2) with autophosphorylated epidermal growth factor receptor tyrosine kinase domain.  Activities of phosphopeptide segments derived from potential src SH2 cognate phosphoprotein partners were detd., with the focal adhesion kinase-derived segment VSETDDY*AEIIDE yielding the highest inhibitory activity.  Structure activity studies starting from acetyl (Ac)-Y*EEIE have identified Ac-Y*Y*Y*IE as the most active compd. screened in the ELISA.  This compd. is at least 20-fold more active than the parent peptide Ac-Y*EEIE.  A high resoln. (2 Å) crystal structure of human src SH2 complexed with Ac-Y*EEIE was obtained and provided a useful framework for understanding the structure-activity relationships.  Addnl., Ac-Y*EEIE was able to block interactions between src and its cellular phosphoprotein partners in vanadate-treated cell lysates from MDA-MB-468 breast carcinoma cells.  However, it is unable to abrogate proliferation of MDA-MB-468 cells in culture, presumably because of poor cell penetration and/or lability of the phosphate group on tyrosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnieHWiS0-yrVg90H21EOLACvtfcHk0lgd3gFkm4FXYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitVSksL8%253D&md5=518ae19a4451a4e9a2a9a102a6ec86da</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilmer%26aufirst%3DT.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DJordan%26aufirst%3DS.%26aulast%3DCrosby%26aufirst%3DR.%26aulast%3DAlligood%26aufirst%3DK.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DKimery%26aufirst%3DM.%26aulast%3DWagner%26aufirst%3DC.%26aulast%3DKinder%26aufirst%3DD.%26aulast%3DCharifson%26aufirst%3DP.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DWillard%26aufirst%3DD.%26aulast%3DLuther%26aufirst%3DM.%26aulast%3DRusnak%26aufirst%3DD.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DMehrotra%26aufirst%3DM.%26aulast%3DPeel%26aufirst%3DM.%26aulast%3DShampine%26aufirst%3DL.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DRobbins%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DI.%2BR.%26aulast%3DKassel%26aufirst%3DD.%26aulast%3DBurkhart%26aufirst%3DW.%26aulast%3DMoyer%26aufirst%3DM.%26aulast%3DBradshaw%26aufirst%3DT.%26aulast%3DBerman%26aufirst%3DJ.%26atitle%3DPeptide%2520inhibitors%2520of%2520src%2520SH3-SH2-phosphoprotein%2520interactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D31711%26epage%3D31719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schembri-King, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betageri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proudfoot, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span> </span><span class="NLM_article-title">Carboxymethyl-phenylalanine as a replacement for phosphotyrosine in SH2 domain binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">20238</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1074/jbc.273.32.20238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.273.32.20238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=9685372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVWgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=20238-42&author=L.+Tongauthor=T.+C.+Warrenauthor=S.+Lukasauthor=J.+Schembri-Kingauthor=R.+Betageriauthor=J.+R.+Proudfootauthor=S.+Jakes&title=Carboxymethyl-phenylalanine+as+a+replacement+for+phosphotyrosine+in+SH2+domain+binding&doi=10.1074%2Fjbc.273.32.20238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxymethyl-phenylalanine as a replacement for phosphotyrosine in SH2 domain binding</span></div><div class="casAuthors">Tong, Liang; Warren, Thomas C.; Lukas, Susan; Schembri-King, Josephine; Betageri, Raj; Proudfoot, John R.; Jakes, Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">20238-20242</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The crystal structure of human p56lck SH2 domain in complex with an inhibitor contg. the singly charged p-(carboxymethyl)phenylalanine residue (cmF) as a phosphotyrosine (Tyr(P) or pY) replacement has been detd. at 1.8 Å resoln.  The binding mode of the acetyl-cmF-Glu-Glu-Ile (cmFEEI) inhibitor is very similar to that of the pYEEI inhibitor, confirming that the cmFEEI inhibitor has a similar mechanism of SH2 domain inhibition despite its significantly reduced potency.  Obsd. conformational differences in the side chain of the cmF residue can be interpreted in terms of maintaining similar interactions with the SH2 domain as the Tyr(P) residue.  The crystal structure of the free p56lck SH2 domain has been detd. at 1.9 Å resoln. and shows an open conformation for the BC loop and an open phosphotyrosine binding pocket, in contrast to earlier studies on the src SH2 domain that showed mostly closed conformation.  The structural information presented here suggests that the carboxymethyl-phenylalanine residue may be a viable Tyr(P) replacement and represents an attractive starting point for the design and development of SH2 domain inhibitors with better pharmaceutical profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCtEGBp8YC-7Vg90H21EOLACvtfcHk0lgd3gFkm4FXYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVWgt7w%253D&md5=e5b2dda75277cf70a95953fb98550ecc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.32.20238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.32.20238%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DWarren%26aufirst%3DT.%2BC.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DSchembri-King%26aufirst%3DJ.%26aulast%3DBetageri%26aufirst%3DR.%26aulast%3DProudfoot%26aufirst%3DJ.%2BR.%26aulast%3DJakes%26aufirst%3DS.%26atitle%3DCarboxymethyl-phenylalanine%2520as%2520a%2520replacement%2520for%2520phosphotyrosine%2520in%2520SH2%2520domain%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D20238%26epage%3D42%26doi%3D10.1074%2Fjbc.273.32.20238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Yao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1021/jm980388x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980388x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=25-35&author=Z.+J.+Yaoauthor=C.+R.+Kingauthor=T.+Caoauthor=J.+Kelleyauthor=G.+W.+Milneauthor=J.+H.+Voigtauthor=T.+R.+Burke&title=Potent+inhibition+of+Grb2+SH2+domain+binding+by+non-phosphate-containing+ligands&doi=10.1021%2Fjm980388x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm980388x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980388x%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DZ.%2BJ.%26aulast%3DKing%26aufirst%3DC.%2BR.%26aulast%3DCao%26aufirst%3DT.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DMilne%26aufirst%3DG.%2BW.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DPotent%2520inhibition%2520of%2520Grb2%2520SH2%2520domain%2520binding%2520by%2520non-phosphate-containing%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D25%26epage%3D35%26doi%3D10.1021%2Fjm980388x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Bradshaw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitaxov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waksman, G.</span><span> </span><span class="NLM_article-title">Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1006/jmbi.1999.3190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1006%2Fjmbi.1999.3190" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=1999&pages=971-85&author=J.+M.+Bradshawauthor=V.+Mitaxovauthor=G.+Waksman&title=Investigation+of+phosphotyrosine+recognition+by+the+SH2+domain+of+the+Src+kinase&doi=10.1006%2Fjmbi.1999.3190"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1999.3190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1999.3190%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26aulast%3DMitaxov%26aufirst%3DV.%26aulast%3DWaksman%26aufirst%3DG.%26atitle%3DInvestigation%2520of%2520phosphotyrosine%2520recognition%2520by%2520the%2520SH2%2520domain%2520of%2520the%2520Src%2520kinase%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D293%26spage%3D971%26epage%3D85%26doi%3D10.1006%2Fjmbi.1999.3190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Luzy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gril, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perdereau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnol, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbay, C.</span><span> </span><span class="NLM_article-title">Development of binding assays for the SH2 domain of Grb7 and Grb2 using fluorescence polarization</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1177/1087057107312124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1177%2F1087057107312124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=18216394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A280%3ADC%252BD1c7ls1Wruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=112-9&author=J.+P.+Luzyauthor=H.+Chenauthor=B.+Grilauthor=W.+Q.+Liuauthor=M.+Vidalauthor=D.+Perdereauauthor=A.+F.+Burnolauthor=C.+Garbay&title=Development+of+binding+assays+for+the+SH2+domain+of+Grb7+and+Grb2+using+fluorescence+polarization&doi=10.1177%2F1087057107312124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Development of binding assays for the SH2 domain of Grb7 and Grb2 using fluorescence polarization</span></div><div class="casAuthors">Luzy Jean-Philippe; Chen Huixiong; Gril Brunilde; Liu Wang-Qing; Vidal Michel; Perdereau Dominique; Burnol Anne-Francoise; Garbay Christiane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-9</span>
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    </div><div class="casAbstract">Adaptor proteins Grb7 and Grb2 have been implicated as being 2 potential therapeutic targets in several human cancers, especially those that overexpress ErbB2.  These 2 proteins contain both a SH2 domain (Src homology 2) that binds to phosphorylated tyrosine residues contained within ErbB2 and other specific protein targets.  Two assays based on enzyme-linked immunosorbent assay and fluorescence polarization methods have been developed and validated to find and rank inhibitors for both proteins binding to the pY(1139).  Fluorescence polarization assays allowed the authors to determine quickly and reproducibly affinities of peptides from low nanomolar to high micromolar range and to compare them directly for Grb7 and Grb2.  As a result, the assays have identified a known peptidomimetic Grb2 SH2 inhibitor (mAZ-pTyr-(alphaMe)pTyr-Asn-NH(2)) that exhibits the most potent affinity for the Grb7 SH2 domain described to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3mLga0R_gaXWEEzDrymxmfW6udTcc2eZ2d0X_HTysXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7ls1Wruw%253D%253D&md5=3c799e3b379686a63ddb5ef461182ff6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1177%2F1087057107312124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057107312124%26sid%3Dliteratum%253Aachs%26aulast%3DLuzy%26aufirst%3DJ.%2BP.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DGril%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DW.%2BQ.%26aulast%3DVidal%26aufirst%3DM.%26aulast%3DPerdereau%26aufirst%3DD.%26aulast%3DBurnol%26aufirst%3DA.%2BF.%26aulast%3DGarbay%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520binding%2520assays%2520for%2520the%2520SH2%2520domain%2520of%2520Grb7%2520and%2520Grb2%2520using%2520fluorescence%2520polarization%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2008%26volume%3D13%26spage%3D112%26epage%3D9%26doi%3D10.1177%2F1087057107312124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2Fj.bmc.2010.10.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=693-701&author=N.+D.+Ambayeauthor=M.+J.+Gunzburgauthor=R.+C.+Limauthor=J.+T.+Priceauthor=M.+C.+Wilceauthor=J.+A.+Wilce&title=Benzopyrazine+derivatives%3A+A+novel+class+of+growth+factor+receptor+bound+protein+7+antagonists&doi=10.1016%2Fj.bmc.2010.10.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DLim%26aufirst%3DR.%2BC.%26aulast%3DPrice%26aufirst%3DJ.%2BT.%26aulast%3DWilce%26aufirst%3DM.%2BC.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DBenzopyrazine%2520derivatives%253A%2520A%2520novel%2520class%2520of%2520growth%2520factor%2520receptor%2520bound%2520protein%25207%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D693%26epage%3D701%26doi%3D10.1016%2Fj.bmc.2010.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">The discovery of phenylbenzamide derivatives as Grb7-based antitumor agents</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1002/cmdc.201200400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1002%2Fcmdc.201200400" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=280-8&author=N.+D.+Ambayeauthor=M.+J.+Gunzburgauthor=R.+C.+Limauthor=J.+T.+Priceauthor=M.+C.+Wilceauthor=J.+A.+Wilce&title=The+discovery+of+phenylbenzamide+derivatives+as+Grb7-based+antitumor+agents&doi=10.1002%2Fcmdc.201200400"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200400%26sid%3Dliteratum%253Aachs%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DLim%26aufirst%3DR.%2BC.%26aulast%3DPrice%26aufirst%3DJ.%2BT.%26aulast%3DWilce%26aufirst%3DM.%2BC.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520discovery%2520of%2520phenylbenzamide%2520derivatives%2520as%2520Grb7-based%2520antitumor%2520agents%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D280%26epage%3D8%26doi%3D10.1002%2Fcmdc.201200400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Morlacchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klostergaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, J. S.</span><span> </span><span class="NLM_article-title">Targeting SH2 domains in breast cancer</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1909</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.4155/fmc.14.120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.4155%2Ffmc.14.120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=25495984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyltr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1909-26&author=P.+Morlacchiauthor=F.+M.+Robertsonauthor=J.+Klostergaardauthor=J.+S.+McMurray&title=Targeting+SH2+domains+in+breast+cancer&doi=10.4155%2Ffmc.14.120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting SH2 domains in breast cancer</span></div><div class="casAuthors">Morlacchi, Pietro; Robertson, Fredika M.; Klostergaard, Jim; McMurray, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1909-1926</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Breast cancer is among the most commonly diagnosed cancer types in women worldwide and is the second leading cause of cancer-related disease in the USA.  SH2 domains recruit signaling proteins to phosphotyrosine residues on aberrantly activated growth factor and cytokine receptors and contribute to cancer cell cycling, metastasis, angiogenesis and so on.  Herein we review phosphopeptide mimetic and small-mol. approaches targeting the SH2 domains of Grb2, Grb7 and STAT3 that inhibit their targets and reduce proliferation in in vitro breast cancer models.  Only STAT3 inhibitors have been evaluated in in vivo models and have led to tumor redn.  Taken together, these studies suggest that targeting SH2 domains is an important approach to the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp32Npe7yuuhLVg90H21EOLACvtfcHk0liOjTUk4yndbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyltr%252FF&md5=0d4052d2ffc3a2396183fd21358aee65</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.120%26sid%3Dliteratum%253Aachs%26aulast%3DMorlacchi%26aufirst%3DP.%26aulast%3DRobertson%26aufirst%3DF.%2BM.%26aulast%3DKlostergaard%26aufirst%3DJ.%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26atitle%3DTargeting%2520SH2%2520domains%2520in%2520breast%2520cancer%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1909%26epage%3D26%26doi%3D10.4155%2Ffmc.14.120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Pace, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, T.</span><span> </span><span class="NLM_article-title">How to measure and predict the molar absorption coefficient of a protein</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1002/pro.5560041120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1002%2Fpro.5560041120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=8563639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK2MXpsVGqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1995&pages=2411-23&author=C.+N.+Paceauthor=F.+Vajdosauthor=L.+Feeauthor=G.+Grimsleyauthor=T.+Gray&title=How+to+measure+and+predict+the+molar+absorption+coefficient+of+a+protein&doi=10.1002%2Fpro.5560041120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">How to measure and predict the molar absorption coefficient of a protein</span></div><div class="casAuthors">Pace, C. Nick; Vajdos, Felix; Fee, Lanette; Grimsley, Gerald; Gray, Theronica</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2411-23</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The molar absorption coeff., ε, of a protein is usually based on concns. measured by dry wt., nitrogen, or amino acid anal.  The studies reported here suggest that the Edelhoch method is the best method for measuring ε for a protein.  (This method is described by Gill and von Hippel [1989, Anal Biochem 182:319-326] and is based on data from Edelhoch [1967, Biochem. 6:1948-1954].).  The av. ε values for these chromophores in a sample of 18 well-characterized proteins have been estd., and the ε values in water, propanol, 6 M guanidine hydrochloride (GdnHCl), and 8 M urea have been measured.  For Trp, the av. ε values for the proteins are intermediate between those measured in 6 M GdnHCl and those measured in propanol.  Based on a sample of 116 measured ε values for 80 proteins, the ε at 280 nm of a folded protein in water, ε(280), can best be predicted with this equation L ε(280) (M-1 cm-1) = (#Trp)(5,500) + (#Tyr)(1,490) + (#cystine)(125).  These ε(280) values are quite reliable for proteins contg. Trp residues, and less reliable for proteins that do not.  However, the Edelhoch method is convenient and accurate, and the best approach is to measure rather than predict ε.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDyrAj6uk11bVg90H21EOLACvtfcHk0liOjTUk4yndbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsVGqt7k%253D&md5=033237a125c7486331bf5180047c3cd4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560041120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560041120%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DC.%2BN.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DFee%26aufirst%3DL.%26aulast%3DGrimsley%26aufirst%3DG.%26aulast%3DGray%26aufirst%3DT.%26atitle%3DHow%2520to%2520measure%2520and%2520predict%2520the%2520molar%2520absorption%2520coefficient%2520of%2520a%2520protein%26jtitle%3DProtein%2520Sci.%26date%3D1995%26volume%3D4%26spage%3D2411%26epage%3D23%26doi%3D10.1002%2Fpro.5560041120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Leslie, A. W.; Powell, H.</span><span> </span><span class="NLM_article-title">Processing Diffraction Data with Mosflm</span>. In  <span class="citation_source-book">Evolving Methods for Macromolecular Crystallography</span>, <span class="NLM_contrib-group">Read, R.; Sussman, J.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">245</span>, pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2F978-1-4020-6316-9_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=41-51&author=A.+W.+Leslie&author=H.+Powellauthor=R.+Read&author=J.+Sussman&title=Evolving+Methods+for+Macromolecular+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6316-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4020-6316-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BW.%26atitle%3DProcessing%2520Diffraction%2520Data%2520with%2520Mosflm%26btitle%3DEvolving%2520Methods%2520for%2520Macromolecular%2520Crystallography%26aulast%3DRead%26aufirst%3DR.%26pub%3DSpringer%26date%3D2007%26volume%3D245%26spage%3D41%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Evans, P.</span><span> </span><span class="NLM_article-title">Scaling and assessment of data quality</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+assessment+of+data+quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0liOjTUk4yndbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520assessment%2520of%2520data%2520quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-42&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0liOjTUk4yndbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D42%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplyakov, A.</span><span> </span><span class="NLM_article-title">Molecular replacement with MOLREP</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span><span class="refDoi"> DOI: 10.1107/S0907444909042589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444909042589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=20057045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=22-5&author=A.+Vaginauthor=A.+Teplyakov&title=Molecular+replacement+with+MOLREP&doi=10.1107%2FS0907444909042589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular replacement with MOLREP</span></div><div class="casAuthors">Vagin, Alexei; Teplyakov, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-25</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MOLREP is an automated program for mol. replacement that utilizes a no. of original approaches to rotational and translational search and data prepn.  Since the first publication describing the program, MOLREP has acquired a variety of features that include weighting of the X-ray data and search models, multi-copy search, fitting the model into electron d., structural superposition of two models and rigid-body refinement.  The program can run in a fully automatic mode using optimized parameters calcd. from the input data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzj5SzYvyu_7Vg90H21EOLACvtfcHk0lgPpILIeTrf_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktw%253D%253D&md5=820d114719aca209994ffb0403e3b20d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042589%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DTeplyakov%26aufirst%3DA.%26atitle%3DMolecular%2520replacement%2520with%2520MOLREP%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D22%26epage%3D5%26doi%3D10.1107%2FS0907444909042589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-32&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lgPpILIeTrf_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D32%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-55&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lgPpILIeTrf_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D55%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustyakimov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urzhumtsev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span> </span><span class="NLM_article-title">Towards automated crystallographic structure refinement with phenix.refine</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1107/S0907444912001308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444912001308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=22505256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=352-67&author=P.+V.+Afonineauthor=R.+W.+Grosse-Kunstleveauthor=N.+Echolsauthor=J.+J.+Headdauthor=N.+W.+Moriartyauthor=M.+Mustyakimovauthor=T.+C.+Terwilligerauthor=A.+Urzhumtsevauthor=P.+H.+Zwartauthor=P.+D.+Adams&title=Towards+automated+crystallographic+structure+refinement+with+phenix.refine&doi=10.1107%2FS0907444912001308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Towards automated crystallographic structure refinement with phenix.refine</span></div><div class="casAuthors">Afonine, Pavel V.; Grosse-Kunstleve, Ralf W.; Echols, Nathaniel; Headd, Jeffrey J.; Moriarty, Nigel W.; Mustyakimov, Marat; Terwilliger, Thomas C.; Urzhumtsev, Alexandre; Zwart, Peter H.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">352-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phenix.refine is a program within the PHENIX package that supports crystallog. structure refinement against exptl. data with a wide range of upper resoln. limits using a large repertoire of model parameterizations.  It has several automation features and is also highly flexible.  Several hundred parameters enable extensive customizations for complex use cases.  Multiple user-defined refinement strategies can be applied to specific parts of the model in a single refinement run.  An intuitive graphical user interface is available to guide novice users and to assist advanced users in managing refinement projects.  X-ray or neutron diffraction data can be used sep. or jointly in refinement. phenix.refine is tightly integrated into the PHENIX suite, where it serves as a crit. component in automated model building, final structure refinement, structure validation and deposition to the wwPDB.  This paper presents an overview of the major phenix.refine features, with extensive literature refs. for readers interested in more detailed discussions of the methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnhn9QwIEkTbVg90H21EOLACvtfcHk0lgjd8qKgfbm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D&md5=1cc7da2cea396f1a75646ea709140cf1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001308%26sid%3Dliteratum%253Aachs%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DMustyakimov%26aufirst%3DM.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DUrzhumtsev%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DTowards%2520automated%2520crystallographic%2520structure%2520refinement%2520with%2520phenix.refine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D352%26epage%3D67%26doi%3D10.1107%2FS0907444912001308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">McPhillips, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhillips, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phizackerley, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltis, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span> </span><span class="NLM_article-title">Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1107/S0909049502015170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0909049502015170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=12409628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=401-6&author=T.+M.+McPhillipsauthor=S.+E.+McPhillipsauthor=H.+J.+Chiuauthor=A.+E.+Cohenauthor=A.+M.+Deaconauthor=P.+J.+Ellisauthor=E.+Garmanauthor=A.+Gonzalezauthor=N.+K.+Sauterauthor=R.+P.+Phizackerleyauthor=S.+M.+Soltisauthor=P.+Kuhn&title=Blu-Ice+and+the+Distributed+Control+System%3A+software+for+data+acquisition+and+instrument+control+at+macromolecular+crystallography+beamlines&doi=10.1107%2FS0909049502015170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines</span></div><div class="casAuthors">McPhillips, Timothy M.; McPhillips, Scott E.; Chiu, Hsiu Ju; Cohen, Aina E.; Deacon, Ashley M.; Ellis, Paul J.; Garman, Elspeth; Gonzalez, Ana; Sauter, Nicholas K.; Phizackerley, R. Paul; Soltis, S. Michael; Kuhn, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-406</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">The Blu-Ice and Distributed Control System (DCS) software packages were developed to provide unified control over the disparate hardware resources available at a macromol. crystallog. beamline.  Blu-Ice is a user interface that provides scientific experimenters and beamline support staff with intuitive graphical tools for collecting diffraction data and configuring beamlines for expts.  Blu-Ice communicates with the hardware at a beamline via DCS, an instrument-control and data-acquisition package designed to integrate hardware resources in a highly heterogeneous networked computing environment.  Together, Blu-Ice and DCS provide a flexible platform for increasing the ease of use, the level of automation and the remote accessibility of beamlines.  Blu-Ice and DCS are currently installed on four Stanford Synchrotron Radiation Lab. crystallog. beamlines and are being implemented at sister light sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVsQUIFJPBLVg90H21EOLACvtfcHk0lgjd8qKgfbm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D&md5=c77228bd50890463f3e43e981a2e238a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1107%2FS0909049502015170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049502015170%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhillips%26aufirst%3DT.%2BM.%26aulast%3DMcPhillips%26aufirst%3DS.%2BE.%26aulast%3DChiu%26aufirst%3DH.%2BJ.%26aulast%3DCohen%26aufirst%3DA.%2BE.%26aulast%3DDeacon%26aufirst%3DA.%2BM.%26aulast%3DEllis%26aufirst%3DP.%2BJ.%26aulast%3DGarman%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DPhizackerley%26aufirst%3DR.%2BP.%26aulast%3DSoltis%26aufirst%3DS.%2BM.%26aulast%3DKuhn%26aufirst%3DP.%26atitle%3DBlu-Ice%2520and%2520the%2520Distributed%2520Control%2520System%253A%2520software%2520for%2520data%2520acquisition%2520and%2520instrument%2520control%2520at%2520macromolecular%2520crystallography%2520beamlines%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2002%26volume%3D9%26spage%3D401%26epage%3D6%26doi%3D10.1107%2FS0909049502015170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Winter, G.</span><span> </span><span class="NLM_article-title">xia2: an expert system for macromolecular crystallography data reduction</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span><span class="refDoi"> DOI: 10.1107/S0021889809045701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0021889809045701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFalsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2010&pages=186-190&author=G.+Winter&title=xia2%3A+an+expert+system+for+macromolecular+crystallography+data+reduction&doi=10.1107%2FS0021889809045701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">xia2: An expert system for macromolecular crystallography data reduction</span></div><div class="casAuthors">Winter, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">186-190, S186/1-S186/5</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An expert system for macromol. crystallog. data redn. is presented, which builds on existing software to automate the complete data redn. process from images to merged structure factor amplitudes.  This can automatically identify multi-wedge, multi-pass and multiwavelength data sets and includes explicit procedures to test for crystallog. special cases.  With the push towards high-throughput crystallog. at synchrotron beamlines and automation of structure soln., the ability to reduce data with no user input fills an important gap in the pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOi3u0ydXbSrVg90H21EOLACvtfcHk0lgjd8qKgfbm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFalsrk%253D&md5=27771caa813f3e828abdf2a331ae55e3</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1107%2FS0021889809045701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889809045701%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%26atitle%3Dxia2%253A%2520an%2520expert%2520system%2520for%2520macromolecular%2520crystallography%2520data%2520reduction%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2010%26volume%3D43%26spage%3D186%26epage%3D190%26doi%3D10.1107%2FS0021889809045701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lht-M9686QQlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span> </span><span class="NLM_article-title">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span><span class="refDoi"> DOI: 10.1107/S0907444909029436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444909029436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=19770504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=1074-80&author=N.+W.+Moriartyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adams&title=electronic+Ligand+Builder+and+Optimization+Workbench+%28eLBOW%29%3A+a+tool+for+ligand+coordinate+and+restraint+generation&doi=10.1107%2FS0907444909029436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span></div><div class="casAuthors">Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The electronic Ligand Builder and Optimization Workbench (eLBOW) is a program module of the PHENIX suite of computational crystallog. software.  It is designed to be a flexible procedure that uses simple and fast quantum-chem. techniques to provide chem. accurate information for novel and known ligands alike.  A variety of input formats and options allow the attainment of a no. of diverse goals including geometry optimization and generation of restraints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnN4AVY_DwrVg90H21EOLACvtfcHk0lht-M9686QQlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN&md5=3f9a9c6c31c9a4b014a9f151fb6aa8d9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1107%2FS0907444909029436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909029436%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3Delectronic%2520Ligand%2520Builder%2520and%2520Optimization%2520Workbench%2520%2528eLBOW%2529%253A%2520a%2520tool%2520for%2520ligand%2520coordinate%2520and%2520restraint%2520generation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D1074%26epage%3D80%26doi%3D10.1107%2FS0907444909029436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendall, W. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keedy, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">MolProbity: all-atom structure validation for macromolecular crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1107/S0907444909042073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444909042073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=20057044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=12-21&author=V.+B.+Chenauthor=W.+B.+Arendallauthor=J.+J.+Headdauthor=D.+A.+Keedyauthor=R.+M.+Immorminoauthor=G.+J.+Kapralauthor=L.+W.+Murrayauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+structure+validation+for+macromolecular+crystallography&doi=10.1107%2FS0907444909042073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom structure validation for macromolecular crystallography</span></div><div class="casAuthors">Chen, Vincent B.; Arendall, W. Bryan, III; Headd, Jeffrey J.; Keedy, Daniel A.; Immormino, Robert M.; Kapral, Gary J.; Murray, Laura W.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MolProbity is a structure-validation web service that provides broad-spectrum solidly based evaluation of model quality at both the global and local levels for both proteins and nucleic acids.  It relies heavily on the power and sensitivity provided by optimized hydrogen placement and all-atom contact anal., complemented by updated versions of covalent-geometry and torsion-angle criteria.  Some of the local corrections can be performed automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms that help guide manual rebuilding.  X-ray crystallog. provides a wealth of biol. important mol. data in the form of at. three-dimensional structures of proteins, nucleic acids and increasingly large complexes in multiple forms and states.  Advances in automation, in everything from crystn. to data collection to phasing to model building to refinement, have made solving a structure using crystallog. easier than ever.  However, despite these improvements, local errors that can affect biol. interpretation are widespread at low resoln. and even high-resoln. structures nearly all contain at least a few local errors such as Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers.  It is crit. both for the crystallographer and for the end user that there are easy and reliable methods to diagnose and correct these sorts of errors in structures.  MolProbity is the authors' contribution to helping solve this problem and this article reviews its general capabilities, reports on recent enhancements and usage, and presents evidence that the resulting improvements are now beneficially affecting the global database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjgsh59dO-7Vg90H21EOLACvtfcHk0lht-M9686QQlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D&md5=b5fc7574f43f01dd6e43c3663ca4f779</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042073%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DKeedy%26aufirst%3DD.%2BA.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520structure%2520validation%2520for%2520macromolecular%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D12%26epage%3D21%26doi%3D10.1107%2FS0907444909042073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Alpeshkumar
K. Malde, Timothy A. Hill, Abishek Iyer, <span class="NLM_string-name hlFld-ContribAuthor">David P. Fairlie</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal Structures of Protein-Bound Cyclic Peptides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (17)
                                     , 9861-9914. <a href="https://doi.org/10.1021/acs.chemrev.8b00807" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00807%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DCrystal%252BStructures%252Bof%252BProtein-Bound%252BCyclic%252BPeptides%26aulast%3DMalde%26aufirst%3DAlpeshkumar%2BK.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D31122018%26date%3D02052019%26volume%3D119%26issue%3D17%26spage%3D9861%26epage%3D9914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabrielle M.  Watson</span>, <span class="hlFld-ContribAuthor ">Ketav  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Jianrong  Sang</span>, <span class="hlFld-ContribAuthor ">Xiuquan  Ma</span>, <span class="hlFld-ContribAuthor ">Menachem J.  Gunzburg</span>, <span class="hlFld-ContribAuthor ">Patrick  Perlmutter</span>, <span class="hlFld-ContribAuthor ">Matthew C.J.  Wilce</span>, and <span class="hlFld-ContribAuthor ">Jacqueline A.  Wilce</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer Target. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (22)
                                     , 9349-9359. <a href="https://doi.org/10.1021/acs.jmedchem.7b01320" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01320%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252BDevelopment%25252C%252Band%252BCellular%252BDelivery%252Bof%252BPotent%252Band%252BSelective%252BBicyclic%252BPeptide%252BInhibitors%252Bof%252BGrb7%252BCancer%252BTarget%26aulast%3DWatson%26aufirst%3DGabrielle%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07092017%26date%3D10112017%26date%3D22112017%26date%3D30102017%26volume%3D60%26issue%3D22%26spage%3D9349%26epage%3D9359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabrielle M.  Watson</span>, <span class="hlFld-ContribAuthor ">Ketav  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Rebecca  Brandt</span>, <span class="hlFld-ContribAuthor ">Mark P.  Del Borgo</span>, <span class="hlFld-ContribAuthor ">Marie-Isabel  Aguilar</span>, and <span class="hlFld-ContribAuthor ">Jacqueline A.  Wilce</span>  . </span><span class="cited-content_cbyCitation_article-title">Shortened Penetratin Cell-Penetrating Peptide Is Insufficient for Cytosolic Delivery of a Grb7 Targeting Peptide. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2017,</strong> <em>2 </em>
                                    (2)
                                     , 670-677. <a href="https://doi.org/10.1021/acsomega.6b00561" title="DOI URL">https://doi.org/10.1021/acsomega.6b00561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.6b00561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.6b00561%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DShortened%252BPenetratin%252BCell-Penetrating%252BPeptide%252BIs%252BInsufficient%252Bfor%252BCytosolic%252BDelivery%252Bof%252Ba%252BGrb7%252BTargeting%252BPeptide%26aulast%3DWatson%26aufirst%3DGabrielle%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03012017%26date%3D13022017%26date%3D28022017%26volume%3D2%26issue%3D2%26spage%3D670%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akshara  Pande</span>, <span class="hlFld-ContribAuthor ">Mahesh  Manchanda</span>, <span class="hlFld-ContribAuthor ">Hans Raj  Bhat</span>, <span class="hlFld-ContribAuthor ">Partha Sarathi  Bairy</span>, <span class="hlFld-ContribAuthor ">Navin  Kumar</span>, <span class="hlFld-ContribAuthor ">Prashant  Gahtori</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular insights into a mechanism of resveratrol action using hybrid computational docking/CoMFA and machine learning approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>9 </em>, 1-15. <a href="https://doi.org/10.1080/07391102.2021.1910572" title="DOI URL">https://doi.org/10.1080/07391102.2021.1910572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1910572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1910572%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMolecular%252Binsights%252Binto%252Ba%252Bmechanism%252Bof%252Bresveratrol%252Baction%252Busing%252Bhybrid%252Bcomputational%252Bdocking%25252FCoMFA%252Band%252Bmachine%252Blearning%252Bapproach%26aulast%3DPande%26aufirst%3DAkshara%26date%3D2021%26date%3D2021%26volume%3D9%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ketav  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Jianrong  Sang</span>, <span class="hlFld-ContribAuthor ">Xiuquan  Ma</span>, <span class="hlFld-ContribAuthor ">Jacqueline A.  Wilce</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison between clickable cyclic TAT and penetratin for delivery of cyclic and bicyclic‐peptide cargos. </span><span class="cited-content_cbyCitation_journal-name">Peptide Science</span><span> <strong>2020,</strong> <em>112 </em>
                                    (4)
                                     <a href="https://doi.org/10.1002/pep2.24163" title="DOI URL">https://doi.org/10.1002/pep2.24163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pep2.24163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpep2.24163%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptide%2520Science%26atitle%3DComparison%252Bbetween%252Bclickable%252Bcyclic%252BTAT%252Band%252Bpenetratin%252Bfor%252Bdelivery%252Bof%252Bcyclic%252Band%252Bbicyclic%2525E2%252580%252590peptide%252Bcargos%26aulast%3DKulkarni%26aufirst%3DKetav%26date%3D2020%26date%3D2020%26volume%3D112%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabrielle M.  Watson</span>, <span class="hlFld-ContribAuthor ">Jacqueline A.  Wilce</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Interaction between Calmodulin and the Grb7 RA-PH Domain. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (4)
                                     , 1336. <a href="https://doi.org/10.3390/ijms21041336" title="DOI URL">https://doi.org/10.3390/ijms21041336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21041336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21041336%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDirect%252BInteraction%252Bbetween%252BCalmodulin%252Band%252Bthe%252BGrb7%252BRA-PH%252BDomain%26aulast%3DWatson%26aufirst%3DGabrielle%2BM.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D4%26spage%3D1336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaqing  Yu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhong</span>, <span class="hlFld-ContribAuthor ">Yali  Han</span>, <span class="hlFld-ContribAuthor ">Qingqing  Huang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Chengyou  Jia</span>, <span class="hlFld-ContribAuthor ">Zhongwei  Lv</span>. </span><span class="cited-content_cbyCitation_article-title">Key candidate genes associated with BRAF
              V600E
              in papillary thyroid carcinoma on microarray analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2019,</strong> <em>234 </em>
                                    (12)
                                     , 23369-23378. <a href="https://doi.org/10.1002/jcp.28906" title="DOI URL">https://doi.org/10.1002/jcp.28906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.28906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.28906%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DKey%252Bcandidate%252Bgenes%252Bassociated%252Bwith%252BBRAF%252BV600E%252Bin%252Bpapillary%252Bthyroid%252Bcarcinoma%252Bon%252Bmicroarray%252Banalysis%26aulast%3DYu%26aufirst%3DXiaqing%26date%3D2019%26date%3D2019%26volume%3D234%26issue%3D12%26spage%3D23369%26epage%3D23378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianrong  Sang</span>, <span class="hlFld-ContribAuthor ">Ketav  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Gabrielle M.  Watson</span>, <span class="hlFld-ContribAuthor ">Xiuquan  Ma</span>, <span class="hlFld-ContribAuthor ">David J.  Craik</span>, <span class="hlFld-ContribAuthor ">Sónia T.  Henriques</span>, <span class="hlFld-ContribAuthor ">Aaron G.  Poth</span>, <span class="hlFld-ContribAuthor ">Aurélie H.  Benfield</span>, <span class="hlFld-ContribAuthor ">Jacqueline A.  Wilce</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (20)
                                     , 3739. <a href="https://doi.org/10.3390/molecules24203739" title="DOI URL">https://doi.org/10.3390/molecules24203739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24203739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24203739%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEvaluation%252Bof%252BCyclic%252BPeptide%252BInhibitors%252Bof%252Bthe%252BGrb7%252BBreast%252BCancer%252BTarget%25253A%252BSmall%252BChange%252Bin%252BCargo%252BResults%252Bin%252BLarge%252BChange%252Bin%252BCellular%252BActivity%26aulast%3DSang%26aufirst%3DJianrong%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D20%26spage%3D3739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subrata  Debnath</span>, <span class="hlFld-ContribAuthor ">Dalibor  Kosek</span>, <span class="hlFld-ContribAuthor ">Harichandra D.  Tagad</span>, <span class="hlFld-ContribAuthor ">Stewart R.  Durell</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Appella</span>, <span class="hlFld-ContribAuthor ">Roderico  Acevedo</span>, <span class="hlFld-ContribAuthor ">Alexander  Grishaev</span>, <span class="hlFld-ContribAuthor ">Fred  Dyda</span>, <span class="hlFld-ContribAuthor ">Ettore  Appella</span>, <span class="hlFld-ContribAuthor ">Sharlyn J.  Mazur</span>. </span><span class="cited-content_cbyCitation_article-title">A trapped human PPM1A–phosphopeptide complex reveals structural features critical for regulation of PPM protein phosphatase activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (21)
                                     , 7993-8008. <a href="https://doi.org/10.1074/jbc.RA117.001213" title="DOI URL">https://doi.org/10.1074/jbc.RA117.001213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA117.001213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA117.001213%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DA%252Btrapped%252Bhuman%252BPPM1A%2525E2%252580%252593phosphopeptide%252Bcomplex%252Breveals%252Bstructural%252Bfeatures%252Bcritical%252Bfor%252Bregulation%252Bof%252BPPM%252Bprotein%252Bphosphatase%252Bactivity%26aulast%3DDebnath%26aufirst%3DSubrata%26date%3D2018%26volume%3D293%26issue%3D21%26spage%3D7993%26epage%3D8008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabrielle M.  Watson</span>, <span class="hlFld-ContribAuthor ">William A. H.  Lucas</span>, <span class="hlFld-ContribAuthor ">Menachem J.  Gunzburg</span>, <span class="hlFld-ContribAuthor ">Jacqueline A.  Wilce</span>. </span><span class="cited-content_cbyCitation_article-title">Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2017,</strong> <em>4 </em><a href="https://doi.org/10.3389/fmolb.2017.00064" title="DOI URL">https://doi.org/10.3389/fmolb.2017.00064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2017.00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2017.00064%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DInsight%252Binto%252Bthe%252BSelectivity%252Bof%252Bthe%252BG7-18NATE%252BInhibitor%252BPeptide%252Bfor%252Bthe%252BGrb7-SH2%252BDomain%252BTarget%26aulast%3DWatson%26aufirst%3DGabrielle%2BM.%26date%3D2017%26date%3D2017%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong-Bing  Zhao</span>, <span class="hlFld-ContribAuthor ">Xi-Feng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xue-Lin  Jia</span>, <span class="hlFld-ContribAuthor ">Hao-Bin  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Grb7 is over-expressed in cervical cancer and facilitate invasion and inhibit apoptosis in cervical cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Pathology - Research and Practice</span><span> <strong>2017,</strong> <em>213 </em>
                                    (9)
                                     , 1180-1184. <a href="https://doi.org/10.1016/j.prp.2017.05.013" title="DOI URL">https://doi.org/10.1016/j.prp.2017.05.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.prp.2017.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.prp.2017.05.013%26sid%3Dliteratum%253Aachs%26jtitle%3DPathology%2520-%2520Research%2520and%2520Practice%26atitle%3DGrb7%252Bis%252Bover-expressed%252Bin%252Bcervical%252Bcancer%252Band%252Bfacilitate%252Binvasion%252Band%252Binhibit%252Bapoptosis%252Bin%252Bcervical%252Bcancer%252Bcells%26aulast%3DZhao%26aufirst%3DHong-Bing%26date%3D2017%26volume%3D213%26issue%3D9%26spage%3D1180%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maurizio  Roveri</span>, <span class="hlFld-ContribAuthor ">Alice  Pfohl</span>, <span class="hlFld-ContribAuthor ">Patricia  Jaaks</span>, <span class="hlFld-ContribAuthor ">Nagjie  Alijaj</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Leroux</span>, <span class="hlFld-ContribAuthor ">Paola  Luciani</span>, <span class="hlFld-ContribAuthor ">Michele  Bernasconi</span>. </span><span class="cited-content_cbyCitation_article-title">Prolonged circulation and increased tumor accumulation of liposomal vincristine in a mouse model of rhabdomyosarcoma. </span><span class="cited-content_cbyCitation_journal-name">Nanomedicine</span><span> <strong>2017,</strong> <em>12 </em>
                                    (10)
                                     , 1135-1151. <a href="https://doi.org/10.2217/nnm-2017-0430" title="DOI URL">https://doi.org/10.2217/nnm-2017-0430</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/nnm-2017-0430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fnnm-2017-0430%26sid%3Dliteratum%253Aachs%26jtitle%3DNanomedicine%26atitle%3DProlonged%252Bcirculation%252Band%252Bincreased%252Btumor%252Baccumulation%252Bof%252Bliposomal%252Bvincristine%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Brhabdomyosarcoma%26aulast%3DRoveri%26aufirst%3DMaurizio%26date%3D2017%26volume%3D12%26issue%3D10%26spage%3D1135%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernard A.  Liu</span>, <span class="hlFld-ContribAuthor ">Kazuya  Machida</span>. </span><span class="cited-content_cbyCitation_article-title">Introduction: History of SH2 Domains and Their Applications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 3-35. <a href="https://doi.org/10.1007/978-1-4939-6762-9_1" title="DOI URL">https://doi.org/10.1007/978-1-4939-6762-9_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-6762-9_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-6762-9_1%26sid%3Dliteratum%253Aachs%26atitle%3DIntroduction%25253A%252BHistory%252Bof%252BSH2%252BDomains%252Band%252BTheir%252BApplications%26aulast%3DLiu%26aufirst%3DBernard%2BA.%26date%3D2017%26date%3D2017%26spage%3D3%26epage%3D35%26pub%3DSpringer%2520New%2520York%26atitle%3DSH2%252BDomains%26aulast%3DMachida%26aufirst%3DKazuya%26date%3D2017%26volume%3D1555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Menachem J.  Gunzburg</span>, <span class="hlFld-ContribAuthor ">Ketav  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Gabrielle M.  Watson</span>, <span class="hlFld-ContribAuthor ">Nigus D.  Ambaye</span>, <span class="hlFld-ContribAuthor ">Mark P.  Del Borgo</span>, <span class="hlFld-ContribAuthor ">Rebecca  Brandt</span>, <span class="hlFld-ContribAuthor ">Stephanie C.  Pero</span>, <span class="hlFld-ContribAuthor ">Patrick  Perlmutter</span>, <span class="hlFld-ContribAuthor ">Matthew C. J.  Wilce</span>, <span class="hlFld-ContribAuthor ">Jacqueline A.  Wilce</span>. </span><span class="cited-content_cbyCitation_article-title">Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep27060" title="DOI URL">https://doi.org/10.1038/srep27060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep27060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep27060%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DUnexpected%252Binvolvement%252Bof%252Bstaple%252Bleads%252Bto%252Bredesign%252Bof%252Bselective%252Bbicyclic%252Bpeptide%252Binhibitor%252Bof%252BGrb7%26aulast%3DGunzburg%26aufirst%3DMenachem%2BJ.%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuefei  Shao</span>, <span class="hlFld-ContribAuthor ">Chunlei  Wang</span>, <span class="hlFld-ContribAuthor ">Atsu  Apedo</span>, <span class="hlFld-ContribAuthor ">Oliver  Mcconnell</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid Separation of Five Cyclosporin Analogs by Supercritical Fluid Chromatography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Analytical Sciences, Methods and Instrumentation</span><span> <strong>2016,</strong> <em>06 </em>
                                    (02)
                                     , 23-32. <a href="https://doi.org/10.4236/jasmi.2016.62004" title="DOI URL">https://doi.org/10.4236/jasmi.2016.62004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4236/jasmi.2016.62004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4236%2Fjasmi.2016.62004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Analytical%2520Sciences%252C%2520Methods%2520and%2520Instrumentation%26atitle%3DRapid%252BSeparation%252Bof%252BFive%252BCyclosporin%252BAnalogs%252Bby%252BSupercritical%252BFluid%252BChromatography%26aulast%3DShao%26aufirst%3DYuefei%26date%3D2016%26volume%3D06%26issue%3D02%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/medium/jm-2015-006095_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00609&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/medium/jm-2015-006095_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure based rationale for a functionalized peptide 2 derivative. (A) Structural overlay of the 2.4 Å Grb7-SH2:peptide <b>1</b> domain complex (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QMS">2QMS</a>: green sticks and purple cartoon, respectively) and the 1.8 Å apo-Grb7-SH2 structure (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ">4WWQ</a>: blue-white cartoon) with malonic acid (orange sticks) in the pY binding pocket. The inset shows the 2Fo-Fc map surrounding malonic acid contoured at 2σ; (B–E) Detail of the pY binding pocket: (B) Malonic acid bound Grb7-SH2, Chain A PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ">4WWQ</a>; (C) Sulfate bound Grb7-SH2, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QMS">2QMS</a>; (D) Ligand free Grb7-SH2, Chain B PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ">4WWQ</a>; (E) peptide <b>1</b> bound Grb7-SH2, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PQZ">3PQZ</a>. Key amino acids are shown as sticks and hydrogen bonds as dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00609&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/medium/jm-2015-006095_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures and synthesis of peptide <b>2</b>. Shown is the synthetic pathway used for the preparation of the cmF containing peptide <b>2</b>. The suitably protected carboxymethylphenylalanine building block (<b>4</b>), for incorporation into the peptide target, is highlighted in blue. Also shown, in the inset, are the chemical structures of peptide <b>1</b> and the cF containing peptide <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00609&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/medium/jm-2015-006095_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SPR binding analysis of peptides <b>1</b>, <b>2</b>, and <b>3</b> binding to Grb7-, Grb2-, and Grb10-SH2 domains. (A) Sensorgrams of peptide <b>1</b> (bottom left), peptide <b>2</b> (top left), and peptide <b>3</b> (top right) at varying concentrations binding the Grb7-SH2 domain at 1 mM phosphate concentration, and the corresponding equilibrium binding curves (bottom right). (B) Equilibrium binding curves for peptide <b>2</b> (left) and peptide <b>3</b> (right) binding the Grb7-SH2 domain under buffers containing different concentrations of phosphate. All buffers contained 150 mM NaCl and 1 mM DTT. (C) Equilibrium binding curves for peptide <b>1</b> (right), peptide <b>2</b> (left), and peptide <b>3</b> (center) binding the SH2 domains of Grb7, Grb2, and Grb10 under 1 mM phosphate concentration. Sensorgrams for all experiments are supplied as <a href="/doi/suppl/10.1021/acs.jmedchem.5b00609/suppl_file/jm5b00609_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00609&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/medium/jm-2015-006095_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of the Grb7-SH2:peptide <b>2</b> complex. (A) Structure of Grb7 SH2 (blue-white cartoon) in complex with peptide <b>2</b> (yellow sticks) (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6S">4X6S</a>). 2Fo-Fc map surrounding peptide <b>2</b> shown contoured at 1.2σ. (B) Structural overlay of peptide <b>2</b> (yellow) and peptide <b>1</b> (green) from PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PQZ">3PQZ</a>. Grb7 SH2 shown as blue-white surface representation. (C–D) Close-up of the pY binding pocket of chain A and chain B. Key amino acids are shown as sticks and hydrogen bonds as black dashed lines (or gray if close to being defined as a hydrogen bond).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00609/20151002/images/large/jm-2015-006095_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00609&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70511" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70511" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 58 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-74&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lgnuWdpgwIYzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D74%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Pradip, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouzyk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyland-Jones, B.</span><span> </span><span class="NLM_article-title">Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules</span> <span class="citation_source-journal">Am. J. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=23593540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A280%3ADC%252BC3srlvFOqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=173-95&author=D.+Pradipauthor=M.+Bouzykauthor=N.+Deyauthor=B.+Leyland-Jones&title=Dissecting+GRB7-mediated+signals+for+proliferation+and+migration+in+HER2+overexpressing+breast+tumor+cells%3A+GTP-ase+rules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules</span></div><div class="casAuthors">Pradip De; Bouzyk Mark; Dey Nandini; Leyland-Jones Brian</div><div class="citationInfo"><span class="NLM_cas:title">American journal of cancer research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Amplification of human Her2 and its aberrant signaling in 20-30% of early breast cancer patients is responsible for highly aggressive tumors with poor outcome.  Grb7 is reported to be co-amplified with Her2.  We report a concurrent high expression of mRNA (from FFPE tumor samples; mRNA correlation, Pearson r(2)= 0.806), and high levels of GRB7 protein (immunoblot) in HER2+ breast cancer cell lines.  We demonstrated the signaling mechanism of HER2 and downstream effectors that contributes to proliferation and migration.  Using HER2+ and trastuzumab-resistant breast cancer cell lines, we identified the interaction between GRB7 and HER2 in the control of HER2+ cell proliferation.  Our co-IP data show that GRB7 recruits SHC into the HER2-GRB7 signaling complex.  This complex formation leads to activation of RAS-GTP.  We also observed that following integrin engagement, GRB7 is phosphorylated at tyrosine in a p-FAK (Y397) dependent manner.  This FAK-GRB7 complex leads to downstream activation of RAC1-GTP (responsible for migration) probably through the recruitment of VAV2.  Our CO-IP data demonstrate that GRB7 directly binds with VAV2 following fibronectin engagement in HER2+ cells.  To address whether GRB7 could serve as a pathway specific therapeutic target, we used siRNA to suppress GRB7 expression.  Knockdown of GRB7 expression in the HER2+ breast cancer cell lines decreases RAS activation, cell proliferation, 2D and 3D colony formation and also blocked integrin-mediated RAC1 activation along with integrin-directed cell migration.  These findings dissected the HER2-mediated signaling cascade into (1) HER2+ cell proliferation (HER2-GRB7-SHC-RAS) and (2) HER2+ cell migration (alpha5 beta1/alpha4 beta1-FAK-GRB7-VAV2-RAC1).  Our data clearly demonstrate that a coupling of GRB7 with HER2 is required for the proliferative and migratory signals in HER2+ breast tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQo49zaaj9yMMyail4HZd-ifW6udTcc2ebb5hlVf7H0MLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srlvFOqtw%253D%253D&md5=a09635d02e188705bcb24085c4b94c4b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPradip%26aufirst%3DD.%26aulast%3DBouzyk%26aufirst%3DM.%26aulast%3DDey%26aufirst%3DN.%26aulast%3DLeyland-Jones%26aufirst%3DB.%26atitle%3DDissecting%2520GRB7-mediated%2520signals%2520for%2520proliferation%2520and%2520migration%2520in%2520HER2%2520overexpressing%2520breast%2520tumor%2520cells%253A%2520GTP-ase%2520rules%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2013%26volume%3D3%26spage%3D173%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Giricz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparano, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. A.</span><span> </span><span class="NLM_article-title">GRB7 is required for triple-negative breast cancer cell invasion and survival</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1007/s10549-011-1822-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2Fs10549-011-1822-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=22005836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFOksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2012&pages=607-15&author=O.+Giriczauthor=V.+Calvoauthor=S.+C.+Peroauthor=D.+N.+Kragauthor=J.+A.+Sparanoauthor=P.+A.+Kenny&title=GRB7+is+required+for+triple-negative+breast+cancer+cell+invasion+and+survival&doi=10.1007%2Fs10549-011-1822-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">GRB7 is required for triple-negative breast cancer cell invasion and survival</span></div><div class="casAuthors">Giricz, Orsi; Calvo, Veronica; Pero, Stephanie C.; Krag, David N.; Sparano, Joseph A.; Kenny, Paraic A.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">607-615</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is a heterogeneous disease that is usually assocd. with poor prognosis, and frequently assocd. with the basal-like breast cancer gene expression profile.  There are no targeted therapeutic modalities for this disease, and no useful biomarkers.  High GRB7 RNA expression levels are assocd. with an elevated risk of recurrence in patients with operable TNBC treated with std. adjuvant anthracycline and taxane therapy.  To det. whether GRB7 is involved in the pathobiol. of TNBC, we evaluated the biol. effects of GRB7 inhibition in a panel of triple-neg. cell lines-MDA-MB-468, MDA-MB-231, HCC70, and T4-2.  We found GRB7 inhibition reduced cell motility and invasion of these cell lines and promoted cell death by apoptosis in 3D culture.  These data suggest that GRB7 itself, or GRB7-dependent pathways, may prove to be important therapeutic targets in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreB0Epb_bbMLVg90H21EOLACvtfcHk0licPBP3Okmnfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFOksbc%253D&md5=8ad42003c4e5536023f81377e6f1bbc1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs10549-011-1822-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-011-1822-6%26sid%3Dliteratum%253Aachs%26aulast%3DGiricz%26aufirst%3DO.%26aulast%3DCalvo%26aufirst%3DV.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DSparano%26aufirst%3DJ.%2BA.%26aulast%3DKenny%26aufirst%3DP.%2BA.%26atitle%3DGRB7%2520is%2520required%2520for%2520triple-negative%2520breast%2520cancer%2520cell%2520invasion%2520and%2520survival%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2012%26volume%3D133%26spage%3D607%26epage%3D15%26doi%3D10.1007%2Fs10549-011-1822-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luoh, S. W.</span><span> </span><span class="NLM_article-title">GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1093/carcin/bgm221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1093%2Fcarcin%2Fbgm221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=473-479&author=T.+Baiauthor=S.+W.+Luoh&title=GRB-7+facilitates+HER-2%2FNeu-mediated+signal+transduction+and+tumor+formation&doi=10.1093%2Fcarcin%2Fbgm221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgm221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgm221%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DT.%26aulast%3DLuoh%26aufirst%3DS.%2BW.%26atitle%3DGRB-7%2520facilitates%2520HER-2%252FNeu-mediated%2520signal%2520transduction%2520and%2520tumor%2520formation%26jtitle%3DCarcinogenesis%26date%3D2007%26volume%3D29%26spage%3D473%26epage%3D479%26doi%3D10.1093%2Fcarcin%2Fbgm221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Chu, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T. L.</span><span> </span><span class="NLM_article-title">EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">29279</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1074/jbc.C110.114124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.C110.114124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=29279-85&author=P.+Y.+Chuauthor=T.+K.+Liauthor=S.+T.+Dingauthor=I.+R.+Laiauthor=T.+L.+Shen&title=EGF-induced+Grb7+recruits+and+promotes+Ras+activity+essential+for+the+tumorigenicity+of+Sk-Br3+breast+cancer+cells&doi=10.1074%2Fjbc.C110.114124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C110.114124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C110.114124%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DP.%2BY.%26aulast%3DLi%26aufirst%3DT.%2BK.%26aulast%3DDing%26aufirst%3DS.%2BT.%26aulast%3DLai%26aufirst%3DI.%2BR.%26aulast%3DShen%26aufirst%3DT.%2BL.%26atitle%3DEGF-induced%2520Grb7%2520recruits%2520and%2520promotes%2520Ras%2520activity%2520essential%2520for%2520the%2520tumorigenicity%2520of%2520Sk-Br3%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D29279%26epage%3D85%26doi%3D10.1074%2Fjbc.C110.114124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Nencioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garuti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passalacqua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffaghello, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoppoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistoia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballestrero, A.</span><span> </span><span class="NLM_article-title">Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e9024</span><span class="refDoi"> DOI: 10.1371/journal.pone.0009024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1371%2Fjournal.pone.0009024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9024&author=A.+Nencioniauthor=M.+Ceaauthor=A.+Garutiauthor=M.+Passalacquaauthor=L.+Raffaghelloauthor=D.+Sonciniauthor=E.+Moranauthor=G.+Zoppoliauthor=V.+Pistoiaauthor=F.+Patroneauthor=A.+Ballestrero&title=Grb7+upregulation+is+a+molecular+adaptation+to+HER2+signaling+inhibition+due+to+removal+of+Akt-mediated+gene+repression&doi=10.1371%2Fjournal.pone.0009024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009024%26sid%3Dliteratum%253Aachs%26aulast%3DNencioni%26aufirst%3DA.%26aulast%3DCea%26aufirst%3DM.%26aulast%3DGaruti%26aufirst%3DA.%26aulast%3DPassalacqua%26aufirst%3DM.%26aulast%3DRaffaghello%26aufirst%3DL.%26aulast%3DSoncini%26aufirst%3DD.%26aulast%3DMoran%26aufirst%3DE.%26aulast%3DZoppoli%26aufirst%3DG.%26aulast%3DPistoia%26aufirst%3DV.%26aulast%3DPatrone%26aufirst%3DF.%26aulast%3DBallestrero%26aufirst%3DA.%26atitle%3DGrb7%2520upregulation%2520is%2520a%2520molecular%2520adaptation%2520to%2520HER2%2520signaling%2520inhibition%2520due%2520to%2520removal%2520of%2520Akt-mediated%2520gene%2520repression%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9024%26doi%3D10.1371%2Fjournal.pone.0009024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flemer, S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span> </span><span class="NLM_article-title">Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1520</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6603732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1038%2Fsj.bjc.6603732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=17426702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1KmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=1520-5&author=S.+C.+Peroauthor=G.+S.+Shuklaauthor=M.+M.+Cooksonauthor=S.+Flemerauthor=D.+N.+Krag&title=Combination+treatment+with+Grb7+peptide+and+Doxorubicin+or+Trastuzumab+%28Herceptin%29+results+in+cooperative+cell+growth+inhibition+in+breast+cancer+cells&doi=10.1038%2Fsj.bjc.6603732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells</span></div><div class="casAuthors">Pero, S. C.; Shukla, G. S.; Cookson, M. M.; Flemer, S., Jr.; Krag, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1520-1525</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Grb7 has potential importance in the progression of cancer.  We have previously identified a novel peptide that binds to the SH2 domain of Grb7 and inhibits its assocn. with several different receptor tyrosine kinases.  We have synthesized the Grb7 peptide, G7-18NATE, with two different cell penetrating peptides, Penetratin and Tat.  In this study, we have shown that both Penetratin- and Tat-conjugated G7-18NATE peptides are able to inhibit the proliferation of SK-BR-3, ZR-75-30, MDA-MB-361 and MDA-MB-231 breast cancer cells.  There was no significant effects on breast cancer MCF-7cells, non-malignant MCF 10A or 3T3 cells.  In addn., there was no significant inhibition of proliferation by Penetratin or Tat alone or by their conjugates with arbitrary peptide sequence in any of the cell lines tested.  We detd. the EC50 of G7-18NATE-P peptide for SK-BR-3 cell proliferation to be 7.663×10-6 M.  Co-treatment of G7-18NATE-P peptide plus Doxorubicin in SK-BR-3 breast cancer cells resulted in an addnl. inhibition of proliferation, resulting in 56 and 84% decreases in the Doxorubicin EC50 value in the presence of 5×10-6 and 1.0×10-5 M G7-18NATE-P peptide, resp.  Importantly, the co-treatment with Doxorubicin and the delivery peptide did not change the Doxorubicin EC50.  Since Grb7 assocs. with ErbB2, we assessed whether the peptide inhibitor would have a combined effect with a mol. that targets ErbB2, Herceptin.  Co-treatment of Herceptin plus 1.0×10-5 M G7-18NATE-P peptide in SK-BR-3 cells resulted in a 46% decrease in the Herceptin EC50 value and no decrease following the co-treatment with Herceptin and penetratin alone.  This Grb7 peptide has potential to be developed as a therapeutic agent alone, in combination with traditional chemotherapy, or in combination with other targeting mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYqBV3GdCebVg90H21EOLACvtfcHk0lhzSaXPrMQ3wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1KmtLc%253D&md5=ef6c823762d834e077e70657ea28162d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603732%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DShukla%26aufirst%3DG.%2BS.%26aulast%3DCookson%26aufirst%3DM.%2BM.%26aulast%3DFlemer%26aufirst%3DS.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26atitle%3DCombination%2520treatment%2520with%2520Grb7%2520peptide%2520and%2520Doxorubicin%2520or%2520Trastuzumab%2520%2528Herceptin%2529%2520results%2520in%2520cooperative%2520cell%2520growth%2520inhibition%2520in%2520breast%2520cancer%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26spage%3D1520%26epage%3D5%26doi%3D10.1038%2Fsj.bjc.6603732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Han, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J. L.</span><span> </span><span class="NLM_article-title">Association of focal adhesion kinase with Grb7 and its role in cell migration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">24425</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1074/jbc.274.34.24425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.274.34.24425" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=24425-30&author=D.+C.+Hanauthor=J.+L.+Guan&title=Association+of+focal+adhesion+kinase+with+Grb7+and+its+role+in+cell+migration&doi=10.1074%2Fjbc.274.34.24425"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.34.24425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.34.24425%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DD.%2BC.%26aulast%3DGuan%26aufirst%3DJ.%2BL.%26atitle%3DAssociation%2520of%2520focal%2520adhesion%2520kinase%2520with%2520Grb7%2520and%2520its%2520role%2520in%2520cell%2520migration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D24425%26epage%3D30%26doi%3D10.1074%2Fjbc.274.34.24425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Lim, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span><span class="refDoi"> DOI: 10.1007/s10549-014-2838-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2Fs10549-014-2838-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=24464577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=593-603&author=R.+C.+Limauthor=J.+T.+Priceauthor=J.+A.+Wilce&title=Context-dependent+role+of+Grb7+in+HER2%2Bve+and+triple-negative+breast+cancer+cell+lines&doi=10.1007%2Fs10549-014-2838-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines</span></div><div class="casAuthors">Lim, Reece C. C.; Price, John T.; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">593-603</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Grb7 is an adapter protein, aberrantly co-overexpressed with HER2 and identified as an independent prognostic marker in breast cancer.  It has been established that Grb7 exacerbates the cellular growth and migratory behavior of HER2+ve breast cancer cells.  Less is known about Grb7's role in the context of HER2-ve cells.  Here we directly compare the effect of stable Grb7 knockdown in estrogen sensitive (T47D), HER2+ve (SKBR3) and triple-neg. (MDA-MB-468 and MDA-MB-231) breast cancer cell lines on anchorage dependent and independent cell growth, wound healing and chemotaxis.  All cell lines showed reduced ability to migrate upon Grb7 knockdown, despite their greatly varied endogenous levels of Grb7.  Decreased cell proliferation was not obsd. in any of the cell lines upon Grb7 knockdown; however, decreased ability to form colonies was obsd. for all but the estrogen sensitive cell line, depending upon the stringency of the growth conditions.  The data reveal that Grb7 plays an important role in breast cancer progression, beyond the context of HER2+ve cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4vHleefRXL7Vg90H21EOLACvtfcHk0lhzSaXPrMQ3wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSqsr8%253D&md5=121ce4f7e3fe1fa16c790a63bdf6dce4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs10549-014-2838-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-014-2838-5%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DR.%2BC.%26aulast%3DPrice%26aufirst%3DJ.%2BT.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DContext-dependent%2520role%2520of%2520Grb7%2520in%2520HER2%252Bve%2520and%2520triple-negative%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2014%26volume%3D143%26spage%3D593%26epage%3D603%26doi%3D10.1007%2Fs10549-014-2838-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arii, S.</span><span> </span><span class="NLM_article-title">Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1093/jnci/djj105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1093%2Fjnci%2Fdjj105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=16595785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlamtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=491-8&author=S.+Tanakaauthor=S.+C.+Peroauthor=K.+Taguchiauthor=M.+Shimadaauthor=M.+Moriauthor=D.+N.+Kragauthor=S.+Arii&title=Specific+peptide+ligand+for+Grb7+signal+transduction+protein+and+pancreatic+cancer+metastasis&doi=10.1093%2Fjnci%2Fdjj105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Peptide Ligand for Grb7 Signal Transduction Protein and Pancreatic Cancer Metastasis</span></div><div class="casAuthors">Tanaka, Shinji; Pero, Stephanie C.; Taguchi, Kenichi; Shimada, Mitsuo; Mori, Masaki; Krag, David N.; Arii, Shigeki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">491-498</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Pancreatic cancer is one of the most aggressive malignancies, with high rates of invasion and metastasis and with generally poor prognosis.  We previously found that metastasis was strongly assocd. with the expression of growth factor receptor-bound protein 7 (Grb7), which contains a Src homol. 2 (SH2) domain.  In this study, we evaluated Grb7 protein as a mol. target of therapy for metastatic pancreatic cancer.  Methods: Grb7 protein expression was measured by immunohistochem. in 36 human pancreatic cancer specimens and adjacent normal pancreatic tissue.  We synthesized a nonphosphorylated peptide inhibitor that binds specifically to the SH2 domain of Grb7.  Intracellular signaling was assessed by immunopptn. and immunoblot assays in cultured human pancreatic cancer cells.  Cell migration was measured with a modified Boyden chamber method.  Peritoneal metastasis of the pancreatic cancer cells was measured with a mouse model.  All statistical tests were two-sided.  Results: We found that 22 (61%) of 36 pancreatic cancer specimens had higher levels of Grb7 protein than their corresponding normal pancreatic tissue specimens.  Grb7 expression was statistically significantly different between specimens from patients without lymph node metastasis (stage N0; two of the 10 patients) and patients with lymph node metastasis (stages N1 + N2; 20 of the 26 patients) (P = .006).  The Grb7 peptide inhibitor selectively blocked the interaction between Grb7 and focal adhesion kinase and blocked the phosphorylation of Grb7 protein.  In vivo Grb7 peptide inhibitor statistically significantly attenuated cell migration (for control peptide, 87.5 cells migrated, 95% confidence interval [CI] = 82.6 to 92.4 cells; for Grb7 peptide, 5.7 cells migrated, 95% CI = 2.3 to 9.0 cells; P<.001) and peritoneal metastasis of the pancreatic cancer cells in a mouse model, as assessed by the no. of nodules (control = 72.6 nodules, 95% CI = 55.8 to 89.4 nodules; and for Grb7 peptide = 3.2 nodules, 95% CI = 1.6 to 4.8 nodules; P<.001, t test) and their wt. (control = 4.13 g, 95% CI = 3.40 to 4.86 g; Grb7 peptide = 0.19 g, 95% CI = 0.06 to 0.32 g; P<.001, t test).  Conclusions: The Grb7 peptide inhibitor appears to be a promising molecularly targeted therapeutic agent against metastatic pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpletsYvkiEs7Vg90H21EOLACvtfcHk0lhzSaXPrMQ3wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlamtL8%253D&md5=8bf8b5624a76b39cde03cd269bb16f27</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjj105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjj105%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DTaguchi%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DArii%26aufirst%3DS.%26atitle%3DSpecific%2520peptide%2520ligand%2520for%2520Grb7%2520signal%2520transduction%2520protein%2520and%2520pancreatic%2520cancer%2520metastasis%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2006%26volume%3D98%26spage%3D491%26epage%3D8%26doi%3D10.1093%2Fjnci%2Fdjj105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ramsey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanlon Newell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troxell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luoh, S. W.</span><span> </span><span class="NLM_article-title">GRB7 protein over-expression and clinical outcome in breast cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span><span class="refDoi"> DOI: 10.1007/s10549-010-1010-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2Fs10549-010-1010-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=20635137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtlyku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2011&pages=659-69&author=B.+Ramseyauthor=T.+Baiauthor=A.+Hanlon+Newellauthor=M.+Troxellauthor=B.+Parkauthor=S.+Olsonauthor=E.+Keenanauthor=S.+W.+Luoh&title=GRB7+protein+over-expression+and+clinical+outcome+in+breast+cancer&doi=10.1007%2Fs10549-010-1010-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">GRB7 protein over-expression and clinical outcome in breast cancer</span></div><div class="casAuthors">Ramsey, Betsy; Bai, Tao; Newell, Amy Hanlon; Troxell, Megan; Park, Byung; Olson, Susan; Keenan, Edward; Luoh, Shiuh-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">659-669</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The growth factor receptor-bound protein-7 gene (GRB7) encodes a multi-domain signal transduction mol.  The purpose of this study was to examine the clin. significance of GRB7 protein expression in human breast cancer.  Western blotting anal. of protein exts. from 563 annotated frozen breast tumors was performed.  Expression status of GRB7 and HER-2 was correlated with clin. covariates and outcomes.  Cox proportional hazards were used to identify factors assocd. with breast cancer-free interval.  The median follow-up was 71 mo.  P values <0.05 were considered statistically significant (two-sided).  A discrepancy between HER-2 and GRB7 protein over-expression was obsd.  GRB7 protein over-expression was assocd. with neg. estrogen and progesterone receptor status, higher tumor grade, larger primary tumor size, (more) axillary lymph node involvement, higher clin. stage, and shortened breast cancer-free interval.  HER-2 protein over-expression was assocd. only with higher tumor grade.  Multi-variate anal. revealed that GRB7 protein over-expression was an independent adverse prognostic factor for breast cancer-free interval (hazard ratio 1.69, 95% confidence interval 1.07-2.67; P = 0.024).  The same was true of the subset of patients who did not receive any adjuvant systemic therapy (hazard ratio 1.68, 95% confidence interval 1.16-2.31; P = 0.0055).  Using FISH anal., 32/32 (100%; 95% CI 89-100%) tumors which over-expressed both HER-2 and GRB7 proteins and 1/35 (3%; 95% CI 0-15%) tumors with HER-2 but no GRB7 protein over-expression with Western blotting anal. demonstrated HER-2 gene amplification.  GRB7 protein over-expression is an independent adverse prognostic factor in human breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrChZB-XTObp7Vg90H21EOLACvtfcHk0lin-hCi5g29Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtlyku7Y%253D&md5=600c4cb4b85ba9646ee9a9ee2e21864c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10549-010-1010-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-010-1010-0%26sid%3Dliteratum%253Aachs%26aulast%3DRamsey%26aufirst%3DB.%26aulast%3DBai%26aufirst%3DT.%26aulast%3DHanlon%2BNewell%26aufirst%3DA.%26aulast%3DTroxell%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DB.%26aulast%3DOlson%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DE.%26aulast%3DLuoh%26aufirst%3DS.%2BW.%26atitle%3DGRB7%2520protein%2520over-expression%2520and%2520clinical%2520outcome%2520in%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2011%26volume%3D127%26spage%3D659%26epage%3D69%26doi%3D10.1007%2Fs10549-010-1010-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Nadler, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimm, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluger, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluger, Y.</span><span> </span><span class="NLM_article-title">Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.1093/annonc/mdp346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1093%2Fannonc%2Fmdp346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=19717535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A280%3ADC%252BC3c7isVCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=466-73&author=Y.+Nadlerauthor=A.+M.+Gonzalezauthor=R.+L.+Campauthor=D.+L.+Rimmauthor=H.+M.+Klugerauthor=Y.+Kluger&title=Growth+factor+receptor-bound+protein-7+%28Grb7%29+as+a+prognostic+marker+and+therapeutic+target+in+breast+cancer&doi=10.1093%2Fannonc%2Fmdp346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer</span></div><div class="casAuthors">Nadler Y; Gonzalez A M; Camp R L; Rimm D L; Kluger H M; Kluger Y</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">466-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Growth factor receptor-bound protein-7 (Grb7) is an adapter-type signaling protein recruited to various tyrosine kinases, including HER2/neu.  Grb7-specific inhibitors are in early development.  As with other targeted therapies, response to therapy might be associated with target expression.  MATERIALS AND METHODS:  Tissue microarrays containing 638 primary breast cancer specimens with 15-year patient follow-up were employed to assess Grb7 expression using our Automated QUantitative Analysis method; cytokeratin defines pixels as breast cancer (tumor mask) within the histospot, and Grb7 expression within the mask is measured with Cy5-conjugated antibodies.  RESULTS:  High Grb7 expression was strongly associated with decreased survival in the entire cohort and in the node-positive subset (P = 0.0034 and P = 0.0019, respectively).  On multivariable analysis, it remained an independent prognostic marker (P = 0.01).  High Grb7 was strongly associated with high HER2/neu, and coexpression of these molecules was associated with worse prognosis than HER2/neu overexpression alone.  CONCLUSIONS:  High Grb7 defines a subset of breast cancer patients with decreased survival, indicating that Grb7 might be a valuable prognostic marker and drug target.  Coexpression with HER2/neu indicates that cotargeting these molecules might be an effective approach for treating HER2/neu-positive breast cancers.  Future studies using Grb7-targeting agents should include assessment of Grb7 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQHJAg2JMrEwkg6wdEZmT2rfW6udTcc2eb7ijJf8yAoF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7isVCltg%253D%253D&md5=d055d28672acb6dcd8fc5fa1a4eebb21</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdp346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdp346%26sid%3Dliteratum%253Aachs%26aulast%3DNadler%26aufirst%3DY.%26aulast%3DGonzalez%26aufirst%3DA.%2BM.%26aulast%3DCamp%26aufirst%3DR.%2BL.%26aulast%3DRimm%26aufirst%3DD.%2BL.%26aulast%3DKluger%26aufirst%3DH.%2BM.%26aulast%3DKluger%26aufirst%3DY.%26atitle%3DGrowth%2520factor%2520receptor-bound%2520protein-7%2520%2528Grb7%2529%2520as%2520a%2520prognostic%2520marker%2520and%2520therapeutic%2520target%2520in%2520breast%2520cancer%26jtitle%3DAnn.%2520Oncol.%26date%3D2010%26volume%3D21%26spage%3D466%26epage%3D73%26doi%3D10.1093%2Fannonc%2Fmdp346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Stein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuqua, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roonprapunt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yajnik, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Eustachio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchberg, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, B.</span><span> </span><span class="NLM_article-title">The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1994&pages=1331-40&author=D.+Steinauthor=J.+Wuauthor=S.+A.+Fuquaauthor=C.+Roonprapuntauthor=V.+Yajnikauthor=P.+D%E2%80%99Eustachioauthor=J.+J.+Moskowauthor=A.+M.+Buchbergauthor=C.+K.+Osborneauthor=B.+Margolis&title=The+SH2+domain+protein+GRB-7+is+co-amplified%2C+overexpressed+and+in+a+tight+complex+with+HER2+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DFuqua%26aufirst%3DS.%2BA.%26aulast%3DRoonprapunt%26aufirst%3DC.%26aulast%3DYajnik%26aufirst%3DV.%26aulast%3DD%25E2%2580%2599Eustachio%26aufirst%3DP.%26aulast%3DMoskow%26aufirst%3DJ.%2BJ.%26aulast%3DBuchberg%26aufirst%3DA.%2BM.%26aulast%3DOsborne%26aufirst%3DC.%2BK.%26aulast%3DMargolis%26aufirst%3DB.%26atitle%3DThe%2520SH2%2520domain%2520protein%2520GRB-7%2520is%2520co-amplified%252C%2520overexpressed%2520and%2520in%2520a%2520tight%2520complex%2520with%2520HER2%2520in%2520breast%2520cancer%26jtitle%3DEMBO%2520J.%26date%3D1994%26volume%3D13%26spage%3D1331%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Fiddes, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivertsen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallasch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span> </span><span class="NLM_article-title">Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">7717</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1074/jbc.273.13.7717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.273.13.7717" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=7717-24&author=R.+J.+Fiddesauthor=D.+H.+Campbellauthor=P.+W.+Janesauthor=S.+P.+Sivertsenauthor=H.+Sasakiauthor=C.+Wallaschauthor=R.+J.+Daly&title=Analysis+of+Grb7+recruitment+by+heregulin-activated+erbB+receptors+reveals+a+novel+target+selectivity+for+erbB3&doi=10.1074%2Fjbc.273.13.7717"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.13.7717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.13.7717%26sid%3Dliteratum%253Aachs%26aulast%3DFiddes%26aufirst%3DR.%2BJ.%26aulast%3DCampbell%26aufirst%3DD.%2BH.%26aulast%3DJanes%26aufirst%3DP.%2BW.%26aulast%3DSivertsen%26aufirst%3DS.%2BP.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DWallasch%26aufirst%3DC.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26atitle%3DAnalysis%2520of%2520Grb7%2520recruitment%2520by%2520heregulin-activated%2520erbB%2520receptors%2520reveals%2520a%2520novel%2520target%2520selectivity%2520for%2520erbB3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D7717%26epage%3D24%26doi%3D10.1074%2Fjbc.273.13.7717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Margolis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roonprapunt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">8894</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1073/pnas.89.19.8894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1073%2Fpnas.89.19.8894" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=8894-8&author=B.+Margolisauthor=O.+Silvennoinenauthor=F.+Comoglioauthor=C.+Roonprapuntauthor=E.+Skolnikauthor=A.+Ullrichauthor=J.+Schlessinger&title=High-efficiency+expression%2Fcloning+of+epidermal+growth+factor-receptor-binding+proteins+with+Src+homology+2+domains&doi=10.1073%2Fpnas.89.19.8894"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.19.8894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.19.8894%26sid%3Dliteratum%253Aachs%26aulast%3DMargolis%26aufirst%3DB.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DComoglio%26aufirst%3DF.%26aulast%3DRoonprapunt%26aufirst%3DC.%26aulast%3DSkolnik%26aufirst%3DE.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DHigh-efficiency%2520expression%252Fcloning%2520of%2520epidermal%2520growth%2520factor-receptor-binding%2520proteins%2520with%2520Src%2520homology%25202%2520domains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26spage%3D8894%26epage%3D8%26doi%3D10.1073%2Fpnas.89.19.8894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">McMurray, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klostergaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, F. M.</span><span> </span><span class="NLM_article-title">The consequences of selective inhibition of signal transducer and activator of transcription 3 (STAT3) tyrosine705 phosphorylation by phosphopeptide mimetic prodrugs targeting the Src homology 2 (SH2) domain</span> <span class="citation_source-journal">Jak-Stat</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span><span class="refDoi"> DOI: 10.4161/jkst.22682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.4161%2Fjkst.22682" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=263-347&author=J.+S.+McMurrayauthor=P.+K.+Mandalauthor=W.+S.+Liaoauthor=J.+Klostergaardauthor=F.+M.+Robertson&title=The+consequences+of+selective+inhibition+of+signal+transducer+and+activator+of+transcription+3+%28STAT3%29+tyrosine705+phosphorylation+by+phosphopeptide+mimetic+prodrugs+targeting+the+Src+homology+2+%28SH2%29+domain&doi=10.4161%2Fjkst.22682"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4161%2Fjkst.22682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fjkst.22682%26sid%3Dliteratum%253Aachs%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26aulast%3DMandal%26aufirst%3DP.%2BK.%26aulast%3DLiao%26aufirst%3DW.%2BS.%26aulast%3DKlostergaard%26aufirst%3DJ.%26aulast%3DRobertson%26aufirst%3DF.%2BM.%26atitle%3DThe%2520consequences%2520of%2520selective%2520inhibition%2520of%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520%2528STAT3%2529%2520tyrosine705%2520phosphorylation%2520by%2520phosphopeptide%2520mimetic%2520prodrugs%2520targeting%2520the%2520Src%2520homology%25202%2520%2528SH2%2529%2520domain%26jtitle%3DJak-Stat%26date%3D2012%26volume%3D1%26spage%3D263%26epage%3D347%26doi%3D10.4161%2Fjkst.22682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kraskouskaya, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duodu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arpin, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Progress towards the development of SH2 domain inhibitors</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3337</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1039/c3cs35449k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1039%2Fc3cs35449k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=3337-70&author=D.+Kraskouskayaauthor=E.+Duoduauthor=C.+C.+Arpinauthor=P.+T.+Gunning&title=Progress+towards+the+development+of+SH2+domain+inhibitors&doi=10.1039%2Fc3cs35449k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2Fc3cs35449k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cs35449k%26sid%3Dliteratum%253Aachs%26aulast%3DKraskouskaya%26aufirst%3DD.%26aulast%3DDuodu%26aufirst%3DE.%26aulast%3DArpin%26aufirst%3DC.%2BC.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DProgress%2520towards%2520the%2520development%2520of%2520SH2%2520domain%2520inhibitors%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2013%26volume%3D42%26spage%3D3337%26epage%3D70%26doi%3D10.1039%2Fc3cs35449k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haser, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechleider, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birge, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fajardo, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanafusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhausen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">SH2 domains recognize specific phosphopeptide sequences</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1016/0092-8674(93)90404-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2F0092-8674%2893%2990404-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=7680959" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1993&pages=767-778&author=S.+Zhouauthor=S.+E.+Shoelsonauthor=M.+Chaudhuriauthor=G.+Gishauthor=T.+Pawsonauthor=W.+G.+Haserauthor=F.+Kingauthor=T.+Robertsauthor=S.+Ratnofskyauthor=R.+J.+Lechleiderauthor=B.+G.+Neelauthor=R.+B.+Birgeauthor=J.+E.+Fajardoauthor=M.+M.+Chouauthor=H.+Hanafusaauthor=B.+Schaffhausenauthor=L.+C.+Cantley&title=SH2+domains+recognize+specific+phosphopeptide+sequences&doi=10.1016%2F0092-8674%2893%2990404-E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2893%2990404-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252893%252990404-E%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DChaudhuri%26aufirst%3DM.%26aulast%3DGish%26aufirst%3DG.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DHaser%26aufirst%3DW.%2BG.%26aulast%3DKing%26aufirst%3DF.%26aulast%3DRoberts%26aufirst%3DT.%26aulast%3DRatnofsky%26aufirst%3DS.%26aulast%3DLechleider%26aufirst%3DR.%2BJ.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DBirge%26aufirst%3DR.%2BB.%26aulast%3DFajardo%26aufirst%3DJ.%2BE.%26aulast%3DChou%26aufirst%3DM.%2BM.%26aulast%3DHanafusa%26aufirst%3DH.%26aulast%3DSchaffhausen%26aufirst%3DB.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DSH2%2520domains%2520recognize%2520specific%2520phosphopeptide%2520sequences%26jtitle%3DCell%26date%3D1993%26volume%3D72%26spage%3D767%26epage%3D778%26doi%3D10.1016%2F0092-8674%2893%2990404-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span> </span><span class="NLM_article-title">Grb7-based molecular therapeutics in cancer</span> <span class="citation_source-journal">Expert Rev. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1017/S1462399403006227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1017%2FS1462399403006227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=14585167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A280%3ADC%252BD3srgvFaltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=1-11&author=S.+C.+Peroauthor=R.+J.+Dalyauthor=D.+N.+Krag&title=Grb7-based+molecular+therapeutics+in+cancer&doi=10.1017%2FS1462399403006227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Grb7-based molecular therapeutics in cancer</span></div><div class="casAuthors">Pero Stephanie C; Daly Roger J; Krag David N</div><div class="citationInfo"><span class="NLM_cas:title">Expert reviews in molecular medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Traditional anti-cancer drugs preferentially kill rapidly growing tumour cells rather than normal cells.  However, most of these drugs have no preferential selection towards cancer cells and are taken up by the whole body, resulting in significant adverse side effects.  Therapeutic molecules that could specifically inhibit undesirable phenotypes are an attractive way of eliminating cancer cells.  There is a widespread effort to develop inhibitors against signal transduction molecules that play a key role in the proliferative, migratory and invasive properties of a cancer cell.  Grb7 is an adaptor-type signalling protein that is recruited via its Src-homology 2 (SH2) domain to a variety of tyrosine kinases.  Grb7 is overexpressed in breast, oesophageal and gastric cancers, and may contribute to the invasive potential of cancer cells.  Molecular interactions involving Grb7 therefore provide attractive targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7Lgiv6JFRiJ6KlWarZTAzfW6udTcc2eYcOjdjRVDn2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srgvFaltw%253D%253D&md5=584ec9b9538c8b523524d2ad26c52fc8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1017%2FS1462399403006227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1462399403006227%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26atitle%3DGrb7-based%2520molecular%2520therapeutics%2520in%2520cancer%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Med.%26date%3D2003%26volume%3D5%26spage%3D1%26epage%3D11%26doi%3D10.1017%2FS1462399403006227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oligino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span> </span><span class="NLM_article-title">Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">11918</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1074/jbc.M111816200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.M111816200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=11918-26&author=S.+C.+Peroauthor=L.+Oliginoauthor=R.+J.+Dalyauthor=A.+L.+Sodenauthor=C.+Liuauthor=P.+P.+Rollerauthor=P.+Liauthor=D.+N.+Krag&title=Identification+of+novel+non-phosphorylated+ligands%2C+which+bind+selectively+to+the+SH2+domain+of+Grb7&doi=10.1074%2Fjbc.M111816200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111816200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111816200%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DOligino%26aufirst%3DL.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DSoden%26aufirst%3DA.%2BL.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26atitle%3DIdentification%2520of%2520novel%2520non-phosphorylated%2520ligands%252C%2520which%2520bind%2520selectively%2520to%2520the%2520SH2%2520domain%2520of%2520Grb7%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D11918%26epage%3D26%26doi%3D10.1074%2Fjbc.M111816200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Porter, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pursglove, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidberger, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leedman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation</span> <span class="citation_source-journal">BMC Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="refDoi"> DOI: 10.1186/1472-6807-7-58</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1186%2F1472-6807-7-58" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=17894853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A280%3ADC%252BD2sjjsFertA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=58&author=C.+J.+Porterauthor=J.+M.+Matthewsauthor=J.+P.+Mackayauthor=S.+E.+Pursgloveauthor=J.+W.+Schmidbergerauthor=P.+J.+Leedmanauthor=S.+C.+Peroauthor=D.+N.+Kragauthor=M.+C.+J.+Wilceauthor=J.+A.+Wilce&title=Grb7+SH2+domain+structure+and+interactions+with+a+cyclic+peptide+inhibitor+of+cancer+cell+migration+and+proliferation&doi=10.1186%2F1472-6807-7-58"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation</span></div><div class="casAuthors">Porter Corrine J; Matthews Jacqueline M; Mackay Joel P; Pursglove Sharon E; Schmidberger Jason W; Leedman Peter J; Pero Stephanie C; Krag David N; Wilce Matthew C J; Wilce Jacqueline A</div><div class="citationInfo"><span class="NLM_cas:title">BMC structural biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Human growth factor receptor bound protein 7 (Grb7) is an adapter protein that mediates the coupling of tyrosine kinases with their downstream signaling pathways.  Grb7 is frequently overexpressed in invasive and metastatic human cancers and is implicated in cancer progression via its interaction with the ErbB2 receptor and focal adhesion kinase (FAK) that play critical roles in cell proliferation and migration.  It is thus a prime target for the development of novel anti-cancer therapies.  Recently, an inhibitory peptide (G7-18NATE) has been developed which binds specifically to the Grb7 SH2 domain and is able to attenuate cancer cell proliferation and migration in various cancer cell lines.  RESULTS:  As a first step towards understanding how Grb7 may be inhibited by G7-18NATE, we solved the crystal structure of the Grb7 SH2 domain to 2.1 A resolution.  We describe the details of the peptide binding site underlying target specificity, as well as the dimer interface of Grb 7 SH2.  Dimer formation of Grb7 was determined to be in the muM range using analytical ultracentrifugation for both full-length Grb7 and the SH2 domain alone, suggesting the SH2 domain forms the basis of a physiological dimer.  ITC measurements of the interaction of the G7-18NATE peptide with the Grb7 SH2 domain revealed that it binds with a binding affinity of Kd = approximately 35.7 microM and NMR spectroscopy titration experiments revealed that peptide binding causes perturbations to both the ligand binding surface of the Grb7 SH2 domain as well as to the dimer interface, suggesting that dimerisation of Grb7 is impacted on by peptide binding.  CONCLUSION:  Together the data allow us to propose a model of the Grb7 SH2 domain/G7-18NATE interaction and to rationalize the basis for the observed binding specificity and affinity.  We propose that the current study will assist with the development of second generation Grb7 SH2 domain inhibitors, potentially leading to novel inhibitors of cancer cell migration and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQIoJI-dpPcf69nzq6467DfW6udTcc2ebrDAaZHNwYtrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjjsFertA%253D%253D&md5=93aa5bd889d183647f9030c25376ce1c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1472-6807-7-58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6807-7-58%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DC.%2BJ.%26aulast%3DMatthews%26aufirst%3DJ.%2BM.%26aulast%3DMackay%26aufirst%3DJ.%2BP.%26aulast%3DPursglove%26aufirst%3DS.%2BE.%26aulast%3DSchmidberger%26aufirst%3DJ.%2BW.%26aulast%3DLeedman%26aufirst%3DP.%2BJ.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DWilce%26aufirst%3DM.%2BC.%2BJ.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DGrb7%2520SH2%2520domain%2520structure%2520and%2520interactions%2520with%2520a%2520cyclic%2520peptide%2520inhibitor%2520of%2520cancer%2520cell%2520migration%2520and%2520proliferation%26jtitle%3DBMC%2520Struct.%2520Biol.%26date%3D2007%26volume%3D7%26spage%3D58%26doi%3D10.1186%2F1472-6807-7-58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertzog, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Borgo, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, M.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Use of SPR to Study the Interaction of G7–18NATE Peptide with the Grb7-SH2 Domain</span> <span class="citation_source-journal">Int. J. Pept. Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.1007/s10989-010-9222-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2Fs10989-010-9222-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlGgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=177-184&author=M.+J.+Gunzburgauthor=N.+D.+Ambayeauthor=J.+T.+Hertzogauthor=M.+P.+del+Borgoauthor=S.+C.+Peroauthor=D.+N.+Kragauthor=M.+C.+J.+Wilceauthor=M.-I.+Aguilarauthor=P.+Perlmutterauthor=J.+A.+Wilce&title=Use+of+SPR+to+Study+the+Interaction+of+G7%E2%80%9318NATE+Peptide+with+the+Grb7-SH2+Domain&doi=10.1007%2Fs10989-010-9222-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Use of SPR to Study the Interaction of G7-18NATE Peptide with the Grb7-SH2 Domain</span></div><div class="casAuthors">Gunzburg, Menachem J.; Ambaye, Nigus D.; Hertzog, Jack T.; Del, Borgo, Mark P.; Pero, Stephanie C.; Krag, David N.; Wilce, Matthew C. J.; Aguilar, Marie-Isabel; Perlmutter, Patrick; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide Research and Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">177-184</span>CODEN:
                <span class="NLM_cas:coden">IJPRFC</span>;
        ISSN:<span class="NLM_cas:issn">1573-3149</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Surface plasmon resonance (SPR) is a useful biosensor technique for the study of biomol. interactions, with the potential for high-throughput screening of ligand interactions with drug targets.  The key to its successful use, however, is in the appropriate design of the expt., including the mode of immobilization to the biosensor chip.  We report an investigation of the use of SPR for measuring the affinity of the G7-18NATE peptide ligand for its Grb7-SH2 domain target involved in the migratory and proliferative potential of cancer cells.  Previous studies have shown that the cyclic non-phosphorylated peptide, G7-18NATE, inhibits Grb7 interactions with upstream binding partners and is able to inhibit both cell migration and proliferation of cancer cells.  We report the synthesis of a biotinylated G7-18NATE covalently attached to a linker (G7-18NATE-ASASASK-Biotin) and compare its interaction with the Grb7-SH2 domain by SPR using three different immobilization strategies; immobilization of the peptide via streptavidin, immobilization of glutathione S-transferase (GST)-Grb7-SH2 domain via anti-GST antibody, and immobilization of biotinylated Grb7-SH2 domain via streptavidin.  This revealed that sensorgrams free from non-specific binding and displaying simple kinetics were most readily achieved by immobilizing the protein rather than the peptide, in spite of the lower response assocd. with this method.  KD values of ∼300 μM were detd. for both strategies at pH 7.4.  This compared with a KD value of 4.4 μM at pH 6 demonstrating the importance of pH on this interaction.  Overall, the immobilized protein systems are most suitable for future comparative screening efforts using SPR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoalIz8FFp587Vg90H21EOLACvtfcHk0ljc5nMYe-obPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlGgu7w%253D&md5=c09eda161f8780e98aebf24bb6da042b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs10989-010-9222-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10989-010-9222-z%26sid%3Dliteratum%253Aachs%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DHertzog%26aufirst%3DJ.%2BT.%26aulast%3Ddel%2BBorgo%26aufirst%3DM.%2BP.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DWilce%26aufirst%3DM.%2BC.%2BJ.%26aulast%3DAguilar%26aufirst%3DM.-I.%26aulast%3DPerlmutter%26aufirst%3DP.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DUse%2520of%2520SPR%2520to%2520Study%2520the%2520Interaction%2520of%2520G7%25E2%2580%259318NATE%2520Peptide%2520with%2520the%2520Grb7-SH2%2520Domain%26jtitle%3DInt.%2520J.%2520Pept.%2520Res.%2520Ther.%26date%3D2010%26volume%3D16%26spage%3D177%26epage%3D184%26doi%3D10.1007%2Fs10989-010-9222-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Spuches, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argiros, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, B. A.</span><span> </span><span class="NLM_article-title">Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain</span> <span class="citation_source-journal">J. Mol. Recognit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1002/jmr.834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1002%2Fjmr.834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=17705331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVagsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=245-52&author=A.+M.+Spuchesauthor=H.+J.+Argirosauthor=K.+H.+Leeauthor=L.+L.+Haasauthor=S.+C.+Peroauthor=D.+N.+Kragauthor=P.+P.+Rollerauthor=D.+E.+Wilcoxauthor=B.+A.+Lyons&title=Calorimetric+investigation+of+phosphorylated+and+non-phosphorylated+peptide+ligand+binding+to+the+human+Grb7-SH2+domain&doi=10.1002%2Fjmr.834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain</span></div><div class="casAuthors">Spuches, A. M.; Argiros, H. J.; Lee, K. H.; Haas, L. Lowell; Pero, S. C.; Krag, D. N.; Roller, P. P.; Wilcox, D. E.; Lyons, B. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">245-252</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Grb7 is a member of the Grb7 family of proteins, which also includes Grb10 and Grb14.  All three proteins have been found to be overexpressed in certain cancers and cancer cell lines.  In particular, Grb7 (along with the receptor tyrosine kinase erbB2) is overexpressed in 20-30% of breast cancers.  In general, growth factor receptor bound (Grb) proteins bind to activated membrane-bound receptor tyrosine kinases (RTKs; e.g., the epidermal growth factor receptor, EGFR) through their Src homol. 2 (SH2) domains.  In particular, Grb7 binds to erbB2 (a.k.a. EGFR2) and may be involved in cell signaling pathways that promote the formation of metastases and inflammatory responses.  In previous studies, we reported the soln. structure and the backbone relaxation behavior of the Grb7-SH2/erbB2 peptide complex.  In this study, isothermal titrn. calorimetry studies have been completed by measuring the thermodn. binding parameters of several phosphorylated and non-phosphorylated peptides representative of natural Grb7 receptor ligands as well as ligands developed through combinatorial peptide screening methods.  The entirety of these calorimetric studies is interpreted in an effort to describe the specific ligand binding characteristics of the Grb7 protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqIL4vuG5eh7Vg90H21EOLACvtfcHk0lgztgonDayEbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVagsbs%253D&md5=8c4c306b56b493d5fda199ecf59f7254</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjmr.834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.834%26sid%3Dliteratum%253Aachs%26aulast%3DSpuches%26aufirst%3DA.%2BM.%26aulast%3DArgiros%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BH.%26aulast%3DHaas%26aufirst%3DL.%2BL.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWilcox%26aufirst%3DD.%2BE.%26aulast%3DLyons%26aufirst%3DB.%2BA.%26atitle%3DCalorimetric%2520investigation%2520of%2520phosphorylated%2520and%2520non-phosphorylated%2520peptide%2520ligand%2520binding%2520to%2520the%2520human%2520Grb7-SH2%2520domain%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2007%26volume%3D20%26spage%3D245%26epage%3D52%26doi%3D10.1002%2Fjmr.834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Borgo, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Interaction of the non-phosphorylated peptide G7–18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity</span> <span class="citation_source-journal">J. Mol. Recognit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1002/jmr.2148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1002%2Fjmr.2148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=22213451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1yntrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=57-67&author=M.+J.+Gunzburgauthor=N.+D.+Ambayeauthor=M.+P.+Del+Borgoauthor=S.+C.+Peroauthor=D.+N.+Kragauthor=M.+C.+Wilceauthor=J.+A.+Wilce&title=Interaction+of+the+non-phosphorylated+peptide+G7%E2%80%9318NATE+with+Grb7-SH2+domain+requires+phosphate+for+enhanced+affinity+and+specificity&doi=10.1002%2Fjmr.2148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity</span></div><div class="casAuthors">Gunzburg, Menachem J.; Ambaye, Nigus D.; Del Borgo, Mark P.; Pero, Stephanie C.; Krag, David N.; Wilce, Matthew C. J.; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-67</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Src-homol. (SH2) domains are an attractive target for the inhibition of specific signaling pathways but pose the challenge of developing a truly specific inhibitor.  The G7-18NATE cyclic peptide is reported to specifically inhibit the growth factor receptor bound protein 7 (Grb7) adapter protein, implicated in the progression of several cancer types, via interactions with its SH2 domain.  G7-18NATE effectively inhibits the interaction of Grb7 with ErbB3 and focal adhesion kinase in cell lysates and, with the addn. of a cell permeability sequence, inhibits the growth and migration of a no. of breast cancer cell lines.  It is thus a promising lead in the development of therapeutics targeted to Grb7.  Here the authors investigate the degree to which G7-18NATE is specific for the Grb7-SH2 domain compared with closely related SH2 domains including those of Grb10, Grb14, and Grb2 using surface plasmon resonance.  The authors demonstrate that G7-18NATE binds with micromolar binding affinity to Grb7-SH2 domain (KD = 4-6 μm) compared with 50-200 times lower affinity for Grb10, Grb14, and Grb2 but that this specificity depends critically on the presence of phosphate in millimolar concns.  Other differences in buffer compn., including use of Tris or 2-(N-Morpholino)ethanesulfonic acid or varying the pH, do not impact on the interaction.  This suggests that under cellular conditions, G7-18NATE binds with highest affinity to Grb7.  In addn., the authors' findings demonstrate that the basis of specificity of G7-18NATE binding to the Grb7-SH2 domain is via other than intrinsic structural features of the protein, representing an unexpected mode of mol. recognition.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVOz6dLoaKNLVg90H21EOLACvtfcHk0lgztgonDayEbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1yntrzK&md5=77073aec5afc99cfbf1f3b7d62039b8f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fjmr.2148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.2148%26sid%3Dliteratum%253Aachs%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DDel%2BBorgo%26aufirst%3DM.%2BP.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DWilce%26aufirst%3DM.%2BC.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DInteraction%2520of%2520the%2520non-phosphorylated%2520peptide%2520G7%25E2%2580%259318NATE%2520with%2520Grb7-SH2%2520domain%2520requires%2520phosphate%2520for%2520enhanced%2520affinity%2520and%2520specificity%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2012%26volume%3D25%26spage%3D57%26epage%3D67%26doi%3D10.1002%2Fjmr.2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. C.</span><span> </span><span class="NLM_article-title">Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span><span class="refDoi"> DOI: 10.1038/362087a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1038%2F362087a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1993&pages=87-91&author=M.+J.+Eckauthor=S.+E.+Shoelsonauthor=S.+C.+Harrison&title=Recognition+of+a+high-affinity+phosphotyrosyl+peptide+by+the+Src+homology-2+domain+of+p56lck&doi=10.1038%2F362087a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2F362087a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F362087a0%26sid%3Dliteratum%253Aachs%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26atitle%3DRecognition%2520of%2520a%2520high-affinity%2520phosphotyrosyl%2520peptide%2520by%2520the%2520Src%2520homology-2%2520domain%2520of%2520p56lck%26jtitle%3DNature%26date%3D1993%26volume%3D362%26spage%3D87%26epage%3D91%26doi%3D10.1038%2F362087a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Phosphotyrosyl mimetics in the development of signal transduction inhibitors</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1021/ar020127o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar020127o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslCmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=426-33&author=T.+R.+Burkeauthor=K.+Lee&title=Phosphotyrosyl+mimetics+in+the+development+of+signal+transduction+inhibitors&doi=10.1021%2Far020127o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphotyrosyl Mimetics in the Development of Signal Transduction Inhibitors</span></div><div class="casAuthors">Burke, Terrence R., Jr.; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">426-433</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Phosphotyrosyl (pTyr) residues play important roles in cellular signal transduction by facilitating recognition and binding necessary for crit. protein-protein interactions, and for this reason pTyr motifs represent attractive starting points in the development of signaling antagonists.  Although the pTyr phosphoryl moiety is central in these phenomena, its incorporation into signaling inhibitors is contraindicated due to enzymic lability and limited bioavailability assocd. with phosphate esters.  To address these limitations, an entire field of study has arisen devoted to the design and utilization of pTyr mimetics.  This Account provides a perspective on the roles of pTyr residues in signal transduction and approaches to pTyr mimetic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqecqbwygKL7bVg90H21EOLACvtfcHk0lgztgonDayEbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslCmtLs%253D&md5=84c9610cea90bfcb3ce91a0ede387e77</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Far020127o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far020127o%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DPhosphotyrosyl%2520mimetics%2520in%2520the%2520development%2520of%2520signal%2520transduction%2520inhibitors%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2003%26volume%3D36%26spage%3D426%26epage%3D33%26doi%3D10.1021%2Far020127o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traore, D. A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Borgo, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonist</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F: Struct. Biol. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1107/S2053230X13033414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS2053230X13033414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=24637751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVejsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=182-186&author=N.+D.+Ambayeauthor=M.+J.+Gunzburgauthor=D.+A.+K.+Traoreauthor=M.+P.+Del+Borgoauthor=P.+Perlmutterauthor=M.+C.+J.+Wilceauthor=J.+A.+Wilce&title=Preparation+of+crystals+for+characterizing+the+Grb7+SH2+domain+before+and+after+complex+formation+with+a+bicyclic+peptide+antagonist&doi=10.1107%2FS2053230X13033414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonist</span></div><div class="casAuthors">Ambaye, Nigus D.; Gunzburg, Menachem J.; Traore, Daouda A. K.; Del Borgo, Mark P.; Perlmutter, Patrick; Wilce, Matthew C. J.; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-186</span>CODEN:
                <span class="NLM_cas:coden">ACSFEN</span>;
        ISSN:<span class="NLM_cas:issn">2053-230X</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Human growth factor receptor-bound protein 7 (Grb7) is an adapter protein involved in cell growth, migration and proliferation.  It is now recognized that Grb7 is an emerging therapeutic target in specific cancer subtypes.  Recently, the discovery of a bicyclic peptide inhibitor that targets the Grb7 SH2 domain, named G7-B1, was reported.  In an attempt to probe the foundation of its interaction with Grb7, the crystn. and preliminary data collection of both the apo and G7-B1-bound forms of the Grb7 SH2 domain are reported here.  Diffraction-quality crystals were obtained using the hanging-drop vapor-diffusion method.  After several rounds of microseeding, crystals of the apo Grb7 SH2 domain were obtained that diffracted to 1.8 Å resoln., while those of the G7-B1-Grb7 SH2 domain complex diffracted to 2.2 Å resoln.  The apo Grb7 SH2 domain crystd. in the trigonal space group P63, whereas the G7-B1-Grb7 SH2 domain complex crystd. in the monoclinic space group P21.  The exptl. aspects of crystn., crystal optimization and data collection and the preliminary data are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK7F-qcXcIQLVg90H21EOLACvtfcHk0lgCIyt9GjCiXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVejsb4%253D&md5=8fcad22b7bbcfa216fbbc5c9bdfe0674</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS2053230X13033414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053230X13033414%26sid%3Dliteratum%253Aachs%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DTraore%26aufirst%3DD.%2BA.%2BK.%26aulast%3DDel%2BBorgo%26aufirst%3DM.%2BP.%26aulast%3DPerlmutter%26aufirst%3DP.%26aulast%3DWilce%26aufirst%3DM.%2BC.%2BJ.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DPreparation%2520of%2520crystals%2520for%2520characterizing%2520the%2520Grb7%2520SH2%2520domain%2520before%2520and%2520after%2520complex%2520formation%2520with%2520a%2520bicyclic%2520peptide%2520antagonist%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Commun.%26date%3D2014%26volume%3D70%26spage%3D182%26epage%3D186%26doi%3D10.1107%2FS2053230X13033414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Stein, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghirlando, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span> </span><span class="NLM_article-title">Structural basis for dimerization of the Grb10 Src homology 2 domain. Implications for ligand specificity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">13257</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1074/jbc.M212026200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.M212026200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=13257-64&author=E.+G.+Steinauthor=R.+Ghirlandoauthor=S.+R.+Hubbard&title=Structural+basis+for+dimerization+of+the+Grb10+Src+homology+2+domain.+Implications+for+ligand+specificity&doi=10.1074%2Fjbc.M212026200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M212026200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M212026200%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DE.%2BG.%26aulast%3DGhirlando%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26atitle%3DStructural%2520basis%2520for%2520dimerization%2520of%2520the%2520Grb10%2520Src%2520homology%25202%2520domain.%2520Implications%2520for%2520ligand%2520specificity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D13257%26epage%3D64%26doi%3D10.1074%2Fjbc.M212026200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Depetris, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimpelevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span> </span><span class="NLM_article-title">Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2Fj.molcel.2005.09.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=325-33&author=R.+S.+Depetrisauthor=J.+Huauthor=I.+Gimpelevichauthor=L.+J.+Holtauthor=R.+J.+Dalyauthor=S.+R.+Hubbard&title=Structural+basis+for+inhibition+of+the+insulin+receptor+by+the+adaptor+protein+Grb14&doi=10.1016%2Fj.molcel.2005.09.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DDepetris%26aufirst%3DR.%2BS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DGimpelevich%26aufirst%3DI.%26aulast%3DHolt%26aufirst%3DL.%2BJ.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520the%2520insulin%2520receptor%2520by%2520the%2520adaptor%2520protein%2520Grb14%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D20%26spage%3D325%26epage%3D33%26doi%3D10.1016%2Fj.molcel.2005.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Porter, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leedman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Grb7-SH2 domain dimerisation is affected by a single point mutation</span> <span class="citation_source-journal">Eur. Biophys. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1007/s00249-005-0480-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2Fs00249-005-0480-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=15841400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVOqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2005&pages=454-60&author=C.+J.+Porterauthor=M.+C.+Wilceauthor=J.+P.+Mackayauthor=P.+Leedmanauthor=J.+A.+Wilce&title=Grb7-SH2+domain+dimerisation+is+affected+by+a+single+point+mutation&doi=10.1007%2Fs00249-005-0480-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Grb7-SH2 domain dimerisation is affected by a single point mutation</span></div><div class="casAuthors">Porter, Corrine J.; Wilce, Matthew C. J.; Mackay, Joel P.; Leedman, Peter; Wilce, Jackie A.</div><div class="citationInfo"><span class="NLM_cas:title">European Biophysics Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">454-460</span>CODEN:
                <span class="NLM_cas:coden">EBJOE8</span>;
        ISSN:<span class="NLM_cas:issn">0175-7571</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Growth factor receptor-bound protein 7 (GRB7) is an adaptor protein that is co-overexpressed and forms a tight complex with the ErbB2 receptor in a no. of breast tumors and breast cancer cell lines.  The interaction of Grb7 with the ErbB2 receptor is mediated via its Src homol. 2 (SH2) domain.  While most SH2 domains exist as monomers, recently reported studies have suggested that the Grb7-SH2 domain exists as a homodimer.  The self-assocn. properties of the Grb7-SH2 domain were therefore studied using sedimentation equil. ultracentrifugation.  Anal. of the data demonstrated that the Grb7-SH2 domain is dimeric with a dissocn. const. of approx. 11 μM.  The authors also demonstrate, using size-exclusion chromatog., that mutation of phenylalanine 511 to an arginine produces a monomeric form of the Grb7-SH2 domain.  This mutation represents the first step in the engineering of a Grb7-SH2 domain with good soln. properties for further biophys. and structural investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_BoXzCvPyNbVg90H21EOLACvtfcHk0ljacwoovcM_Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVOqsbg%253D&md5=d5cdec99e46b1b7ef98c80758181b1a2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00249-005-0480-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00249-005-0480-1%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DC.%2BJ.%26aulast%3DWilce%26aufirst%3DM.%2BC.%26aulast%3DMackay%26aufirst%3DJ.%2BP.%26aulast%3DLeedman%26aufirst%3DP.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DGrb7-SH2%2520domain%2520dimerisation%2520is%2520affected%2520by%2520a%2520single%2520point%2520mutation%26jtitle%3DEur.%2520Biophys.%2520J.%26date%3D2005%26volume%3D34%26spage%3D454%26epage%3D60%26doi%3D10.1007%2Fs00249-005-0480-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pero, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Borgo, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peletskaya, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krag, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer progression</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">412</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span><span class="refDoi"> DOI: 10.1016/j.jmb.2011.07.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2Fj.jmb.2011.07.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=21802427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFarurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=412&publication_year=2011&pages=397-411&author=N.+D.+Ambayeauthor=S.+C.+Peroauthor=M.+J.+Gunzburgauthor=M.+Yapauthor=D.+J.+Claytonauthor=M.+P.+Del+Borgoauthor=P.+Perlmutterauthor=M.+I.+Aguilarauthor=G.+S.+Shuklaauthor=E.+Peletskayaauthor=M.+M.+Cooksonauthor=D.+N.+Kragauthor=M.+C.+Wilceauthor=J.+A.+Wilce&title=Structural+basis+of+binding+by+cyclic+nonphosphorylated+peptide+antagonists+of+Grb7+implicated+in+breast+cancer+progression&doi=10.1016%2Fj.jmb.2011.07.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Binding by Cyclic Nonphosphorylated Peptide Antagonists of Grb7 Implicated in Breast Cancer Progression</span></div><div class="casAuthors">Ambaye, Nigus D.; Pero, Stephanie C.; Gunzburg, Menachem J.; Yap, Min Yin; Clayton, Daniel J.; Del Borgo, Mark P.; Perlmutter, Patrick; Aguilar, Marie-Isabel; Shukla, Girja S.; Peletskaya, Elena; Cookson, Michelle M.; Krag, David N.; Wilce, Matthew C. J.; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">412</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-411</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Growth-receptor-bound protein (Grb)7 is an adapter protein aberrantly overexpressed, along with the erbB-2 receptor in breast cancer and in other cancers.  Normally recruited to focal adhesions with a role in cell migration, it is assocd. with erbB-2 in cancer cells and is found to exacerbate cancer progression via stimulation of cell migration and proliferation.  The G7-18NATE peptide (sequence: WFEGYDNTFPC cyclized via a thioether bond) is a nonphosphorylated peptide that was developed for the specific inhibition of Grb7 by blocking its SH2 domain.  Cell-permeable versions of G7-18NATE are effective in the redn. of migration and proliferation in Grb7-overexpressing cells.  It thus represents a promising starting point for the development of a therapeutic against Grb7.  Here, the authors report the crystal structure of the G7-18NATE peptide in complex with the Grb7-SH2 domain, revealing the structural basis for its interaction.  The authors also report further rounds of phage display that have identified G7-18NATE analogs with micromolar affinity for Grb7-SH2.  These peptides retained amino acids F2, G4, and F9, as well as the YDN motif that the structural biol. study showed to be the main residues in contact with the Grb7-SH2 domain.  Isothermal titrn. calorimetry measurements reveal similar and better binding affinity of these peptides compared with G7-18NATE.  Together, this study facilitates the optimization of second-generation inhibitors of Grb7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEQ_mNcka417Vg90H21EOLACvtfcHk0ljacwoovcM_Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFarurbF&md5=d00128a2cfbc35681abb5fd4f569840f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2011.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2011.07.030%26sid%3Dliteratum%253Aachs%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DPero%26aufirst%3DS.%2BC.%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DYap%26aufirst%3DM.%26aulast%3DClayton%26aufirst%3DD.%2BJ.%26aulast%3DDel%2BBorgo%26aufirst%3DM.%2BP.%26aulast%3DPerlmutter%26aufirst%3DP.%26aulast%3DAguilar%26aufirst%3DM.%2BI.%26aulast%3DShukla%26aufirst%3DG.%2BS.%26aulast%3DPeletskaya%26aufirst%3DE.%26aulast%3DCookson%26aufirst%3DM.%2BM.%26aulast%3DKrag%26aufirst%3DD.%2BN.%26aulast%3DWilce%26aufirst%3DM.%2BC.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DStructural%2520basis%2520of%2520binding%2520by%2520cyclic%2520nonphosphorylated%2520peptide%2520antagonists%2520of%2520Grb7%2520implicated%2520in%2520breast%2520cancer%2520progression%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D412%26spage%3D397%26epage%3D411%26doi%3D10.1016%2Fj.jmb.2011.07.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Waksman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pant, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowburn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/0092-8674(93)90405-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2F0092-8674%2893%2990405-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=7680960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1ejsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1993&pages=779-90&author=G.+Waksmanauthor=S.+E.+Shoelsonauthor=N.+Pantauthor=D.+Cowburnauthor=J.+Kuriyan&title=Binding+of+a+high+affinity+phosphotyrosyl+peptide+to+the+Src+SH2+domain%3A+crystal+structures+of+the+complexed+and+peptide-free+forms&doi=10.1016%2F0092-8674%2893%2990405-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of a high affinity phosphotyrosyl peptide the the Src SH2 domain: Crystal structures of the complexed and peptide-free forms</span></div><div class="casAuthors">Waksman, Gabriel; Shoelson, Steven E.; Pant, Nalin; Cowburn, David; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">779-90</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">The crystal structure of the Src SH2 domain complexed with a high affinity 11-residue phosphopeptide has been detd. at 2.7 Å resoln. by x-ray diffraction.  The peptide binds in an extended conformation and makes primary interactions with the SH2 domain at six central residues: PQ(pY)EEI.  The phosphotyrosine and the isoleucine are tightly bound by two well-defined pockets on the protein surface, resulting in a complex that resembles a two-pronged plug engaging a two-holed socket.  The glutamate residues are in solvent-exposed environments in the vicinity of basic side chains of the SH2 domain, and the two N-terminal residues cap the phosphotyrosine-binding site.  The crystal structure of Src SH2 in the absence of peptide has been detd. at 2.5 Å resoln., and comparison with the structure of the high affinity complex reveals only localized and relatively small changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1igz-31nXDbVg90H21EOLACvtfcHk0ljacwoovcM_Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1ejsb0%253D&md5=1e9673f84cea2c549b2d47a57add2472</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2893%2990405-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252893%252990405-F%26sid%3Dliteratum%253Aachs%26aulast%3DWaksman%26aufirst%3DG.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DPant%26aufirst%3DN.%26aulast%3DCowburn%26aufirst%3DD.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DBinding%2520of%2520a%2520high%2520affinity%2520phosphotyrosyl%2520peptide%2520to%2520the%2520Src%2520SH2%2520domain%253A%2520crystal%2520structures%2520of%2520the%2520complexed%2520and%2520peptide-free%2520forms%26jtitle%3DCell%26date%3D1993%26volume%3D72%26spage%3D779%26epage%3D90%26doi%3D10.1016%2F0092-8674%2893%2990405-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span> </span><span class="NLM_article-title">Monocarboxylic-based phosphotyrosyl mimetics in the design of GRB2 SH2 domain inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/S0960-894X(98)00740-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2FS0960-894X%2898%2900740-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=347-52&author=T.+R.+Burkeauthor=J.+Luoauthor=Z.+J.+Yaoauthor=Y.+Gaoauthor=H.+Zhaoauthor=G.+W.+Milneauthor=R.+Guoauthor=J.+H.+Voigtauthor=C.+R.+Kingauthor=D.+Yang&title=Monocarboxylic-based+phosphotyrosyl+mimetics+in+the+design+of+GRB2+SH2+domain+inhibitors&doi=10.1016%2FS0960-894X%2898%2900740-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2898%2900740-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252898%252900740-9%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DZ.%2BJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMilne%26aufirst%3DG.%2BW.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKing%26aufirst%3DC.%2BR.%26aulast%3DYang%26aufirst%3DD.%26atitle%3DMonocarboxylic-based%2520phosphotyrosyl%2520mimetics%2520in%2520the%2520design%2520of%2520GRB2%2520SH2%2520domain%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D347%26epage%3D52%26doi%3D10.1016%2FS0960-894X%2898%2900740-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramdas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeyesekere, N. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budde, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, J. S.</span><span> </span><span class="NLM_article-title">Cyclic peptides incorporating 4-carboxyphenylalanine and phosphotyrosine are potent inhibitors of pp60(c-) (src)</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5221</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1021/bi992994f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi992994f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=5221-8&author=W.+Wangauthor=L.+Ramdasauthor=G.+Sunauthor=S.+Keauthor=N.+U.+Obeyesekereauthor=R.+J.+Buddeauthor=J.+S.+McMurray&title=Cyclic+peptides+incorporating+4-carboxyphenylalanine+and+phosphotyrosine+are+potent+inhibitors+of+pp60%28c-%29+%28src%29&doi=10.1021%2Fbi992994f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi992994f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi992994f%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DRamdas%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DKe%26aufirst%3DS.%26aulast%3DObeyesekere%26aufirst%3DN.%2BU.%26aulast%3DBudde%26aufirst%3DR.%2BJ.%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26atitle%3DCyclic%2520peptides%2520incorporating%25204-carboxyphenylalanine%2520and%2520phosphotyrosine%2520are%2520potent%2520inhibitors%2520of%2520pp60%2528c-%2529%2520%2528src%2529%26jtitle%3DBiochemistry%26date%3D2000%26volume%3D39%26spage%3D5221%26epage%3D8%26doi%3D10.1021%2Fbi992994f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Tilley, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarabu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulkerins, K.</span><span> </span><span class="NLM_article-title">Preparation of carboalkoxyalkylphenylalanine derivatives from tyrosine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span><span class="refDoi"> DOI: 10.1021/jo00290a021</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00290a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK3cXnslyqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=906-910&author=J.+W.+Tilleyauthor=R.+Sarabuauthor=R.+Wagnerauthor=K.+Mulkerins&title=Preparation+of+carboalkoxyalkylphenylalanine+derivatives+from+tyrosine&doi=10.1021%2Fjo00290a021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of carboalkoxyalkylphenylalanine derivatives from tyrosine</span></div><div class="casAuthors">Tilley, Jefferson W.; Sarabu, Ramakanth; Wagner, Rolf; Mulkerins, Kathleen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">906-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">In order to provide the means for the synthesis of peptides incorporating stable and relatively nonpolar mimics of tyrosine phosphates and sulfates, procedures have been developed for the conversion of tyrosine derivs. to carbalkoxyalkylphenylalanines.  Thus, tyrosine triflates I (Boc = Me3CO2C; R = CHPh2, CH2Ph) are coupled with an acrylate ester or preferably a 2-(trialkylstannyl)acrylate in the presence of Pd(PPh3)2Cl2 to give carbalkoxyethenylphenylalanine derivs. II (R = CHPh2, R1 = CMe3; R = CH2Ph, R1 = Me).  Hydrogenation of II affords the carbalkoxyethylphenylalanine derivs. III (R1 = same).  For the prepn. of carbalkoxymethylphenylalanines I (R = CH2Ph, Me) are coupled with CH2=CHCH2SnBu3 in the presence of Pd(PPh3)2Cl2 and LiCl to give an ester of 4-allylphenylalanine.  A two-stage oxidn. using RuO4-NaIO4 followed by NaO2Cl in phosphate buffer gives a carboxymethylphenylalanine.  Esterification of the newly formed carboxylic acid and selective deesterification of the α-carboxylate completes the synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_P9Dk0loiXbVg90H21EOLACvtfcHk0lgXAFyz2diu2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXnslyqug%253D%253D&md5=48f6c47b28f14bd8e42730a1ef43e380</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo00290a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00290a021%26sid%3Dliteratum%253Aachs%26aulast%3DTilley%26aufirst%3DJ.%2BW.%26aulast%3DSarabu%26aufirst%3DR.%26aulast%3DWagner%26aufirst%3DR.%26aulast%3DMulkerins%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520carboalkoxyalkylphenylalanine%2520derivatives%2520from%2520tyrosine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D906%26epage%3D910%26doi%3D10.1021%2Fjo00290a021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Janes, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span> </span><span class="NLM_article-title">Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">8490</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1074/jbc.272.13.8490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.272.13.8490" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=8490-7&author=P.+W.+Janesauthor=M.+Lackmannauthor=W.+B.+Churchauthor=G.+M.+Sandersonauthor=R.+L.+Sutherlandauthor=R.+J.+Daly&title=Structural+determinants+of+the+interaction+between+the+erbB2+receptor+and+the+Src+homology+2+domain+of+Grb7&doi=10.1074%2Fjbc.272.13.8490"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.13.8490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.13.8490%26sid%3Dliteratum%253Aachs%26aulast%3DJanes%26aufirst%3DP.%2BW.%26aulast%3DLackmann%26aufirst%3DM.%26aulast%3DChurch%26aufirst%3DW.%2BB.%26aulast%3DSanderson%26aufirst%3DG.%2BM.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520determinants%2520of%2520the%2520interaction%2520between%2520the%2520erbB2%2520receptor%2520and%2520the%2520Src%2520homology%25202%2520domain%2520of%2520Grb7%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D8490%26epage%3D7%26doi%3D10.1074%2Fjbc.272.13.8490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bevington, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundy, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanis, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radda, G. K.</span><span> </span><span class="NLM_article-title">A study of intracellular orthophosphate concentration in human muscle and erythrocytes by 31P nuclear magnetic resonance spectroscopy and selective chemical assay</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">729</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1042/cs0710729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1042%2Fcs0710729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=3024899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaL2sXkvVWnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1986&pages=729-35&author=A.+Bevingtonauthor=K.+I.+Mundyauthor=A.+J.+Yatesauthor=J.+A.+Kanisauthor=R.+G.+Russellauthor=D.+J.+Taylorauthor=B.+Rajagopalanauthor=G.+K.+Radda&title=A+study+of+intracellular+orthophosphate+concentration+in+human+muscle+and+erythrocytes+by+31P+nuclear+magnetic+resonance+spectroscopy+and+selective+chemical+assay&doi=10.1042%2Fcs0710729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A study of intracellular orthophosphate concentration in human muscle and erythrocytes by phosphorus-31 nuclear magnetic resonance spectroscopy and selective chemical assay</span></div><div class="casAuthors">Bevington, A.; Mundy, K. I.; Yates, A. J. P.; Kanis, J. A.; Russell, R. G. G.; Taylor, D. J.; Rajagopalan, B.; Radda, G. K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">729-35</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    </div><div class="casAbstract">To study the relation between extracellular and intracellular concns. of orthophosphate (Pi), phosphorus NMR spectra were recorded, at rest, from the flexor digitorum superficialis muscle of hypophosphatemic patients with vitamin D-resistant rickets, and patients with Paget's disease of bone before and after they had been made hyperphosphatemic by treatment with ethylidene-1-hydroxy-1,1-bisphosphonate.  Changes in i.m. Pi were estd. from the ratio of the areas of the Pi to ATP peaks.  Even though the plasma Pi concn. in these patients spanned a 4-fold range (0.5-2.0 mmol/L) the corresponding i.m. Pi concn. increased by only 70%.  A similar effect was obsd. in erythrocytes from patients with these disorders which were incubated in autologous plasma at 37°, under an atm. of O2 + CO2.  However, there was no general effect on passive anion distribution.  When erythrocytes from normal subjects were incubated in autologous plasma and in plasma supplemented with Pi the Pi concn. in the cells, at steady state, increased only from 0.57 to 0.78 mmol/L cells, suggesting that effect was not an artifact of disease or drug therapy.  Thus, in human skeletal myocytes and erythrocytes, the percentage change in the concn. of cytoplasmic Pi is lower than that in plasma.  This implies that these cells can buffer or regulate cytoplasmic Pi when the extracellular concn. is disturbed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVQuVo95gnZbVg90H21EOLACvtfcHk0ljXy5h6gzvO4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXkvVWnsA%253D%253D&md5=55a9afb0860b8079327f9bc6814ab888</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1042%2Fcs0710729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fcs0710729%26sid%3Dliteratum%253Aachs%26aulast%3DBevington%26aufirst%3DA.%26aulast%3DMundy%26aufirst%3DK.%2BI.%26aulast%3DYates%26aufirst%3DA.%2BJ.%26aulast%3DKanis%26aufirst%3DJ.%2BA.%26aulast%3DRussell%26aufirst%3DR.%2BG.%26aulast%3DTaylor%26aufirst%3DD.%2BJ.%26aulast%3DRajagopalan%26aufirst%3DB.%26aulast%3DRadda%26aufirst%3DG.%2BK.%26atitle%3DA%2520study%2520of%2520intracellular%2520orthophosphate%2520concentration%2520in%2520human%2520muscle%2520and%2520erythrocytes%2520by%252031P%2520nuclear%2520magnetic%2520resonance%2520spectroscopy%2520and%2520selective%2520chemical%2520assay%26jtitle%3DClin.%2520Sci.%26date%3D1986%26volume%3D71%26spage%3D729%26epage%3D35%26doi%3D10.1042%2Fcs0710729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Gilmer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimery, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternbach, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehrotra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradshaw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, J.</span><span> </span><span class="NLM_article-title">Peptide inhibitors of src SH3-SH2-phosphoprotein interactions</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">31711</span><span class="NLM_x">–</span> <span class="NLM_lpage">31719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=7527393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK2MXitVSksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=31711-31719&author=T.+Gilmerauthor=M.+Rodriguezauthor=S.+Jordanauthor=R.+Crosbyauthor=K.+Alligoodauthor=M.+Greenauthor=M.+Kimeryauthor=C.+Wagnerauthor=D.+Kinderauthor=P.+Charifsonauthor=A.+M.+Hassellauthor=D.+Willardauthor=M.+Lutherauthor=D.+Rusnakauthor=D.+D.+Sternbachauthor=M.+Mehrotraauthor=M.+Peelauthor=L.+Shampineauthor=R.+Davisauthor=J.+Robbinsauthor=I.+R.+Patelauthor=D.+Kasselauthor=W.+Burkhartauthor=M.+Moyerauthor=T.+Bradshawauthor=J.+Berman&title=Peptide+inhibitors+of+src+SH3-SH2-phosphoprotein+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide inhibitors of src SH3-SH2-phosphoprotein interactions</span></div><div class="casAuthors">Gilmer, Tona; Rodriguez, Marc; Jordan, Steve; Crosby, Renae; Alligood, Krystal; Green, Michael; Kimery, Millard; Wagner, Craig; Kinder, Dan; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">31711-19</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Activated pp60c-src has been implicated in a no. of human malignancies including colon carcinoma and breast adenocarcinoma.  Assocn. of the src SH2 domain with tyrosine-phosphorylated proteins plays a role in src-mediated signal transduction.  Inhibitors of src SH2 domain-phosphoprotein interactions are, thus, of great interest in defining the role(s) of src in signal transduction pathways.  To facilitate such studies, an ELISA was developed to detect inhibitors of src SH2-phosphoprotein interactions.  This assay measures inhibition of binding of a fusion construct (glutathione S-transferase src SH3-SH2) with autophosphorylated epidermal growth factor receptor tyrosine kinase domain.  Activities of phosphopeptide segments derived from potential src SH2 cognate phosphoprotein partners were detd., with the focal adhesion kinase-derived segment VSETDDY*AEIIDE yielding the highest inhibitory activity.  Structure activity studies starting from acetyl (Ac)-Y*EEIE have identified Ac-Y*Y*Y*IE as the most active compd. screened in the ELISA.  This compd. is at least 20-fold more active than the parent peptide Ac-Y*EEIE.  A high resoln. (2 Å) crystal structure of human src SH2 complexed with Ac-Y*EEIE was obtained and provided a useful framework for understanding the structure-activity relationships.  Addnl., Ac-Y*EEIE was able to block interactions between src and its cellular phosphoprotein partners in vanadate-treated cell lysates from MDA-MB-468 breast carcinoma cells.  However, it is unable to abrogate proliferation of MDA-MB-468 cells in culture, presumably because of poor cell penetration and/or lability of the phosphate group on tyrosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnieHWiS0-yrVg90H21EOLACvtfcHk0ljXy5h6gzvO4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitVSksL8%253D&md5=518ae19a4451a4e9a2a9a102a6ec86da</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilmer%26aufirst%3DT.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DJordan%26aufirst%3DS.%26aulast%3DCrosby%26aufirst%3DR.%26aulast%3DAlligood%26aufirst%3DK.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DKimery%26aufirst%3DM.%26aulast%3DWagner%26aufirst%3DC.%26aulast%3DKinder%26aufirst%3DD.%26aulast%3DCharifson%26aufirst%3DP.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DWillard%26aufirst%3DD.%26aulast%3DLuther%26aufirst%3DM.%26aulast%3DRusnak%26aufirst%3DD.%26aulast%3DSternbach%26aufirst%3DD.%2BD.%26aulast%3DMehrotra%26aufirst%3DM.%26aulast%3DPeel%26aufirst%3DM.%26aulast%3DShampine%26aufirst%3DL.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DRobbins%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DI.%2BR.%26aulast%3DKassel%26aufirst%3DD.%26aulast%3DBurkhart%26aufirst%3DW.%26aulast%3DMoyer%26aufirst%3DM.%26aulast%3DBradshaw%26aufirst%3DT.%26aulast%3DBerman%26aufirst%3DJ.%26atitle%3DPeptide%2520inhibitors%2520of%2520src%2520SH3-SH2-phosphoprotein%2520interactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D31711%26epage%3D31719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schembri-King, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betageri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proudfoot, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span> </span><span class="NLM_article-title">Carboxymethyl-phenylalanine as a replacement for phosphotyrosine in SH2 domain binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">20238</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1074/jbc.273.32.20238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1074%2Fjbc.273.32.20238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=9685372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVWgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=20238-42&author=L.+Tongauthor=T.+C.+Warrenauthor=S.+Lukasauthor=J.+Schembri-Kingauthor=R.+Betageriauthor=J.+R.+Proudfootauthor=S.+Jakes&title=Carboxymethyl-phenylalanine+as+a+replacement+for+phosphotyrosine+in+SH2+domain+binding&doi=10.1074%2Fjbc.273.32.20238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxymethyl-phenylalanine as a replacement for phosphotyrosine in SH2 domain binding</span></div><div class="casAuthors">Tong, Liang; Warren, Thomas C.; Lukas, Susan; Schembri-King, Josephine; Betageri, Raj; Proudfoot, John R.; Jakes, Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">20238-20242</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The crystal structure of human p56lck SH2 domain in complex with an inhibitor contg. the singly charged p-(carboxymethyl)phenylalanine residue (cmF) as a phosphotyrosine (Tyr(P) or pY) replacement has been detd. at 1.8 Å resoln.  The binding mode of the acetyl-cmF-Glu-Glu-Ile (cmFEEI) inhibitor is very similar to that of the pYEEI inhibitor, confirming that the cmFEEI inhibitor has a similar mechanism of SH2 domain inhibition despite its significantly reduced potency.  Obsd. conformational differences in the side chain of the cmF residue can be interpreted in terms of maintaining similar interactions with the SH2 domain as the Tyr(P) residue.  The crystal structure of the free p56lck SH2 domain has been detd. at 1.9 Å resoln. and shows an open conformation for the BC loop and an open phosphotyrosine binding pocket, in contrast to earlier studies on the src SH2 domain that showed mostly closed conformation.  The structural information presented here suggests that the carboxymethyl-phenylalanine residue may be a viable Tyr(P) replacement and represents an attractive starting point for the design and development of SH2 domain inhibitors with better pharmaceutical profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCtEGBp8YC-7Vg90H21EOLACvtfcHk0ljXy5h6gzvO4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVWgt7w%253D&md5=e5b2dda75277cf70a95953fb98550ecc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.32.20238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.32.20238%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DWarren%26aufirst%3DT.%2BC.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DSchembri-King%26aufirst%3DJ.%26aulast%3DBetageri%26aufirst%3DR.%26aulast%3DProudfoot%26aufirst%3DJ.%2BR.%26aulast%3DJakes%26aufirst%3DS.%26atitle%3DCarboxymethyl-phenylalanine%2520as%2520a%2520replacement%2520for%2520phosphotyrosine%2520in%2520SH2%2520domain%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D20238%26epage%3D42%26doi%3D10.1074%2Fjbc.273.32.20238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Yao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1021/jm980388x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980388x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=25-35&author=Z.+J.+Yaoauthor=C.+R.+Kingauthor=T.+Caoauthor=J.+Kelleyauthor=G.+W.+Milneauthor=J.+H.+Voigtauthor=T.+R.+Burke&title=Potent+inhibition+of+Grb2+SH2+domain+binding+by+non-phosphate-containing+ligands&doi=10.1021%2Fjm980388x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm980388x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980388x%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DZ.%2BJ.%26aulast%3DKing%26aufirst%3DC.%2BR.%26aulast%3DCao%26aufirst%3DT.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DMilne%26aufirst%3DG.%2BW.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DPotent%2520inhibition%2520of%2520Grb2%2520SH2%2520domain%2520binding%2520by%2520non-phosphate-containing%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D25%26epage%3D35%26doi%3D10.1021%2Fjm980388x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Bradshaw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitaxov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waksman, G.</span><span> </span><span class="NLM_article-title">Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1006/jmbi.1999.3190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1006%2Fjmbi.1999.3190" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=1999&pages=971-85&author=J.+M.+Bradshawauthor=V.+Mitaxovauthor=G.+Waksman&title=Investigation+of+phosphotyrosine+recognition+by+the+SH2+domain+of+the+Src+kinase&doi=10.1006%2Fjmbi.1999.3190"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1999.3190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1999.3190%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26aulast%3DMitaxov%26aufirst%3DV.%26aulast%3DWaksman%26aufirst%3DG.%26atitle%3DInvestigation%2520of%2520phosphotyrosine%2520recognition%2520by%2520the%2520SH2%2520domain%2520of%2520the%2520Src%2520kinase%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D293%26spage%3D971%26epage%3D85%26doi%3D10.1006%2Fjmbi.1999.3190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Luzy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gril, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perdereau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnol, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbay, C.</span><span> </span><span class="NLM_article-title">Development of binding assays for the SH2 domain of Grb7 and Grb2 using fluorescence polarization</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1177/1087057107312124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1177%2F1087057107312124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=18216394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A280%3ADC%252BD1c7ls1Wruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=112-9&author=J.+P.+Luzyauthor=H.+Chenauthor=B.+Grilauthor=W.+Q.+Liuauthor=M.+Vidalauthor=D.+Perdereauauthor=A.+F.+Burnolauthor=C.+Garbay&title=Development+of+binding+assays+for+the+SH2+domain+of+Grb7+and+Grb2+using+fluorescence+polarization&doi=10.1177%2F1087057107312124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Development of binding assays for the SH2 domain of Grb7 and Grb2 using fluorescence polarization</span></div><div class="casAuthors">Luzy Jean-Philippe; Chen Huixiong; Gril Brunilde; Liu Wang-Qing; Vidal Michel; Perdereau Dominique; Burnol Anne-Francoise; Garbay Christiane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-9</span>
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    </div><div class="casAbstract">Adaptor proteins Grb7 and Grb2 have been implicated as being 2 potential therapeutic targets in several human cancers, especially those that overexpress ErbB2.  These 2 proteins contain both a SH2 domain (Src homology 2) that binds to phosphorylated tyrosine residues contained within ErbB2 and other specific protein targets.  Two assays based on enzyme-linked immunosorbent assay and fluorescence polarization methods have been developed and validated to find and rank inhibitors for both proteins binding to the pY(1139).  Fluorescence polarization assays allowed the authors to determine quickly and reproducibly affinities of peptides from low nanomolar to high micromolar range and to compare them directly for Grb7 and Grb2.  As a result, the assays have identified a known peptidomimetic Grb2 SH2 inhibitor (mAZ-pTyr-(alphaMe)pTyr-Asn-NH(2)) that exhibits the most potent affinity for the Grb7 SH2 domain described to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3mLga0R_gaXWEEzDrymxmfW6udTcc2eawrov0aPwsk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7ls1Wruw%253D%253D&md5=3c799e3b379686a63ddb5ef461182ff6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1177%2F1087057107312124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057107312124%26sid%3Dliteratum%253Aachs%26aulast%3DLuzy%26aufirst%3DJ.%2BP.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DGril%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DW.%2BQ.%26aulast%3DVidal%26aufirst%3DM.%26aulast%3DPerdereau%26aufirst%3DD.%26aulast%3DBurnol%26aufirst%3DA.%2BF.%26aulast%3DGarbay%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520binding%2520assays%2520for%2520the%2520SH2%2520domain%2520of%2520Grb7%2520and%2520Grb2%2520using%2520fluorescence%2520polarization%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2008%26volume%3D13%26spage%3D112%26epage%3D9%26doi%3D10.1177%2F1087057107312124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1016%2Fj.bmc.2010.10.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=693-701&author=N.+D.+Ambayeauthor=M.+J.+Gunzburgauthor=R.+C.+Limauthor=J.+T.+Priceauthor=M.+C.+Wilceauthor=J.+A.+Wilce&title=Benzopyrazine+derivatives%3A+A+novel+class+of+growth+factor+receptor+bound+protein+7+antagonists&doi=10.1016%2Fj.bmc.2010.10.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DLim%26aufirst%3DR.%2BC.%26aulast%3DPrice%26aufirst%3DJ.%2BT.%26aulast%3DWilce%26aufirst%3DM.%2BC.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DBenzopyrazine%2520derivatives%253A%2520A%2520novel%2520class%2520of%2520growth%2520factor%2520receptor%2520bound%2520protein%25207%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D693%26epage%3D701%26doi%3D10.1016%2Fj.bmc.2010.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Ambaye, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzburg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilce, J. A.</span><span> </span><span class="NLM_article-title">The discovery of phenylbenzamide derivatives as Grb7-based antitumor agents</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1002/cmdc.201200400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1002%2Fcmdc.201200400" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=280-8&author=N.+D.+Ambayeauthor=M.+J.+Gunzburgauthor=R.+C.+Limauthor=J.+T.+Priceauthor=M.+C.+Wilceauthor=J.+A.+Wilce&title=The+discovery+of+phenylbenzamide+derivatives+as+Grb7-based+antitumor+agents&doi=10.1002%2Fcmdc.201200400"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200400%26sid%3Dliteratum%253Aachs%26aulast%3DAmbaye%26aufirst%3DN.%2BD.%26aulast%3DGunzburg%26aufirst%3DM.%2BJ.%26aulast%3DLim%26aufirst%3DR.%2BC.%26aulast%3DPrice%26aufirst%3DJ.%2BT.%26aulast%3DWilce%26aufirst%3DM.%2BC.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520discovery%2520of%2520phenylbenzamide%2520derivatives%2520as%2520Grb7-based%2520antitumor%2520agents%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D280%26epage%3D8%26doi%3D10.1002%2Fcmdc.201200400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Morlacchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klostergaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, J. S.</span><span> </span><span class="NLM_article-title">Targeting SH2 domains in breast cancer</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1909</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.4155/fmc.14.120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.4155%2Ffmc.14.120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=25495984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyltr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1909-26&author=P.+Morlacchiauthor=F.+M.+Robertsonauthor=J.+Klostergaardauthor=J.+S.+McMurray&title=Targeting+SH2+domains+in+breast+cancer&doi=10.4155%2Ffmc.14.120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting SH2 domains in breast cancer</span></div><div class="casAuthors">Morlacchi, Pietro; Robertson, Fredika M.; Klostergaard, Jim; McMurray, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1909-1926</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Breast cancer is among the most commonly diagnosed cancer types in women worldwide and is the second leading cause of cancer-related disease in the USA.  SH2 domains recruit signaling proteins to phosphotyrosine residues on aberrantly activated growth factor and cytokine receptors and contribute to cancer cell cycling, metastasis, angiogenesis and so on.  Herein we review phosphopeptide mimetic and small-mol. approaches targeting the SH2 domains of Grb2, Grb7 and STAT3 that inhibit their targets and reduce proliferation in in vitro breast cancer models.  Only STAT3 inhibitors have been evaluated in in vivo models and have led to tumor redn.  Taken together, these studies suggest that targeting SH2 domains is an important approach to the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp32Npe7yuuhLVg90H21EOLACvtfcHk0ljNCIkGfNuRnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyltr%252FF&md5=0d4052d2ffc3a2396183fd21358aee65</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.120%26sid%3Dliteratum%253Aachs%26aulast%3DMorlacchi%26aufirst%3DP.%26aulast%3DRobertson%26aufirst%3DF.%2BM.%26aulast%3DKlostergaard%26aufirst%3DJ.%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26atitle%3DTargeting%2520SH2%2520domains%2520in%2520breast%2520cancer%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1909%26epage%3D26%26doi%3D10.4155%2Ffmc.14.120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Pace, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, T.</span><span> </span><span class="NLM_article-title">How to measure and predict the molar absorption coefficient of a protein</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1002/pro.5560041120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1002%2Fpro.5560041120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=8563639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK2MXpsVGqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1995&pages=2411-23&author=C.+N.+Paceauthor=F.+Vajdosauthor=L.+Feeauthor=G.+Grimsleyauthor=T.+Gray&title=How+to+measure+and+predict+the+molar+absorption+coefficient+of+a+protein&doi=10.1002%2Fpro.5560041120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">How to measure and predict the molar absorption coefficient of a protein</span></div><div class="casAuthors">Pace, C. Nick; Vajdos, Felix; Fee, Lanette; Grimsley, Gerald; Gray, Theronica</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2411-23</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The molar absorption coeff., ε, of a protein is usually based on concns. measured by dry wt., nitrogen, or amino acid anal.  The studies reported here suggest that the Edelhoch method is the best method for measuring ε for a protein.  (This method is described by Gill and von Hippel [1989, Anal Biochem 182:319-326] and is based on data from Edelhoch [1967, Biochem. 6:1948-1954].).  The av. ε values for these chromophores in a sample of 18 well-characterized proteins have been estd., and the ε values in water, propanol, 6 M guanidine hydrochloride (GdnHCl), and 8 M urea have been measured.  For Trp, the av. ε values for the proteins are intermediate between those measured in 6 M GdnHCl and those measured in propanol.  Based on a sample of 116 measured ε values for 80 proteins, the ε at 280 nm of a folded protein in water, ε(280), can best be predicted with this equation L ε(280) (M-1 cm-1) = (#Trp)(5,500) + (#Tyr)(1,490) + (#cystine)(125).  These ε(280) values are quite reliable for proteins contg. Trp residues, and less reliable for proteins that do not.  However, the Edelhoch method is convenient and accurate, and the best approach is to measure rather than predict ε.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDyrAj6uk11bVg90H21EOLACvtfcHk0ljYfHuM2Z_mlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsVGqt7k%253D&md5=033237a125c7486331bf5180047c3cd4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560041120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560041120%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DC.%2BN.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DFee%26aufirst%3DL.%26aulast%3DGrimsley%26aufirst%3DG.%26aulast%3DGray%26aufirst%3DT.%26atitle%3DHow%2520to%2520measure%2520and%2520predict%2520the%2520molar%2520absorption%2520coefficient%2520of%2520a%2520protein%26jtitle%3DProtein%2520Sci.%26date%3D1995%26volume%3D4%26spage%3D2411%26epage%3D23%26doi%3D10.1002%2Fpro.5560041120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Leslie, A. W.; Powell, H.</span><span> </span><span class="NLM_article-title">Processing Diffraction Data with Mosflm</span>. In  <span class="citation_source-book">Evolving Methods for Macromolecular Crystallography</span>, <span class="NLM_contrib-group">Read, R.; Sussman, J.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">245</span>, pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1007%2F978-1-4020-6316-9_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=41-51&author=A.+W.+Leslie&author=H.+Powellauthor=R.+Read&author=J.+Sussman&title=Evolving+Methods+for+Macromolecular+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6316-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4020-6316-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BW.%26atitle%3DProcessing%2520Diffraction%2520Data%2520with%2520Mosflm%26btitle%3DEvolving%2520Methods%2520for%2520Macromolecular%2520Crystallography%26aulast%3DRead%26aufirst%3DR.%26pub%3DSpringer%26date%3D2007%26volume%3D245%26spage%3D41%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Evans, P.</span><span> </span><span class="NLM_article-title">Scaling and assessment of data quality</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+assessment+of+data+quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0ljYfHuM2Z_mlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520assessment%2520of%2520data%2520quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-42&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0ljYfHuM2Z_mlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D42%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplyakov, A.</span><span> </span><span class="NLM_article-title">Molecular replacement with MOLREP</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span><span class="refDoi"> DOI: 10.1107/S0907444909042589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444909042589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=20057045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=22-5&author=A.+Vaginauthor=A.+Teplyakov&title=Molecular+replacement+with+MOLREP&doi=10.1107%2FS0907444909042589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular replacement with MOLREP</span></div><div class="casAuthors">Vagin, Alexei; Teplyakov, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-25</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MOLREP is an automated program for mol. replacement that utilizes a no. of original approaches to rotational and translational search and data prepn.  Since the first publication describing the program, MOLREP has acquired a variety of features that include weighting of the X-ray data and search models, multi-copy search, fitting the model into electron d., structural superposition of two models and rigid-body refinement.  The program can run in a fully automatic mode using optimized parameters calcd. from the input data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzj5SzYvyu_7Vg90H21EOLACvtfcHk0lhQ8EED2F2dOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktw%253D%253D&md5=820d114719aca209994ffb0403e3b20d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042589%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DTeplyakov%26aufirst%3DA.%26atitle%3DMolecular%2520replacement%2520with%2520MOLREP%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D22%26epage%3D5%26doi%3D10.1107%2FS0907444909042589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-32&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhQ8EED2F2dOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D32%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-55&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lhQ8EED2F2dOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D55%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustyakimov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urzhumtsev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span> </span><span class="NLM_article-title">Towards automated crystallographic structure refinement with phenix.refine</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1107/S0907444912001308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444912001308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=22505256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=352-67&author=P.+V.+Afonineauthor=R.+W.+Grosse-Kunstleveauthor=N.+Echolsauthor=J.+J.+Headdauthor=N.+W.+Moriartyauthor=M.+Mustyakimovauthor=T.+C.+Terwilligerauthor=A.+Urzhumtsevauthor=P.+H.+Zwartauthor=P.+D.+Adams&title=Towards+automated+crystallographic+structure+refinement+with+phenix.refine&doi=10.1107%2FS0907444912001308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Towards automated crystallographic structure refinement with phenix.refine</span></div><div class="casAuthors">Afonine, Pavel V.; Grosse-Kunstleve, Ralf W.; Echols, Nathaniel; Headd, Jeffrey J.; Moriarty, Nigel W.; Mustyakimov, Marat; Terwilliger, Thomas C.; Urzhumtsev, Alexandre; Zwart, Peter H.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">352-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phenix.refine is a program within the PHENIX package that supports crystallog. structure refinement against exptl. data with a wide range of upper resoln. limits using a large repertoire of model parameterizations.  It has several automation features and is also highly flexible.  Several hundred parameters enable extensive customizations for complex use cases.  Multiple user-defined refinement strategies can be applied to specific parts of the model in a single refinement run.  An intuitive graphical user interface is available to guide novice users and to assist advanced users in managing refinement projects.  X-ray or neutron diffraction data can be used sep. or jointly in refinement. phenix.refine is tightly integrated into the PHENIX suite, where it serves as a crit. component in automated model building, final structure refinement, structure validation and deposition to the wwPDB.  This paper presents an overview of the major phenix.refine features, with extensive literature refs. for readers interested in more detailed discussions of the methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnhn9QwIEkTbVg90H21EOLACvtfcHk0lg--QkIQ1rSUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D&md5=1cc7da2cea396f1a75646ea709140cf1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001308%26sid%3Dliteratum%253Aachs%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DMustyakimov%26aufirst%3DM.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DUrzhumtsev%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DTowards%2520automated%2520crystallographic%2520structure%2520refinement%2520with%2520phenix.refine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D352%26epage%3D67%26doi%3D10.1107%2FS0907444912001308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">McPhillips, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhillips, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phizackerley, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltis, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span> </span><span class="NLM_article-title">Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines</span> <span class="citation_source-journal">J. Synchrotron Radiat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1107/S0909049502015170</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0909049502015170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=12409628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=401-6&author=T.+M.+McPhillipsauthor=S.+E.+McPhillipsauthor=H.+J.+Chiuauthor=A.+E.+Cohenauthor=A.+M.+Deaconauthor=P.+J.+Ellisauthor=E.+Garmanauthor=A.+Gonzalezauthor=N.+K.+Sauterauthor=R.+P.+Phizackerleyauthor=S.+M.+Soltisauthor=P.+Kuhn&title=Blu-Ice+and+the+Distributed+Control+System%3A+software+for+data+acquisition+and+instrument+control+at+macromolecular+crystallography+beamlines&doi=10.1107%2FS0909049502015170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines</span></div><div class="casAuthors">McPhillips, Timothy M.; McPhillips, Scott E.; Chiu, Hsiu Ju; Cohen, Aina E.; Deacon, Ashley M.; Ellis, Paul J.; Garman, Elspeth; Gonzalez, Ana; Sauter, Nicholas K.; Phizackerley, R. Paul; Soltis, S. Michael; Kuhn, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Synchrotron Radiation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-406</span>CODEN:
                <span class="NLM_cas:coden">JSYRES</span>;
        ISSN:<span class="NLM_cas:issn">0909-0495</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">The Blu-Ice and Distributed Control System (DCS) software packages were developed to provide unified control over the disparate hardware resources available at a macromol. crystallog. beamline.  Blu-Ice is a user interface that provides scientific experimenters and beamline support staff with intuitive graphical tools for collecting diffraction data and configuring beamlines for expts.  Blu-Ice communicates with the hardware at a beamline via DCS, an instrument-control and data-acquisition package designed to integrate hardware resources in a highly heterogeneous networked computing environment.  Together, Blu-Ice and DCS provide a flexible platform for increasing the ease of use, the level of automation and the remote accessibility of beamlines.  Blu-Ice and DCS are currently installed on four Stanford Synchrotron Radiation Lab. crystallog. beamlines and are being implemented at sister light sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVsQUIFJPBLVg90H21EOLACvtfcHk0lg--QkIQ1rSUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotleluro%253D&md5=c77228bd50890463f3e43e981a2e238a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1107%2FS0909049502015170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0909049502015170%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhillips%26aufirst%3DT.%2BM.%26aulast%3DMcPhillips%26aufirst%3DS.%2BE.%26aulast%3DChiu%26aufirst%3DH.%2BJ.%26aulast%3DCohen%26aufirst%3DA.%2BE.%26aulast%3DDeacon%26aufirst%3DA.%2BM.%26aulast%3DEllis%26aufirst%3DP.%2BJ.%26aulast%3DGarman%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DPhizackerley%26aufirst%3DR.%2BP.%26aulast%3DSoltis%26aufirst%3DS.%2BM.%26aulast%3DKuhn%26aufirst%3DP.%26atitle%3DBlu-Ice%2520and%2520the%2520Distributed%2520Control%2520System%253A%2520software%2520for%2520data%2520acquisition%2520and%2520instrument%2520control%2520at%2520macromolecular%2520crystallography%2520beamlines%26jtitle%3DJ.%2520Synchrotron%2520Radiat.%26date%3D2002%26volume%3D9%26spage%3D401%26epage%3D6%26doi%3D10.1107%2FS0909049502015170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Winter, G.</span><span> </span><span class="NLM_article-title">xia2: an expert system for macromolecular crystallography data reduction</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span><span class="refDoi"> DOI: 10.1107/S0021889809045701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0021889809045701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFalsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2010&pages=186-190&author=G.+Winter&title=xia2%3A+an+expert+system+for+macromolecular+crystallography+data+reduction&doi=10.1107%2FS0021889809045701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">xia2: An expert system for macromolecular crystallography data reduction</span></div><div class="casAuthors">Winter, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">186-190, S186/1-S186/5</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An expert system for macromol. crystallog. data redn. is presented, which builds on existing software to automate the complete data redn. process from images to merged structure factor amplitudes.  This can automatically identify multi-wedge, multi-pass and multiwavelength data sets and includes explicit procedures to test for crystallog. special cases.  With the push towards high-throughput crystallog. at synchrotron beamlines and automation of structure soln., the ability to reduce data with no user input fills an important gap in the pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOi3u0ydXbSrVg90H21EOLACvtfcHk0lg--QkIQ1rSUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFalsrk%253D&md5=27771caa813f3e828abdf2a331ae55e3</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1107%2FS0021889809045701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889809045701%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%26atitle%3Dxia2%253A%2520an%2520expert%2520system%2520for%2520macromolecular%2520crystallography%2520data%2520reduction%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2010%26volume%3D43%26spage%3D186%26epage%3D190%26doi%3D10.1107%2FS0021889809045701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lg--QkIQ1rSUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span> </span><span class="NLM_article-title">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span><span class="refDoi"> DOI: 10.1107/S0907444909029436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444909029436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=19770504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=1074-80&author=N.+W.+Moriartyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adams&title=electronic+Ligand+Builder+and+Optimization+Workbench+%28eLBOW%29%3A+a+tool+for+ligand+coordinate+and+restraint+generation&doi=10.1107%2FS0907444909029436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span></div><div class="casAuthors">Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The electronic Ligand Builder and Optimization Workbench (eLBOW) is a program module of the PHENIX suite of computational crystallog. software.  It is designed to be a flexible procedure that uses simple and fast quantum-chem. techniques to provide chem. accurate information for novel and known ligands alike.  A variety of input formats and options allow the attainment of a no. of diverse goals including geometry optimization and generation of restraints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnN4AVY_DwrVg90H21EOLACvtfcHk0lhuJTRRm0bR4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN&md5=3f9a9c6c31c9a4b014a9f151fb6aa8d9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1107%2FS0907444909029436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909029436%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3Delectronic%2520Ligand%2520Builder%2520and%2520Optimization%2520Workbench%2520%2528eLBOW%2529%253A%2520a%2520tool%2520for%2520ligand%2520coordinate%2520and%2520restraint%2520generation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D1074%26epage%3D80%26doi%3D10.1107%2FS0907444909029436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendall, W. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keedy, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">MolProbity: all-atom structure validation for macromolecular crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1107/S0907444909042073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=10.1107%2FS0907444909042073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=20057044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=12-21&author=V.+B.+Chenauthor=W.+B.+Arendallauthor=J.+J.+Headdauthor=D.+A.+Keedyauthor=R.+M.+Immorminoauthor=G.+J.+Kapralauthor=L.+W.+Murrayauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+structure+validation+for+macromolecular+crystallography&doi=10.1107%2FS0907444909042073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom structure validation for macromolecular crystallography</span></div><div class="casAuthors">Chen, Vincent B.; Arendall, W. Bryan, III; Headd, Jeffrey J.; Keedy, Daniel A.; Immormino, Robert M.; Kapral, Gary J.; Murray, Laura W.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MolProbity is a structure-validation web service that provides broad-spectrum solidly based evaluation of model quality at both the global and local levels for both proteins and nucleic acids.  It relies heavily on the power and sensitivity provided by optimized hydrogen placement and all-atom contact anal., complemented by updated versions of covalent-geometry and torsion-angle criteria.  Some of the local corrections can be performed automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms that help guide manual rebuilding.  X-ray crystallog. provides a wealth of biol. important mol. data in the form of at. three-dimensional structures of proteins, nucleic acids and increasingly large complexes in multiple forms and states.  Advances in automation, in everything from crystn. to data collection to phasing to model building to refinement, have made solving a structure using crystallog. easier than ever.  However, despite these improvements, local errors that can affect biol. interpretation are widespread at low resoln. and even high-resoln. structures nearly all contain at least a few local errors such as Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers.  It is crit. both for the crystallographer and for the end user that there are easy and reliable methods to diagnose and correct these sorts of errors in structures.  MolProbity is the authors' contribution to helping solve this problem and this article reviews its general capabilities, reports on recent enhancements and usage, and presents evidence that the resulting improvements are now beneficially affecting the global database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjgsh59dO-7Vg90H21EOLACvtfcHk0lhuJTRRm0bR4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D&md5=b5fc7574f43f01dd6e43c3663ca4f779</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042073%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DKeedy%26aufirst%3DD.%2BA.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520structure%2520validation%2520for%2520macromolecular%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D12%26epage%3D21%26doi%3D10.1107%2FS0907444909042073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QMS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QMS','PDB','2QMS'); return false;">PDB: 2QMS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ','PDB','4WWQ'); return false;">PDB: 4WWQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PQZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PQZ','PDB','3PQZ'); return false;">PDB: 3PQZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6S" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6S','PDB','4X6S'); return false;">PDB: 4X6S</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i23"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00609">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_20636"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00609">10.1021/acs.jmedchem.5b00609</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Validation of compounds prepared for this study are provided, as are SPR sensorgrams used for <i>K</i><sub>D</sub> determination. <b>I</b>. Supporting Information and Methods. <b>II</b>. <sup>1</sup>H and <sup>13</sup>C NMR spectra of Fmoc-cmF(OMe)-OH <b>4</b>. <b>III</b>. MS for Fmoc-cmF(OMe)-OH <b>4</b>. <b>IV</b>. LC chromatogram for peptide <b>2</b>. <b>V</b>. MS for peptide <b>2</b>. <b>VI</b>. LC chromatogram for peptide <b>3</b>. <b>VII</b>. MS for peptide <b>3</b>. <b>VIII</b>. SPR sensorgrams for peptides <b>1</b>, <b>2</b>, and <b>3</b> binding to the SH2 domains of Grb2, Grb7, and Grb10. <b>IX</b>. SPR sensorgrams and equilibrium binding curves for peptides <b>1</b>, <b>2</b>, and <b>3</b> binding to full-length Grb7 and Grb7-SH2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00609/suppl_file/jm5b00609_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00609/suppl_file/jm5b00609_si_001.pdf">jm5b00609_si_001.pdf (2.4 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited in the PDB with accession numbers <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WWQ">4WWQ</a> for apo-Grb7-SH2 and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X6S">4X6S</a> for Grb7-SH2:<b>2</b> complex.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00609&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00609%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-19%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00609" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6798ff4c0a6f2440","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
